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A b st r a c t
Diseases which result in chronic dysfunction of the gastrointestinal tract (GIT) in the horse are an important 
category of diseases because they are usually severely debilitating and in many cases fatal. However, reaching a 
definitive diagnosis in such cases is often difficult precluding a rational approach to treatment/management.
A retrospective clinical study of 29 confirmed cases of chronic gastrointestinal disease in the adult horse was 
undertaken to investigate the relative prevalence of different disorders and their associated historical, clinical 
and clinicopathological features; chronic inflammatory bowel disease (CIBD) (11 cases), cyathostomosis (9 
cases) and alimentary lymphosarcoma (7 cases) were the most common diagnoses. Eight cases of 
cyathostomosis were diagnosed on the basis of faecal examinations and the clinical features characteristic of this 
diagnosis included young adult animals presenting in winter/spring because of sudden onset diarrhoea and rapid 
weight loss with pyrexia, neutrophilia and hypoalbuminaemia. Both CIBD and alimentary lymphosarcoma 
were diagnosed in older animals and a definitive ante mortem diagnosis was achieved in 2 cases of alimentary 
lymphosarcoma by histopathological examination of rectal biopsy tissue: An ante mortem diagnosis was not 
reached in 19 (65.5 %) of the 29 cases. Against this background, a variety of studies were performed to evaluate 
the ability of different techniques to provide objective information on certain aspects of gastrointestinal function, 
which may, in turn, improve objective assessment of cases of chronic gastrointestinal disease.
An assay for measurement of fructosamine (glycated serum protein) in equine plasma was validated and a 
reference range for plasma fructosamine concentration in housed British-native breed ponies was calculated to 
be 203-310 pmol/L. Plasma fructosamine concentrations decreased in ponies following experimental infection 
with cyathostome larvae and this was assumed to be due to enteric protein loss and/or altered protein 
composition and/or increased protein turnover. There was evidence to suggest that fructosamine measurement 
may be more sensitive than albumin measurement, as an indicator of altered protein metabolism.
In experimental studies, it was shown that both age and diet have a significant effect (p<0.05) on plasma 
glucose concentration measured during an oral glucose tolerance test (OGTT). Retrospective analysis of OGTTs 
performed on clinical cases demonstrated that the conventional OGTT protocol offers no advantage over a 
‘modified’ test protocol based on a single sample taken at 120 minutes following oral glucose administration. 
When employing the modified protocol, total malabsorption, defined as failure of plasma glucose concentration 
to increase above 120 % of the basal glucose concentration, had a sensitivity of 64 % and a specificity of 90 % 
for the detection/exclusion of small intestinal (SI) pathology.
Several studies were performed in order to investigate the diagnostic/research potential of breath hydrogen 
(H2) measurement for assessment of gastrointestinal function in ponies. The initial study indicated that fasting 
resulted in negligible levels of H2 excretion and significant concentrations of H2 were excreted in breath of all 
ponies following either the ingestion of oats or the administration of wheat flour by stomach tube. However, H2 
was excreted in the breath of three ponies following oral glucose administration which suggests that incomplete 
glucose absorption may be a normal phenomenon in some healthy ponies. Consequently, this technique is likely 
to be of limited benefit for the detection of glucose malabsorption in clinical cases. By contrast, H2 was 
infrequently excreted in breath following the administration of the non-absorbable carbohydrate, lactulose, the 
reasons for which are unclear. However, it was confirmed that lactulose is not absorbed from the equine SI and 
that repeat exposure of intestinal bacteria to this sugar does not enhance hydrogen production/excretion.
The results of another study demonstrated that maintenance diet has a significant effect (p<0.05) on breath 
H2 excretion following the administration of a test meal, and, by inference, gastrointestinal function. Total H2 
excreted in breath was greater when ponies were maintained on a hay diet compared to when maintained on a 
high fibre pelleted ration, which presumably reflected an effect of maintenance diet on small intestinal 
digestive/absorptive capacity and/or conditions in the large intestine which facilitates H2 production/excretion. 
In addition, analysis of the patterns of breath H2 excretion indicated more rapid presentation of the unabsorbed 
component of the test meal to intestinal bacteria when on the pelleted ration which may reflect an effect of diet 
on gastrointestinal transit.
In a separate study, measurement of breath H2 concentration after the ingestion of a high fibre pelleted meal 
was used to evaluate the effects of cisapride and codeine phosphate on intestinal function in three healthy 
ponies. Compared to control data, the patterns of hydrogen excretion following premedication with cisapride 
were interpreted as providing evidence of reduced mouth-to-caecum transit time (MCTT), whereas the results of 
tests where animals were premedicated with codeine phosphate were indicative of delayed presentation of 
substrate to large intestinal bacteria (i.e. interpreted as evidence of prolonged gastric/small intestinal transit).
In conclusion, the results presented in this thesis highlight historical, clinical and clinicopathological 
features which may help differentiate between a variety of chronic GIT diseases in the adult horse. In such 
cases, identification of total glucose malabsorption, by means of the modified OGTT, is suggestive of severe 
small intestinal pathology and can be considered an indicator of poor prognosis. In addition, this work provides 
evidence which indicates that the use of plasma fructosamine measurement, as a means of monitoring protein 
metabolism, may prove to be a useful parameter for the assessment and/or clinical monitoring of equine chronic 
enteropathies. Although the findings of these studies indicate that the technique of breath H2 testing is likely to 
be of limited benefit for the investigation of individual clinical cases with GIT dysfunction, there is sufficient 
evidence to suggest that it may be a useful, non-invasive means of assessing MCTT in groups of equine animals.
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1C h a p t e r  1
Ch r o n ic  G a st r o in t e st in a l  D ise a se  in  t h e  Ad u l t  H o r se
1.1 Introduction
Diseases which result in chronic dysfunction of the gastrointestinal tract are an important 
category of conditions because they are usually severely debilitating and in many cases fatal. 
Causes of chronic gastrointestinal dysfunction are numerous and diverse in nature: most are 
associated with pathological/physiological changes in the gastrointestinal tract itself, but 
diseases of other body systems may result in secondary gastrointestinal disturbances. The 
principle pathophysiological mechanisms by which gastrointestinal function is influenced 
include one or a combination of the following: disruption of normal mucosal/submucosal 
architecture leading to reduced absorptive capacity and/or enteric protein loss; altered 
gastrointestinal motility and/or physical obstruction of the gastrointestinal lumen; increased 
intestinal secretion and disruption to the normal balance of intestinal microflora. None of 
these mechanisms are specific for a single disease process, and consequently, there is a 
paucity of specific diagnostic tests for the investigation of these disorders. This, coupled 
with the inaccessible nature of the gastrointestinal tract, makes the investigation of chronic 
equine gastrointestinal disease a difficult, time-consuming task which is often both 
expensive and unrewarding. The diagnostic challenge posed by equine chronic 
gastrointestinal disease was evident in a recent review by Love, Mair & Hillyer (1992); of 
51 adult equine animals which presented with chronic diarrhoea, a diagnosis was reached in 
37 animals, of which only 15 were diagnosed ante mortem.
The purpose of this chapter is to review the possible causes of chronic gastrointestinal 
disease in the adult horse and the techniques which may be used in their investigation.
1.2 Aetiology
1.2.1 Intestinal parasitism
Cyathostomes, or small strongyles, are a group of equine nematode parasites which belong 
to the family strongylidae and include over 40 species (Lichtenfels, 1975). These parasites 
are found in the large intestine of virtually all grazing equidae. Under normal 
circumstances, the larval stages of cyathostomes undergo a local migration in the large 
intestinal wall, and commonly become arrested in their development in the caecal/colonic 
mucosa. At present, it is recognised that cyathostome infection is the most common cause 
of chronic diarrhoea in adult horses in the UK (Mair, de Westerlaken, Cripps & Love, 1990;
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Love, Mair & Hillyer, 1992) and recent studies suggest that cyathostomes are an important 
cause of equine colic (Uhlinger, 1990). Clinical disease has been associated with the 
emergence of large numbers of previously inhibited fourth stage cyathostome larvae, en 
masse, from the wall of the large intestine resulting in physical disruption of the mucosal 
and submucosal architecture, and consequently typhlitis and/or colitis (Giles, Urquhart & 
Longstaffe, 1985). Other pathogenic mechanisms by which cyathostome infections produce 
intestinal dysfunction remain unclear. However, experimental studies have shown that 
infective larvae can alter both intestinal motility (Bueno, Ruckebusch & Dorchies, 1979) 
and mucosal permeability (Love, Escala, Duncan & MacLean, 1991). Additional 
mechanisms which may contribute to the occurrence of cyathostome-associated colic 
include intestinal mucosal oedema and/or vasoconstriction induced by local production of 
vasoactive substances in response to the presence of cyathostome mucosal stages (Mair & 
Pearson, 1995).
For many years, Strongylus vulgaris was considered to be the internal parasite of major 
concern in equine animals (Drudge, 1979) and was frequently associated with severe 
gastrointestinal dysfunction in adult horses (Greatorex, 1975; Merritt, Bolton & Cimprich, 
1975). However, regular administration of broad-spectrum anthelmintics has been 
associated with a reduction in the prevalence of large strongyles in recent years (Herd, 
1990), and these parasites and their associated lesions are now uncommonly encountered in 
necropsied horses (Lyons, Drudge, Swerczek, Crowe & Tolliver, 1981; Reinemeyer, Smith, 
Gabel & Herd, 1984). Similarly, recent studies have demonstrated that cyathostomes, 
rather than large strongyles, account for the majority of infective parasite larvae on pasture 
(Herd, 1986; Uhlinger, 1990). The principle pathological effect of S. vulgaris, arteritis and 
thrombosis of the cranial mesenteric artery, is caused by the extra-intestinal migration of the 
developing larval stages (Duncan & Pirie, 1975). Thromboembolism from such lesions was 
often associated with the occurrence of non-strangulating intestinal infarction. However, 
White (1981) reported that pathological evidence to support this theory was uncommon and 
proposed that the development of non-strangulating intestinal infarction was a consequence 
of non-occlusive restriction of blood flow to affected intestine, caused by an immune 
response initiated by parasitic antigens. Later, White (1985) proposed that interference 
with the blood supply to the gastrointestinal tract may result following the release of 
vasoactive substances from leucocytes or platelets. Reduced mucosal blood flow secondary 
to parasitic damage of the arterial blood supply has been suggested as a possible cause of 
small intestinal malabsorption (Murray, 1989). Experimental studies have shown that
Chapter 1 3
altered gastrointestinal motility is also a feature of S. vulgaris infection (Sellars, Lowe, 
Drost, Rendano, Georgi & Roberts, 1982; Berry, Merritt, Burrows, Campbell & Drudge, 
1986; Lester, Bolton, Cambridge & Thurgate, 1989). Alterations in gastrointestinal motility 
patterns, following either large or small strongyle infection, are generally regarded as 
biphasic. The first phase occurs within the first few days post-infection and is associated 
with larval penetration of the mucosa, whereas the second phase is associated with the 
induction of mesenteric arteritis by S. vulgaris or the emergence of cyathostome larvae from 
the mucosa (Bueno, Ruckebusch & Dorchies, 1979; Sellars et al., 1982; Berry et al., 1986; 
Lester et a l , 1989). Dyson (1983) and Mair, Hillyer & Taylor (1990) suggested that 
alimentary tract lesions secondary to S. vulgar is-mduced cranial mesenteric arteritis may be 
a common cause of peritonitis in adult horses. In addition to the pathogenic effects of S. 
vulgaris larvae, adult stages may also cause intestinal pathology. When feeding, adult large 
strongyles remove plugs of mucosa or submucosa and thus damage small blood vessels 
resulting in incidental blood loss. Duncan & Dargie (1975) demonstrated an increase in 
albumin and red blood cell loss into the intestinal tract of animals which were infected with 
adult S. vulgaris.
Infection with Parascaris equorum is common in foals and yearlings, the incidence 
decreasing with age (Clayton, 1978) and it is an uncommon cause of intestinal dysfunction 
in the adult horse. The pathophysiological mechanisms by which P. equorum results in 
clinical disease are unclear. Histopathological lesions associated with ascaridiasis are rarely 
seen in the intestinal tract of affected animals. Clayton, Duncan & Dargie (1980) suggested 
that the decreased food intake which occurs in ascarid infections and consequent lowering 
of the protein intake of infected animals were important factors resulting in reduced weight 
gain. In addition, these authors provided experimental evidence to suggest that adult 
worms may take up dietary amino acids, thereby impairing amino acid utilisation by the 
host. Occasionally, these parasites have been associated with acute abdominal crises in 
heavily infected animals due to either intussusception, intestinal impaction or small intestinal 
rupture (Becht, 1984).
Necropsy surveys have demonstrated a high prevalence of tapeworm infection in 
horses, Anoplocephala perfoliata being the most common species encountered (Bain & 
Kelly, 1977; Lyons, Tolliver, Drudge, Swerczek & Crowe, 1983; Lyons, Tolliver, Drudge, 
Swerczek & Crowe, 1987). Occasionally, cestodiasis has been incriminated as a cause of 
acute intestinal dysfunction, particularly, as a possible factor in the development of intestinal 
intussusception and intestinal rupture (Barclay, Phillips & Foerner, 1982; Beroza, Williams,
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Marcus & Mille, 1986; Edwards, 1986) and more recently as a risk factor for both 
spasmodic colic and ileal impaction (C.J. Proudman, personal communication). In addition, 
Beroza et al. (1986) suggested that tapeworm infection may be a cause of chronic intestinal 
disease which is manifest clinically as unthriftiness, intermittent colic, or diarrhoea. The 
proposed mechanisms by which tapeworms are hypothesised to cause intestinal disease are 
numerous and unproven. The predilection site for attachment of A. perfoliata to the 
intestinal mucosa is in the region of the ileocaecal valve and the pathological changes 
associated with these infections include mucosal thickening, oedema, ulceration, 
eosinophilic infiltration and diphtheresis (Pearson, Davies, White & O’Brien, 1993; Nilsson, 
Ljungstrom, Hoglund, Lundquist & Uggla, 1995). In addition, Lyons, Drudge, Tolliver, 
Swerczek & Crowe (1984) described pathological evidence of ileal hypertrophy in a horse 
with a heavy tapeworm burden, although there was no known evidence of intestinal disease 
before euthanasia. Intussusceptions, which have been associated with A. perfoliata 
infestation, are thought to result from either a disruption to the normal pattern of intestinal 
motility or variations in muscle contractility due to oedema, ulceration and granulation 
tissue at the site of tapeworm attachment (French & Chapman, 1992). Severe ulceration of 
the intestinal mucosa may progress to intestinal rupture (Beroza, Barclay, Phillips, Foerner 
& Donawick, 1983).
Although rarely documented, other parasitic agents incriminated as possible causes of 
chronic gastrointestinal disease, in particular chronic diarrhoea, in the adult horse include 
Giardia spp. (Kirkpatrick & Shand, 1985), Eimeria spp. (Wheeldon & Greig, 1977) and 
Trichomonas infection (Bennett & Franco, 1969). Failure to produce gastrointestinal 
disease by experimental infection with either Eimeria leukarti (Laufenstein-Dufly, 1969) or 
Trichomonas spp. (Barker & Remmler, 1970) and the demonstration of these organisms in 
the faeces of healthy equine animals (Damron, 1976; Lyons, Drudge & Tolliver, 1988; Xiao 
& Herd, 1994) suggest that these parasites are of little pathogenic significance in horses.
1.2.2 Neoplasia
Although rare, squamous cell carcinoma of the stomach is considered to be the most 
common primary neoplasm of the equine gastrointestinal tract (Boulton, 1987). The 
tumour appears to originate from the oesophageal region of the stomach and metastatic 
spread to other organs within the abdomen, particularly the liver, is a common feature 
(Meagher, Wheat, Tennant & Osburn, 1974; Tennant, Keirn, White, Bentinck-Smith & 
King, 1982; Olsen, 1992). The aetiology of gastric squamous cell carcinoma in the horse is
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unknown. In cattle, a direct relationship has been noted between the density of bracken fern 
infestation of pasture, the incidence of viral papilloma of the intestinal tract and the 
prevalence of squamous cell carcinoma of the upper alimentary tract (Jarrett, 1980). In 
addition, oesophageal carcinoma in man has a higher incidence in certain geographical 
locations (Doll, 1969). Based on these facts it has been suggested that dietary and/or 
environmental factors may be important in the aetiology of gastric squamous cell carcinoma 
in the horse (Tennant et a l , 1982).
Lymphosarcoma is characterised by lymphatic tissue enlargement or invasion of non­
lymphatic tissue by cells of lymphoblastic character. In the horse, lymphosarcoma is the 
most common neoplastic condition affecting the haemopoetic system (Gupta, Keahey & 
Ellis, 1972) and is classified, according to origin, into four different forms; multicentric, 
alimentary, thoracic and cutaneous (van den Hoven & Fraken, 1983; Mair & Hillyer, 1991). 
Alimentary lymphosarcoma occurs with a greater frequency than the other forms and was 
reported to be the second most commonly diagnosed form of intestinal tract neoplasia 
(Boulton, 1987). In a review of 77 cases of equine lymphosarcoma seen by Mair & Hillyer 
(1991), 42 animals were affected by an intestinal form of lymphosarcoma which was further 
categorised as either diffuse intestinal (n=15) or focal intestinal and/or mesenteric (n=27). 
In most cases, the small intestine and/or associated lymph nodes are infiltrated by neoplastic 
cells. Platt (1987) described, in detail, the pathology of alimentary lymphosarcoma in nine 
cases and reported that the wall of the large intestine was rarely infiltrated. Other authors 
have described individual cases where both small and large intestine were affected 
(Wiseman, Petrie & Murray, 1974; Roberts & Pinsent, 1975). The role of viruses in the 
aetiology of feline lymphosarcoma (Jarrett, Crawford, Martin & Davie, 1964) and enzootic 
bovine leukosis (Ferrer, 1980) are well recognised. However, although virus-like particles 
have been detected in a foal with lymphosarcoma (Tomlinson, Doster & Wright, 1979), the 
cause of this condition remains obscure. Interestingly, human patients with malabsorption 
due to coeliac disease are predisposed to lymphoreticular neoplasia of the gut (Spencer, 
MacDonald, Diss, Walker-Smith, Ciclitira & Isaacson, 1989).
Other tumours of the gastrointestinal tract which have been documented include 
adenocarcinoma (Wright & Edwards, 1984; Honnas, Snyder, Olander & Wheat, 1987; 
Fulton, Brown & Yamini, 1990), leiomyoma (Hanes & Robertson, 1983; Livesey, Hulland 
& Yovich, 1986) and myxosarcoma (Edens, Taylor, Murray, Spurlock & Anver, 1992).
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1.2.3 Chronic inflammatory bowel disease
The term chronic inflammatory bowel disease (CIBD) is used to describe chronic conditions 
of the intestine which are characterised by severe focal or diffuse inflammatory cell 
infiltrates into the lamina propria, submucosa or entire wall of either a region or throughout 
the whole intestine (Roberts, 1984). The infiltrate may be composed of predominantly one 
or a mixture of cell types, which may include eosinophils, plasma cells, lymphocytes, 
macrophages, occasional multinucleate giant cells, neutrophils and epitheliod cells. These 
conditions are characterised histologically to give classifications such as granulomatous 
enteritis (GE), eosinophilic gastroenteritis (EGE), chronic eosinophilic granulomatous 
enteritis and lymphocytic-plasmacytic enteritis. Frequently the inflammatory infiltrate 
spreads to regional lymph nodes and/or associated organs e.g. stomach, liver and pancreas 
(Breider, Kiely & Edwards, 1985; Lindberg, Persson, Jones, Thoren-Tolling & Ederoth, 
1985; Platt, 1986). Transmural extension of the disease process may give rise to a focal 
peritonitis (Dyson, 1983; Lindberg, 1984). Occasionally, as seen in some cases of EGE, 
distant structures such as the skin may be infiltrated with inflammatory cells (Pass & Bolton, 
1982; Lindberg et a l , 1985). In addition the condition described as multisystemic 
eosinophilic epitheliotrophic disease may have gastrointestinal involvement (Hillyer & Mair, 
1992).
The aetiopathogenesis of equine chronic inflammatory bowel disease is unknown. 
Equine GE has been compared to regional enteritis (Crohn’s Disease) in humans (Merritt, 
Cimprich & Beech, 1976). A familial prevalence for regional enteritis is recognised in man 
(Kirsner, 1984) and although little evidence exists to suggest that this is the case in horses, 
Sweeney, Sweeney, Saik & Lichtensteiger (1986) described GE in three siblings and 
Lindberg et al. (1985) confirmed either GE or EGE in five pairs of siblings in a series of 36 
cases. Solid evidence implicating an infectious agent as a cause of regional enteritis is 
lacking and it is generally accepted that the condition is associated with a basic defect in the 
patients immune response (Lindberg, 1984). Lindberg (1984) proposed that the lesions of 
equine GE may represent an abnormal host response to gut flora. However, parasitism 
(Breider, Kiely & Edwards, 1985; Platt, 1986; Cohen, Loy, Lay, Craig & McMullan, 1992) 
and mycobacterial infections (Merritt, Merkal, Skye & Selway, 1975; Merritt, Cimprich & 
Beech, 1976; Platt, 1986; Buergelt, Green, Mayhew, Wilson & Merritt, 1988; Cline, 
Schlafer, Callihan, Vanderwall & Drazek, 1991) have also been implicated in the 
pathogenesis of these lesions. In addition, small intestinal granulomatous lesions have 
developed in young horses experimentally infected with either Mycobacterium johnei
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(Larsen, Moon & Merkal, 1972) or Rhodococcus equi (Johnson, Prescott & Markham,
1983) and granulomatous colitis has been described in horses with naturally occurring 
Histoplasma capsulatum infection (Dade, Lickfeldt & McAllister, 1973; Goetz & Coffman,
1984).
Secondary features of infiltrative conditions (either inflammatory or neoplastic) of the 
bowel include villous atrophy, mucosal oedema, mucosal ulceration, crypt abscessation, 
peri-lymphatic and transmural inflammation and lymphangiectasia (Lindberg, 1984). 
Interestingly, lymphangiectasia has been reported as a cause of chronic diarrhoea in an aged 
horse in the absence of an identifiable predisposing lesion (Milne, Woodman, Rowland, 
Patrick & Arthur, 1994). Similarly, weight loss and carbohydrate malabsorption due to 
idiopathic villous atrophy and idiopathic mucosal oedema has been described (Bolton, 
Merritt, Cimprich, Ramberg & Streett, 1976).
1.2.4 Gastric ulceration
Although information is sparse with regard to the prevalence of gastric ulceration in 
populations of adult horses, Hammond, Mason & Watkins (1986) reported the presence of 
gastric ulcers in 128 of 195 horses (65.6 %) necropsied over a two year period. Sixteen 
(8.2 %) of these animals were described as having severe gastric lesions, although no 
suggestion was made that any of these animals were suffering from clinical signs related to 
the lesions. Murray (1992a) demonstrated a causal association between gastric ulceration 
and signs of abdominal pain in horses: Gastric ulceration was present in 91 of 111 horses 
investigated because of abdominal discomfort of variable duration and severity, and was 
determined to be the primary cause of colic in 31 animals based on failure to identify other 
abnormalities, clinical response to treatment with histamine type-2 receptor antagonists, and 
confirmation of improvement or resolution of gastric ulceration via endoscopy. Gastric 
ulceration was the suspected cause of colic in 26 additional horses based on lack of other 
identifiable abnormalities and clinical response to treatment with histamine type-2 receptor 
antagonists (Murray, 1992a). The aetiopathogenesis of equine gastroduodenal ulceration is 
still a topic of much debate. Furr & Murray (1989) reported 55 cases of spontaneous 
chronic gastroduodenal ulceration, but failed to identify any specific causative agents. 
However, ulceration of the gastrointestinal tract due to phenylbutazone toxicity has been 
described (Snow, Bogan, Douglas & Thompson, 1979), and it is also generally accepted 
that ‘stress’ may be an important factor in the aetiology of gastric ulcers in horses. In some 
reports it has been concluded that there is a greater prevalence and severity of gastric
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lesions in racehorses in-training when compared to retired or pleasure horses (Hammond, 
Mason & Watkins, 1986; Murray, Grodinsky, Anderson, Radue & Schmidt, 1989). In 
addition, Murray & Eichorn (1996) demonstrated that, compared with being at pasture, 
stable confinement alone appeared to be an important factor in the development of gastric 
ulcers in horses and that this was probably as a result of altered feeding behaviour. 
Although an infectious agent (Helicobacter pylori) has been identified as a cause of gastric 
ulceration in man, to date no similar type pathogens have been reported to cause gastric 
ulceration in adult horses (Murray, 1992b). Irrespective of the specific cause, ulceration is 
likely to develop because of disruption of the gastric mucosal barrier that protects the 
gastric mucosa from the potentially harmful effects of gastric acid and pepsin. Disruption of 
the gastric mucosal barrier allows the diffusion of hydrogen ions and pepsin into the mucosa 
resulting in auto-digestion and ulcer formation (Murray, 1992b). Although pyloric 
obstruction and gastric retention is an uncommon sequel to gastric ulceration in equine 
animals it has been reported in mature horses on a number of occasions (Church, Baker & 
May, 1986; Laing & Hutchins, 1992; Murphy, Howie & Love, 1994). The primary 
pathology in each case was extensive ulceration of the gastric pyloric region resulting in 
dramatic fibrous tissue development within the pyloric wall and consequently a reduction in 
the pyloric lumen diameter. Pyloric outflow obstruction due to congenital pyloric stenosis 
has been described in a yearling (Munroe, 1984) and a single case of partial gastric 
obstruction (gastric stenosis), which was assumed to occur secondary to chronic gastric 
irritation (Peterson, Donawick, Merritt, Raker, Reid & Rooney, 1972).
1.2.5 Gastric impaction
Primary gastric impaction, defined as a chronic abnormal accumulation of dry, non-swelling, 
poorly fermentable material, may occur due to a variety of reasons in the horse which 
include ingestion of dry fibrous grass, irregular watering, irregular feeding, poor 
mastication, defective gastric secretion, idiopathic gastric atony and pyloric stenosis (Owen, 
Jagger & Jagger, 1987).
1.2.6 Non-steroidal anti-inflammatory drug toxicity
The pathogenic potential of non-steroidal anti-inflammatory drugs (NSAID), particularly 
phenylbutazone, has been demonstrated both experimentally (Snow et al., 1979; Snow, 
Douglas, Thompson, Parkins & Holmes, 1981; Lees, Creed, Gerring, Gould, Humphreys, 
Maitho, Michell & Taylor, 1983; Collins & Tyler, 1985) and in clinical reports (Roberts,
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1981; Behm & Berg, 1987). The mechanism of mucosal damage is not well defined but 
appears to be associated with a loss of prostaglandin cytoprotective effects which results in 
microvascular injury (Meschter, Gilbert, Krook, Maylin & Corradino, 1990). A variety of 
pathological effects may occur as a consequence of NSAID toxicity and include oral, gastric 
and duodenal ulceration, colonic necrosis, renal crest necrosis, hepatotoxicity and vasculitis 
(Snow et a l , 1979, 1981; Gunson & Soma, 1983; Collins & Tyler, 1985; Meschter et a l, 
1990). A discrete syndrome of right dorsal colitis has been described in adult horses, which 
in most cases was attributed to the administration of NSAIDs to dehydrated animals 
(Karcher, Dill, Anderson & King, 1990; Cohen, Mealey, Chaffin & Carter, 1995). These 
authors proposed that the right dorsal colon is the only segment of the large intestine with a 
net water flux in a secretory direction suggesting some intrinsic mucosal membrane 
differences which might explain the localised nature of the colitis.
1.2.7 Sand enteropathy
Chronic gastrointestinal dysfunction associated with the accumulation of sand in the 
gastrointestinal tract of horses occurs occasionally in the UK (Love, Mair & Hillyer, 1992) 
but is well recognised in certain regions of the USA (Bertone, Traub-Dargatz, Wrigley, 
Bennett & Williams, 1988). The common sites of sand deposition in the intestinal tract are 
the right colons, pelvic flexure and transverse colon (Colahan, 1987) and the mechanisms by 
which this causes clinical disease include colonic irritation and/or physical obstruction of the 
intestinal lumen.
1.2.8 Ileal hypertrophy
Muscular hypertrophy of the ileum is recognised as an infrequent cause of partial intestinal 
obstruction in the horse (Chaffin, Fuenteabla, Schumacher, Welch & Edwards, 1992). 
Compensatory (secondary) intestine muscular hypertrophy occurs in response to chronic, 
caudal intestinal stenosis (e.g. impaction, intussusception, neoplasia, adhesions). Muscular 
hypertrophy which develops in the absence of such a lesion is referred to as idiopathic 
(primary) and it has been proposed that neurological abnormalities producing uncontrolled 
peristalsis or prolonged spastic contraction may be involved in the pathogenesis of 
idiopathic muscular hypertrophy of the small intestine (Robertson, 1990; 1991). 
Hypertrophied muscle reduces the diameter of the intestinal lumen creating a partial, or in 
rare cases a complete, obstruction and, consequently, gaseous distension and/or feed 
impaction may occur cranial to the lesion.
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1.2.9 Idiopathic enteropathy
Occasionally, gastrointestinal dysfunction occurs in the horse without any predisposing 
pathological lesion. Manahan (1970) described a chronic diarrhoea syndrome in horses 
which, in the majority of cases, was associated with stress and the administration of 
antibiotics. The diarrhoea, in these cases, was considered to be caused by a disruption to 
the normal balance of caecal/colonic flora. Argenzio, Southworth & Lowe (1977) reported 
that volatile fatty acids (VFA), by-products of colonic fermentation, contributed to the 
control of water fluxes across the large intestinal mucosa. Analysis of VFA concentrations 
in the faeces of horses with chronic idiopathic diarrhoea indicated that fermentation 
disorders do exist in many of these cases and may contribute to the increased intra-luminal 
water load (Merritt & Smith, 1980; Minder, Merritt & Chalupa, 1980). However, it has not 
been determined whether the altered fermentative activity was the cause or effect of 
increased water in the faeces. Other possible mechanisms which contribute to the intra­
luminal retention of water in cases of idiopathic chronic diarrhoea remain to be elucidated.
1.3 Differential Diagnosis
Only in rare cases of chronic gastrointestinal tract disease will the clinical features be 
suggestive of a specific aetiological diagnosis. Indeed, horses may present without 
manifesting overt signs of gastrointestinal dysfunction. Furthermore, clinical signs of 
gastrointestinal dysfunction (i.e. diarrhoea and/or colic) may be features of a variety of 
conditions which are not primary gastrointestinal diseases and exclusion of these disorders 
is often necessary before the clinician can focus attention to the investigation of a primary 
gastrointestinal disorder.
1.3.1 Equine dysautonomias
Grass sickness is a disease of unknown aetiology associated with dysfunction of the 
autonomic nervous system, the principle manifestation of which is reduced gastrointestinal 
motility. The disease occurs in three overlapping forms acute, subacute and chronic: acute 
and subacute cases invariably die within days of presentation but, chronic cases may live for 
weeks/months and a proportion may survive the disease (Milne, Woodman & Doxey, 
1994). Obel (1955) observed characteristic histopathological lesions in the paravertebral 
and prevertebral ganglia of grass sickness cases which included chromatolytic ganglion 
cells, pyknotic nuclei and vacuolation of cytoplasm. Similar histopathological changes have 
been observed in central brain stem nuclei (Barlow, 1969) and the plexuses of the enteric
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nervous system (Pogson, Doxey, Gilmour, Milne & Chisholm, 1992). The epidemiology of 
grass sickness, particularly the association with grazing, or change in pasture, suggests that 
the disease is caused by a toxin ingested with the herbage (Gilmour & Jolly, 1974; Wood, 
Doxey & Milne, 1994). In experimental studies, Gilmour (1973) and Gilmour & Mould 
(1977) reproduced the neurological lesions of grass sickness by injecting normal ponies with 
serum and plasma from acute grass sickness cases, confirming that a neurotoxin was present 
within the blood of affected animals. Griffiths, Smith, Doxey, Whitwell & Love (1994) 
reported that serum from cases of acute grass sickness, injected into the parotid salivary 
gland of healthy ponies, had a specific effect on the post-ganglionic neurone supplying the 
tissue and that there was retrograde axonal transport to the cell body. Although there have 
been recent reports of a grass sickness-like syndrome (‘mal seco’) in Argentina (Uzal, 
Robles & Olaechea, 1992), it is generally accepted that grass sickness does not occur 
outside Europe, its incidence being highest in the UK.
Other reports of equine enteric neuropathy are limited to congenital intestinal 
aganglionosis/hypoganglionosis in foals (Dyke, Laing & Hutchins, 1990) and a single case 
of chronic intestinal pseudo-obstruction due to small colon myenteric ganglionitis in a 4- 
year-old mare (Burns, Karcher & Cummings, 1990).
1.3.2 Hepatopathies
Occasionally, horses with chronic liver disease may present with clinical signs suggestive of 
gastrointestinal disease. In the horse, chronic liver failure may occur for a variety of 
reasons, but is most commonly associated with prolonged ingestion of hepatotoxic plants 
containing pyrrolizine alkaloids (e.g. senecio jacobea) (O’Brien, 1985; West, 1996; 
McGorum, Milne & Love, 1997). Chronic liver disease may occur in aged horses with no 
identifiable precipitating cause and can be considered to be ‘senile cirrhosis’. The 
pathophysiological mechanisms which result in gastrointestinal dysfunction in cases of 
chronic liver disease are complex and poorly understood. It is suggested that diarrhoea may 
occur consequent upon portal vein hypertension and intestinal oedema (Pearson, 1990). In 
addition, Milne, Pogson & Doxey (1990) reported three cases of secondary impaction 
associated with ragwort poisoning and proposed that altered gastrointestinal motility may 
be a result of the production of neurotoxic products in cases of chronic liver failure. It is 
possible, therefore, that altered intestinal motility may become apparent clinically as 
diarrhoea and/or colic. Similarly, Murray (1989) suggested that increased hydrostatic
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pressure within the colonic microvasculature secondary to congestive heart failure and 
associated hepatic fibrosis may result in colonic dysfunction manifest clinically as diarrhoea.
1.3.3 Hyperlipaemia
Chronic diarrhoea has been recorded as a clinical feature in cases of equine hyperlipaemia 
(Love, Mair & Hillyer, 1992; Watson, Murphy & Love, 1992). Hyperlipaemia is a disorder 
of lipid metabolism commonly observed in pony breeds where fatty acids are mobilised from 
adipose tissue in response to reduced food intake (caused by malnutrition, stress or 
underlying illness) or to meet the demands of pregnancy and lactation (Naylor, 1987). The 
fatty acids are subsequently deposited in body tissues, including liver, kidney and muscle, 
frequently resulting in organ failure. The pathophysiological mechanism which results in 
diarrhoea is unclear in many cases but may reflect either underlying illness (e.g. parasitism) 
or prolonged anorexia or liver dysfunction.
1.3.4 Peritonitis
In the horse, peritonitis is usually acute and diffuse (Semrad, 1990), but it has also been 
reported as a cause of chronic gastrointestinal dysfunction in this species (Dyson, 1983; 
Mair, Hillyer & Taylor, 1990). The mechanisms by which chronic peritonitis may affect 
gastrointestinal function include direct constriction of intestine resulting in decreased lumen 
diameter which can impair ingesta flow, intestine vascular compromise secondary to 
adhesion-induced mesenteric contraction and by placing tension on normally mobile bowel 
which can cause functional impairment of motility secondary to pain (Trent, 1995). 
Factors, apart from abdominal surgery, which predispose horses to the development of 
peritonitis remain undetermined in many cases. The most commonly identified source of 
infection of the abdominal cavity is the intestinal tract. Intestinal lesions which may be 
involved in the pathogenesis of peritonitis include intestinal perforations, foreign body 
penetration, inflammatory bowel disease (Dyson, 1983), and neoplasia. Mair, Hillyer & 
Taylor (1990) reported that intestinal lesions attributed to cranial mesenteric arteritis, 
induced by S. vulgaris larvae migration, were an important cause of peritonitis and it has 
also been suggested that peritonitis may occur secondary to larval migration of S. edentatus 
(Love, 1992). Other possible causes of peritonitis include uterine trauma/infection, 
complications following castration and septicaemia (Semrad, 1990). Abdominal 
abscessation involving lymph nodes and/or abdominal organs is a reported cause of weight 
loss and intermittent colic in the horse (Rumbaugh, Smith & Carlson, 1978). The most
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commonly isolated causal organisms are Streptococcus equi, Streptococcus zooepidemicus 
and Corynebacterium pseudotuberculosis, and affected animals will often have a history of 
upper respiratory tract infection/lymphadenitis (Rumbaugh, Smith & Carlson, 1978).
1.4 Investigation of Chronic Gastrointestinal Dysfunction
1.4.1 History
Although usually non-specific, historical information may, in certain cases of chronic 
gastrointestinal disease, suggest a particular diagnosis. Therefore, a detailed history is an 
important prerequisite to clinical examination and further investigation. The history should 
establish the duration of illness, rapidity of onset, numbers of animals affected, previous or 
intercurrent disorders, changes in feed and water intake and faecal consistency, 
dietary/grazing management, recent management changes, anthelmintic and health care 
programmes and recently administered medications.
Reid, Mair, Hillyer & Love (1995) reported that history alone may be useful in the 
differentiation of cyathostomosis from other causes of diarrhoea, with age, season and 
period since last receiving anthelmintics identified as important risk factors. Affected 
animals are usually young adults (i.e. less than 6 years old) and present in late winter or 
spring. Gibson (1953) and Smith (1976) suggested that the removal of adult worms from 
the intestinal lumen, either by natural ageing or anthelmintic treatments, stimulate inhibited 
stages to develop. This effect has been demonstrated in experimental studies (Smith, 1976) 
and may account for the apparent induction of naturally occurring clinical disease in some 
horses following prophylactic anthelmintic treatments (Mair, 1993; Reid et al., 1995). 
However, cases of cyathostomosis have been reported to occur at other times of the year 
and the condition has been described in aged ponies (Mair, 1993). In addition, the majority 
of disease conditions which result in chronic gastrointestinal tract dysfunction in the adult 
horse occur sporadically in individual animals, but it is known that cyathostome-related 
illnesses may present as an outbreak in a group of animals (Kelly & Fogarty, 1993; Mair,
1994). The long-term deworming history of individual clinical cases is of limited diagnostic 
value in suspected cases of cyathostomosis. Although regular prophylactic anthelmintic 
therapies have been associated with a reduction in the prevalence of S. vulgaris infection in 
the horse (Herd, 1990), substantial cyathostome burdens may be present as inhibited stages 
within the large intestinal mucosa of some horses despite the regular administration of 
anthelmintics. Love (1992) suggested that historical information concerning the parasite 
prophylaxis program used on the farm (including worming strategy, pasture hygiene and
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stocking density) is more appropriate since it may give some indication of the possible level 
of larval challenge.
An accurate knowledge of management factors and previous drug therapies may be of 
value for including/excluding other possible diagnoses in suspected cases of chronic 
gastrointestinal tract dysfunction. Horses at risk of developing sand enteropathy are those 
grazing paddocks of sandy soil with little or no grass cover (Byars, 1990). For these 
reasons, the condition is seldom detected in the UK (Love, Mair & Hillyer, 1992), but is 
well recognised in certain regions of the USA (Bertone et al., 1988; Byars, 1990) where the 
environmental/managemental conditions necessary for the ingestion of large amounts of 
sand, with feed, are present. Non-steroidal anti-inflammatory drug toxicity should be 
considered in animals which have a history of recent treatment with drugs of this class: 
Toxicity may occur when NSAIDs are administered at doses exceeding those 
recommended, when used in combination with other NSAIDs or when administered to 
dehydrated animals or to animals with liver dysfunction (Murray, 1990). Manahan (1970) 
described a chronic diarrhoea syndrome in adult horses which, in the majority of cases, was 
associated with stress and the administration of antibiotics. No underlying pathological 
process was identified and the diarrhoea in these animals was considered to have been 
caused by a disruption to the normal balance of caecal/colonic flora. Interestingly, Mair 
(1993) observed an apparent association between the onset of diarrhoea in some cases of 
cyathostomosis and recent management changes and suggested that stress-induced 
immunosuppression may precipitate clinical disease.
Lindberg et al. (1985) indicated that young Standardbreds may be predisposed to 
develop chronic inflammatory bowel diseases: Of 36 confirmed cases of either GE or EGE, 
all but one were standardbreds and 34 cases were in animals four years of age or younger. 
A similar breed and age incidence was reported by Merritt, Cimprich & Beech (1976) when 
describing nine cases of GE. However, these conditions have been described in older 
animals and in other breeds of horse (Pass & Bolton, 1982; Platt, 1986) and ponies (Howie,
1995). Conversely, neoplasms of the gastrointestinal tract generally affect older animals. 
Tennant et al. (1982) reviewed clinical information available from 21 reported cases of 
gastric squamous cell carcinoma with a mean age of 10.7 years (range 6-16 years). 
Similarly, the mean age of 42 cases of alimentary lymphosarcoma reported by Mair & 
Hillyer (1991) was 9-10 years. However, animals in that series ranged in age from 2 to 20 
years and Platt (1987) described the pathology of alimentary lymphosarcoma in nine horses 
with an age range of 2-6 years.
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1.4.2 Clinical examination
Case history and clinical presentation may enable the clinician to focus attention to the 
gastrointestinal tract. However, horses with gastropathies/enteropathies may not present 
with clinical signs directly attributable to gastrointestinal disease, and conversely, it is 
possible that diseases of other body systems affect normal gastrointestinal tract function 
(Love, Mair & Hillyer, 1992), such that further investigations are frequently required to 
confirm gastrointestinal involvement/exclude other possible diagnoses.
In horses with chronic gastrointestinal tract disease, the clinical features may include 
poor body condition and/or diarrhoea and/or peripheral oedema and/or colic and/or pyrexia, 
none of which are specific for a particular disease process. Poor body condition is often the 
predominant clinical feature in animals with a chronic pathological lesion(s) of the 
gastrointestinal tract and may be due to one or a number of factors such as inappetance, 
maldigestion, small and/or large intestinal malabsorption, enteric protein loss and cachexia. 
The occurrence of diarrhoea in the adult horse is indicative of colonic dysfunction due to 
pathological and/or physiological disturbances in that organ (Murray, 1989): Therefore, 
diarrhoea is usually absent in animals with lesions limited to the stomach or small intestine. 
Peripheral oedema, associated with decreased plasma oncotic pressure, is a relatively 
common feature of chronic gastropathies/enteropathies and may develop secondary to 
enteric protein loss. The pathophysiological mechanisms involved in the development of 
colic in animals with chronic gastrointestinal disease are numerous: It may occur due to 
intense intestinal inflammation, altered intestinal motility, physical obstruction of the 
gastrointestinal tract, non-strangulating intestinal infarction, and abnormal tension on 
serosal surfaces and/or mesentry. Pyrexia is a non-specific host response to infection, 
inflammation or neoplasia (Mair, Taylor & Pinsent, 1989) and is associated with the 
production of an endogenous pyrogen (monokine interleukin-1) which stimulates 
prostaglandin synthesis in the hypothalmic thermoregulatory centre (Haskins, 1995).
Occasionally, an animal may exhibit clinical features which are suggestive of a 
particular diagnosis. Although the majority of chronic gastrointestinal diseases have an 
insidious onset, the classical presentation in cases of cyathostomosis is sudden onset 
diarrhoea and rapid weight loss (Giles, Urquhart & Longstaffe, 1985). However, recent 
reports indicate that cyathostome-related disease is not limited to the classical presentation 
of acute larval cyathostomosis and that clinical manifestations may range from failure to 
thrive to life-threatening gastrointestinal disorders (Mair, 1993, 1994; Lyons, Swerczek,
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Tolliver, Drudge, Stamper, Granstorm & Holland, 1994; Mair & Pearson, 1995; Matthews 
& Morris, 1995).
Horses with chronic gastropathies may exhibit dysphagia and/or ptyalism (Tennant et 
a l , 1982; Olsen, 1992; Murphy, Howie & Love, 1994). In addition, in a proportion of 
these cases, behaviour at feeding time can be characterised by initial interest in food and 
ingestion of a small quantity before becoming disinterested and refusing to eat and/or 
exhibiting signs of abdominal discomfort (Tennant et a l , 1982). Oral/tongue ulceration, 
associated with mucosal ischemia, has been observed in experimental NSAID toxicity 
(Snow et a l , 1979; Gunson & Soma, 1983) and therefore may be a feature of inadvertent 
toxicity. In animals, where the history may indicate a possible diagnosis of sand 
enteropathy, auscultation of the ventral abdomen has been advocated as a useful diagnostic 
aid in that it may be possible to appreciate the sound of pouring sand in the colon of 
affected animals (Ragle & Meagher, 1987).
A number of conditions which primarily affect the gastrointestinal tract may progress to 
involve extraintestinal organs. Pass & Bolton (1982) and Lindberg et a l (1985) reported 
severe skin lesions, characterised by excessive scaling, patchy alopecia, lichenification and 
excoriations, and ulcerative coronitis in a proportion of cases with EGE. The aetiology of 
the skin lesions was unknown, but suggested to be immune-mediated with a common 
antigen responsible for both gastrointestinal and skin lesions (Pass & Bolton, 1982). 
Interestingly, the condition described as multi-systemic eosinophilic epitheliotrophic disease 
may have gastrointestinal involvement (Nimmo-Wilkie, Yager, Nation, Clark, Townsend & 
Baird, 1985; Sanford, 1989; Hillyer & Mair, 1992). Furthermore, Nimmo-Wilkie et al 
(1985) suggested that chronic eosinophilic dermatitis and chronic EGE are variants of a 
multi-systemic eosinophilic epitheliotrophic disease. Both ulcerative coronitis (Wilson, 
Sutton, Groenendyk & Seawright, 1985) and polysynovitis (Platt, 1987) have been reported 
in association with alimentary lymphosarcoma and, again, were assumed to be immune 
mediated. Occasionally, tumours of the gastrointestinal tract may metastasise to involve 
other organ systems and affected animals may present with clinical signs referable to 
secondary organ involvement. Wrigley, Gay, Lording & Haywood (1981) described a case 
of gastric squamous cell carcinoma where extensive metastases to the pleural cavity resulted 
in pleural effusion and signs of respiratory distress. Similarly, paraneoplastic syndromes 
have been documented in association with equine alimentary tract tumours and may result in 
secondary clinical features. Hypercalcaemia of malignancy (pseudohyperparathyroidism) is 
the most common paraneoplastic syndrome in horses (Turrel, 1995) and has been described
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in animals with gastric carcinoma (Meuten, Price, Seiler & Krook, 1978b; Miller, 1983) and 
alimentary lymphosarcoma (Mair, Yeo & Lucke, 1990). Extrapolating from human 
medicine, it has been proposed that, in animals, tumours produce parathyroid hormone- 
related protein, which results in increased osteoclastic bone resorption and renal resorption 
of calcium. Soft tissue mineralisation and calcium-induced nephropathy leading to renal 
failure, are complications of this syndrome (Marr, Love & Pirie, 1989; Mair, Yeo & Lucke, 
1990).
1.4.3 Rectal findings
Rectal examination is an important component of the initial investigation of any case 
suspected of having chronic gastrointestinal disease. Occasionally, in animals with 
gastrointestinal neoplasia and CIBD enlarged mesenteric lymph nodes and/or abnormal 
abdominal masses are palpable per rectum. Mair & Hillyer (1991) reported that, of 27 
horses with focal intestinal and/or mesenteric lymphosarcoma, abnormalities were palpated 
in 12 animals. Interestingly, many cases of gastric squamous cell carcinoma which have 
been described in the literature had abnormal findings on rectal examination: Of 21 cases 
reported up to 1982, 11 were examined rectally and, of these, eight had abnormal anterior 
abdominal masses and/or adhesions palpable per rectum (Tennant et al., 1982). Similarly, 
Olsen (1992) reported that abnormal masses were palpable in all of four cases of gastric 
squamous cell carcinoma examined by this means. Palpation of masses in the mesentery or 
associated with the gut wall was a common feature in one series of horses with GE (Merritt, 
Cimprich & Beech, 1976). This observation is supported by other single case reports of 
that condition (Hodgson & Allen, 1982; Roberts, 1983). It has been suggested that 
palpation of the cranial mesenteric artery per rectum may permit a diagnosis of S. vulgaris 
infection (Merritt, Bolton & Cimprich, 1975; Meuten, Butler, Thomson & Lumsden, 
1978a), but White (1981) demonstrated little correlation between impressions of the size of 
the cranial mesenteric artery acquired per rectum and the presence of cranial mesenteric 
arteritis.
Chaffin et al. (1992) suggested that muscular hypertrophy of the ileum should be a 
differential diagnosis when a thickened, rigid, tubular mass is palpated per rectum in the 
right dorsal quadrant of the abdomen: These authors reported that this feature was evident 
in two of their series of 10 cases of small intestinal muscular hypertrophy. Similarly, 
abnormal rectal findings were described in a case of small intestinal muscular hypertrophy 
reported by Schneider, Kennedy & Leipoid (1979).
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Although no abnormalities are palpated during rectal examination of cases of 
cyathostomosis, a frequent incidental finding is the presence of large numbers of 
cyathostome larvae on the rectal sleeve thereby effecting a diagnosis. Cyathostome larvae 
were grossly visible, following rectal examination, in five of the 15 cases of cyathostomosis 
described by Giles, Urquhart & Longstaffe (1985).
1.4.4 Haematological features
Haematological abnormalities in animals with chronic gastrointestinal tract disease are 
usually non-specific, the most frequent abnormalities being anaemia and/or neutrophilia. 
The commonest causes of anaemia in such cases are the normocytic, normochromic 
anaemia of chronic inflammatory disease and chronic blood loss secondary to ulcerative 
lesions of the gastrointestinal tract. Interestingly, immune-mediated haemolytic anaemia 
and thrombocytopaenia were features of two cases of alimentary lymphosarcoma reported 
by Reef, Dyson & Beech (1984). In addition, Mair & Hillyer (1991) confirmed immune- 
mediated haemolytic anaemia in two of 42 cases with alimentary lymphosarcoma. Although 
the mechanism by which these occur is unclear, factors which may be involved in their 
development include tumour antibody production, tumour stimulation of antibodies that 
cross react with red blood cells and multisystem immunological incompetence (Reef, Dyson 
& Beech, 1984). Leukaemia may be rarely encountered in cases of equine lymphosarcoma 
(Madewell, Carlson, MacLaughlin & Feldman, 1982).
Neutrophilia is a non-specific feature that is a common response to infection, 
inflammation or neoplasia in the horse (Mair, Taylor & Pinsent, 1989) and therefore may be 
detected in animals with any chronic pathological lesion of the gastrointestinal tract. 
Eosinophilia is popularly attributed to intestinal parasitism, in particular strongylosis. 
However, reports of both naturally occurring clinical cases (Giles, Urquhart & Longstaffe 
1985; Uhlinger, 1991; Love, Mair & Hillyer, 1992) and also experimental infections (Love 
et al., 1991) suggest that this is an inconsistent feature of strongyle-associated disease.
Hyperfibrinogenaemia is, again, non-specific and indicates infection, inflammation or 
neoplasia (Mair, Taylor & Pinsent, 1989). Allen & Kold (1988) indicated that plasma 
fibrinogen is a sensitive indicator of inflammation in the horse becoming elevated within 48 
hours of an inflammatory process and Jain (1986) suggested that this parameter is a better 
monitor of recovery than leucocyte count.
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1.4.5 Blood biochemical features
Apart from eliminating liver disease as a possible differential diagnosis, blood biochemical 
analysis provides little/no specific diagnostic information when investigating suspected cases 
of chronic gastro-/enteropathy, but it is often valuable in the overall assessment of these 
conditions. The most common biochemical abnormalities in animals with chronic 
gastrointestinal disease are non-specific and include hypoalbuminaemia, hypo- or 
hyperglobulinaemia and increased serum AP concentrations.
Hypoalbuminaemia and/or hypoproteinaemia is a common phenomenon which has been 
demonstrated in association with numerous chronic gastrointestinal disorders (Knox, Reid, 
Love, Murray & Gettinby, 1997) and is assumed to be a primary consequence of enteric 
protein loss. Enteric protein loss may be exacerbated by concurrent decreased absorption 
due to inappetance and/or small intestinal malabsorption. Abnormal loss of serum proteins 
into the gastrointestinal tract may occur secondary to either obstruction of the 
gastrointestinal lymphatics with loss of lymph into the intestinal lumen or exudation through 
an inflamed/ulcerated mucosa or a disorder of mucosal cell metabolism (Scrutchfield, 1975). 
In patients with protein-losing enteropathy all serum proteins are lost into the intestinal tract 
at the same rate. However, the amount of reduction in serum protein concentration is not 
the same for the different classes of proteins with the concentration of albumin and 
gammaglobulin, proteins with the longest half-life, usually the most severely depressed. In 
addition, increased total plasma globulin concentration, a non-specific indicator of chronic 
inflammation/immune stimulation (Coffmann, 1979), may accompany hypoalbuminaemia 
and maintain total protein concentrations within normal limits or, in certain cases, result in 
an increase in total protein concentrations.
Alkaline phosphatase has a wide tissue distribution, therefore increases in serum AP 
concentrations may occur in association with physiological/disease processes in a variety of 
organs. The development of analytical techniques for the quantification of tissue-specific 
AP isoenzymes has improved the diagnostic specificity of this variable such that, in human 
medicine, it is widely accepted as an indicator of bone disease, cholestatic liver disease, 
pregnancy complications and as a tumour marker (Moss, 1987). Increases in total serum 
AP is a common biochemical feature in horses with chronic gastrointestinal disease 
(Lindberg et al., 1985; Love, Mair & Hillyer, 1992). In addition, Blackmore & Palmer 
(1977) reported that, in horses with intestinal parasitism and/or diarrhoea, increases in total 
serum AP were due to an increase in the intestinal isoenzyme which was differentiated from 
other isoenzymes by L-phenylalanine inhibition. However, subsequent studies, using
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different biochemical methods, failed to support the findings of Blackmore & Palmer (1977) 
and there is a general consensus that normal horse sera does not contain significant levels of 
intestinal derived AP and that intestinal AP is not likely to appear in equine serum even 
when gastrointestinal disease is present (Hoffmann, Dorner & Morris, 1983; Trueman, 
Lumsden & McSherry, 1983; Ellison & Jacobs, 1990; Hank, Hoffmann, Sanecki, Schaeffer 
& Dorner, 1993). Interestingly, Lindberg et al. (1985) reported that, although intestinal 
disease was generally severe and widespread in horses with either GE or EGE, the intestinal 
isoenzyme of AP was not identified in serum from any case. Further analysis indicated that 
increases in total serum AP were due to isoenzymes originating from bile ducts or liver and 
reflected cholangitis or cholangiohepatitis which most often occurred in association with 
eosinophilic gastroenteritis (Lindberg et al., 1985). In addition, extension of the intestinal 
disease process to involve the liver often resulted in mild to moderate elevations in GGT 
concentrations (Lindberg et al., 1985). In the majority of horses with chronic 
gastrointestinal tract disease and increases in serum AP, the origin of this increase is still 
unclear.
In animals with diarrhoea, biochemical assessment of electrolyte status (sodium, 
chloride, potassium), renal function (urea and creatinine) and protein status is diagnostically 
non-specific, but is useful in the overall assessment of the case and may influence approach 
to therapy. Disorders of calcium metabolism/homeostasis are rarely reported in animals 
with chronic gastrointestinal tract disease. Hypocalcaemia may occur in association with 
enteric protein loss, but is unlikely to be of clinical significance, with the lost calcium carried 
by plasma proteins in a bound, biologically inactive form. In addition, tumour-associated 
pseudohyperparathyroidism may result in hypercalcaemia.
Mair et al. (1990) indicated that the results of both haematological and blood 
biochemical tests may provide useful prognostic information in animals with diarrhoea. 
They demonstrated that the packed cell volumes, neutrophil counts and AP concentrations 
were higher and the total protein and albumin concentrations were significantly lower in 
horses that died when compared to those that survived. However, these authors concluded 
that, owing to the wide variety of their results, those for an individual horse could not be 
used to predict the outcome of that case (Mair et al. 1990).
1.4.6 Serum protein electrophoresis
Although the determination of total serum protein and albumin concentrations provides 
useful information with regard to protein loss/inflammatory responses in animals with
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chronic alimentary tract disease, these biochemical parameters are limited in their definition 
of protein response to specific diseases. In addition, measurement of serum albumin 
concentrations by the chemical dye-method assays used routinely in many biochemical 
profiles may provide inaccurate results, particularly when the concentration of albumin is 
low and globulin concentrations are increased (Blackmore, Henley & Mapp, 1983). 
Because of this serum protein electrophoresis (SPE) is the preferred test for determining 
serum albumin and globulin concentrations. In addition, Coffmann & Hammond (1979) 
suggested that electrophoretic separation of serum globulins enhances the diagnostic 
potential of serum protein analysis. In particular, it has been suggested that serum protein 
electrophoresis is a useful aid in the diagnosis of strongylosis with increases in (3-globulin 
fraction having been demonstrated in horses experimentally infected with both Strongylus 
vulgaris (Round, 1970; Duncan & Pirie, 1975; Patton, Mock, Drudge & Morgan, 1978; 
Kent, 1987) and also cyathostome larvae (Round, 1970). However, Love et al. (1991) 
observed no notable changes in values of any of the serum globulin fractions in ponies 
experimentally infected with either two or 11.5 million cyathostome larvae. In addition, 
although hyperbetaglobulinaemia has been described as a characteristic of acute larval 
cyathostomosis (Giles, Urquhart & Longstaffe, 1985), this was not a consistent feature of 
other reports of naturally-acquired cyathostome infections (Mair, Cripps & Ricketts, 1993) 
and should not be considered pathognomic of this condition. Furthermore, Matthews
(1982) detected considerable variation in serum globulin components among apparently 
healthy animals casting doubt upon the use of quantitative electrophoresis in individual 
clinical cases. Similarly, in a study of serum protein changes in ponies on different parasite 
control programmes, Herd & Kent (1986) observed marked variation between individuals 
and no correlation between protein responses and increasing levels of pasture infectivity 
(and therefore, by inference, no correlation with infection rate of grazing animals).
Mair, Cripps & Ricketts (1993) investigated the diagnostic potential of SPE for 
differentiating cyathostomosis from other causes of chronic diarrhoea in the adult horse: 
These authors demonstrated that animals with cyathostomosis had significantly higher 
values for (3-1-globulin than animals with diarrhoea due to other causes and that the 
sensitivity and specificity of P-l-globulin estimation for the diagnosis of cyathostomosis 
were 45.5 % and 86.0 %, respectively. They concluded that, in individual horses with 
diarrhoea, the identification of high P-l-globulin concentrations is suggestive of 
cyathostomosis, whereas the presence of normal P-l-globulin concentrations should not be 
considered as an indicator of the absence of the disease (Mair, Cripps & Ricketts, 1993).
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1.4.7 Faecal analysis
Faecal analysis is an important component of the laboratory investigation of animals with 
chronic gastrointestinal disease. Perhaps the most useful and readily attainable diagnostic 
feature in cases with cyathostome-associated illnesses is identification of large numbers of 
4th/5th stage cyathostome larvae on the rectal sleeve following rectal examination or in wet 
faecal preparations. However, in a proportion of cyathostomosis cases either small numbers 
or no larvae will be demonstrable making confirmation of the diagnosis difficult: Love, Mair 
& Hillyer (1992) documented that an ante mortem diagnosis was achieved in only seven of 
14 cases of chronic diarrhoea due to cyathostome infection. In cyathostome-associated 
diseases faecal worm egg counts are usually low or negative, due to the fact that infection is 
often prepatent when clinical signs occur (Mair et a l, 1990). Similarly, in animals with 
large strongyle-associated disease, the major pathogenic parasite stages are immature and 
migratory (Duncan & Pirie, 1975), and consequently, eggs and larvae are not detected in 
faeces. Currently, it is considered that estimation of faecal worm egg counts in grazing 
cohorts, rather than in an individual case suspected of having strongyle-associated disease, 
is more beneficial, in that, it may provide some indirect indication of the probable level of 
larval challenge on a grazing area.
Although rarely documented, other parasitological agents have been incriminated as 
possible causes of gastrointestinal tract dysfunction, based on their identification in faeces, 
and include Giardia spp., Eimeria leukarti and trichomonads. Kirkpatrick & Shand (1985) 
suggested that giardia infection of horses may be underdiagnosed due to the infrequent use 
of the zinc sulphate flotation technique, the preferred diagnostic method for Giardia spp., in 
the routine parasitological examination of faeces. Similarly, standard faecal flotation 
methods are often inadequate for detecting E. leukarti oocysts which are most often readily 
identified using saturated sodium nitrate solutions or Sheather’s sugar solution (Klei, 1986). 
However, both Giardia spp. and E. leukarti have been identified in the faeces of clinically 
healthy animals suggesting that, in general, they are of minor pathogenic significance in the 
adult horse. It is now recognised that, rather than being a cause of chronic diarrhoea in the 
horse, trichomonas populations are part of the normal equine colonic microflora (Damron, 
1976) and their presence in large numbers may, as suggested by Manahan (1970), reflect a 
disruption in the intra-luminal environment. However, Love (1992) suggested that when 
protozoal agents are detected in the faeces of animals with chronic diarrhoea, empirical 
treatment may be justified if other causes of diarrhoea cannot be identified.
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Salmonellosis is frequently incriminated as a cause of chronic diarrhoea in adult horses 
when cultured from diarrhoeic faeces (Merritt, Bolton & Cimprich, 1975). However, faecal 
bacteriological results from cases of chronic diarrhoea should be interpreted with caution: 
Salmonella spp. can be shed in the faeces secondary to another disease of the alimentary 
tract, such as cyathostomosis (Giles, Urquhart & Longstaffe, 1985) and alimentary 
lymphosarcoma (Love, Mair & Hillyer, 1992). In these cases, the salmonella shedding was 
considered a consequence of concurrent illness and/or alteration in the intestinal 
environment. In the horse, chronic diarrhoea has not been induced following experimental 
salmonella infection, such that serious doubt exists about this entity (Smith, Reina-Guerra, 
Hardy & Habasha, 1979). Other bacteria which might be of significance if isolated from 
faecal samples include non-haemolytic Escherichia coli, Clostridium perfringens type A, 
other clostridia, Actinobacillus equuli, Bacteroides vulgatus, Pseudomonas putrefaciens, 
Aeromonas hydrophila, Campylobacter jejuni and Campylobacter coli (Al-Mashat & 
Taylor, 1986). However, none of these bacteria are recognised as a primary cause of 
chronic intestinal disease in the horse and, as with Salmonella spp., their presence may 
reflect altered colonic environment secondary to another disease process. Mycobacterium 
spp., in particular Mycobacterium avium-intercellularae complex, have been implicated as a 
cause of chronic intestinal granulomatous lesions in the horse and the diagnosis of intestinal 
mycobacteriosis may be achieved by faecal culture using specific media, but it takes several 
weeks for colonies to grow (Buergelt et al., 1988).
Demonstration of large amounts of sand in faeces, by means of the ‘gloveV’swirl’ test, 
is suggestive of sand-induced enteropathy. The test is based on the fact that when faeces is 
added to water in a rectal sleeve sand, if present in significant amounts, will become visible 
as it settles to the bottom. However, failure to detect sand in faeces by this means should 
not rule out sand enteropathy as a possible diagnosis, whereas the presence of large 
amounts of sand indicates that more extensive efforts should be undertaken to determine the 
role of sand in the pathogenesis of the enteropathy (Merritt, 1994).
1.4.8 Peritoneal fluid analysis
Gross, cytological, biochemical and bacteriological analyses of peritoneal fluid, obtained by 
abdominocentesis, are commonly employed for the investigation of acute abdominal crises 
in the horse (Nelson, 1979). However, apart from eliminating a possible diagnosis of 
peritonitis/abdominal abscess, it is generally considered that these analyses are of little 
diagnostic value in the investigation of chronic alimentary tract disease. Occasionally,
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cytological examination of peritoneal fluid may yield a specific diagnosis in cases of 
gastrointestinal tract neoplasia: Neoplastic cells were detected in the peritoneal fluid of 
three of the five cases of gastric squamous cell carcinoma described by Olsen (1992) and a 
case of intestinal adenocarcinoma reported by Fulton, Brown & Yamini (1990). However, 
exfoliated malignant cells were rarely identified in peritoneal fluid samples obtained from 
horses with alimentary lymphosarcoma (Mair & Hillyer, 1991). Therefore, while 
identification of neoplastic cells in peritoneal fluid provides a certain diagnosis, the absence 
of such cells cannot be interpreted as absence of a neoplastic process. Moreover, in chronic 
inflammatory lesions of the peritoneum mesothelial cells may become hyperplastic and, as 
such, mimic neoplastic cells (Nelson, 1979).
Although analysis of peritoneal fluid in cases of CIBD is often normal, Merritt, 
Cimprich & Beech (1976) reported that reduced phagocytic activity of cells in peritoneal 
fluid was a consistent feature in horses with GE and was possibly an indication of altered 
immune response. However, this is a subjective evaluation which may be difficult to 
document in individual clinical cases and, consequently, this technique has not become 
established in the investigation of suspected GE cases (Murray, 1989). Increased numbers 
of peritoneal fluid eosinophils have been recorded in a case of chronic EGE (Gibson & 
Alders, 1987), but is not a consistent feature of this condition. Similarly, it has been 
suggested that increased numbers of eosinophils in the peritoneal fluid are suggestive of 
parasitic mesenteric arteritis (Bach & Ricketts, 1974; Sweeney et al., 1986), but Dyson
(1983) indicated that the presence of eosinophils in peritoneal fluid is an unreliable indicator 
of strongyle-associated disease.
Occasionally, in animals with pathological lesions of the gastrointestinal tract, the 
disease process may progress to involve the serosal surface of the intestine and/or other 
abdominal structures resulting in peritonitis and, consequently, non-specific increases in 
inflammatory cells and protein content in abdominal fluid samples. This progression has 
been reported to occur in association with EGE (Dyson, 1983), abdominal neoplasia (Mair 
& Hillyer, 1991; Olsen, 1992) and non-strangulating intestinal infarction due to Strongylus 
vulgaris infection (Dyson, 1983) and cyathostomosis (Mair & Pearson, 1995).
1.4.9 Intestinal function tests
Although the findings of investigative techniques detailed above may provide a diagnosis in 
certain cases of chronic gastrointestinal disease, they are generally non-specific and provide 
no/little information regarding gastrointestinal function. For this purpose a variety of
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techniques have been developed to assess specific functions such as small intestinal 
absorptive capacity, mucosal integrity and intestinal transit.
1.4.9.1 Carbohydrate absorption studies
Four carbohydrate absorption tests have been developed for assessment of small intestinal 
function in the horse: the starch tolerance test (Loeb, McKenzie & Hoffsis, 1972), the 
OGTT (Roberts & Hill, 1973), the oral xylose tolerance test (Roberts, 1974) and the oral 
lactose tolerance test (Breukink, 1974; Roberts, 1975). Although the lactose tolerance test 
may allow detection of lactase deficiency/small intestinal mucosal damage in diarrhoeic 
foals, it is recognised that as horses mature they lose the ability to hydrolyse lactose 
(Breukink, 1974: Roberts, 1975) and therefore this test of no diagnostic relevance in the 
adult equine animal. Of the remainder, the OGTT is the most frequently employed for 
assessing small intestine absorptive capacity. Following the administration of anhydrous 
glucose (1 g/kg bwt, 20 % w/v solution) to healthy animals, plasma glucose concentrations 
increase by approximately 100 % above basal glucose concentrations (BGC) and 
subsequently decline to pretest values within the six hour sampling period (Roberts & Hill, 
1973).
Although the test is simple to perform and assay, repeat blood sampling over a six hour 
period is often impractical in a practice situation. In addition, numerous extraintestinal 
factors are known to influence plasma glucose response following oral glucose loading 
(Roberts, 1985) and only limited information is available with regard to the reliability of the 
OGTT to detect small intestinal pathology. Mair, Hillyer, Taylor & Pearson (1991) 
reported that a ‘total’ malabsorption (defined as tests where plasma glucose concentration 
at 60 and 120 minutes (min) showed a lower than 15 % increase above BGC) was 100 % 
specific for detecting small intestinal pathology; however, a report published at roughly the 
same time questioned the ability of the OGTT to differentiate between large and small 
intestinal disease processes based on the fact that several horses with confirmed 
cyathostomosis exhibited carbohydrate malabsorption (Love, Mair & Hillyer, 1992).
1.4.9.2 Intestinal permeability tests
Increased intestinal permeability is a well recognised feature of numerous gastrointestinal 
diseases in man and the dog. Although it is generally accepted that increased intestinal 
permeability is secondary to a disruption of mucosal integrity, it has also been hypothesised 
that a primary permeability disorder could permit passage of intraluminal molecules across
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the intestinal mucosa and thereby initiate a pathological process, possibly by an immune 
mediated mechanism (Bjarnason, Peters & Veall, 1983). Therefore, techniques which are 
used to assess intestinal barrier function serve not only as indicators of intestinal disease but 
may also advance the understanding of the pathogenesis of certain intestinal disorders.
Intestinal permeability is assessed non-invasively by measuring urinary excretion of 
orally administered test substrates. The desired physicochemical properties of a marker 
molecule include water solubility, first-order kinetics of permeation, non-toxic, non- 
degradable, and that it remains in extracellular compartments and is not metabolised before, 
during or after permeating the intestine. In addition, it is preferable that the marker 
molecule(s) is not naturally present in urine and that its measurement is easy, sensitive and 
accurate (Bjarnason, MacPherson & Hollander, 1995). The marker molecules used in 
intestinal permeability studies in human gastroenterology include lactulose, L-rhamnose, 
mannitol, polyethylene glycol, 51Chromium-ethylenediaminetetraacetic (51Cr-EDTA) and 
" mTechnetium-diethylenetriaminopentaacetate (99mTc-DTPA) (Bjarnason, MacPherson & 
Hollander, 1995). In human gastroenterology, it is now generally accepted that 
measurement of permeability to a single marker molecule may be influenced by a variety of 
factors, apart from intestinal permeability itself, including rate of gastric emptying, small 
intestinal transit, renal excretion and sampling technique. This has led to formulation of the 
principle of dual probe permeability studies, where differential urinary excretion of two test 
substrates (e.g. lactulose and L-rhamnose) is calculated, eliminating the potential for error 
and providing a specific index of intestinal permeability. Indeed, it is possible to extend this 
principle further and devise ways of assessing specific intestinal functions. For example, 
simultaneous oral administration of lactulose and 51Cr-EDTA has been used to distinguish 
between small intestinal and colonic disease in man (Jenkins, Nukajam, Menzies & Creamer, 
1992). This is based on the principle that increased urinary excretion of both marker 
molecules indicates small intestinal permeability, whereas increased urinary excretion of 
5lCr-EDTA (which is not degraded by colonic bacteria) in the absence of a similar increase 
in urinary excretion of lactulose (which is rapidly fermented by colonic bacteria) provides an 
index of colonic permeability.
In veterinary medicine, assessment of intestinal permeability using a single marker 
molecule (51Cr-EDTA) has been applied to the investigation of experimental parasite 
infections of gerbils (Sinski, MacLean & Holmes, 1987), rats (Ramage, Stanisz, 
Scicchitano, Hunt & Perdue, 1988), lambs (MacLean, Sinski & Holmes, 1989) and ponies 
(Love, 1990; Love et al., 1991). Hall & Batt (1990) demonstrated that this technique
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reliably detected small intestinal disease in the dog and could be a useful means of 
monitoring the efficacy of treatment. Love (1990) investigated the suitability of 51Cr-EDTA 
as a test of intestinal permeability in ponies and applied this technique to monitor the 
pathogenic effects of experimental cyathostome infection. A significant difference in the 
urinary excretion of 51Cr-EDTA between control and infected animals was not detected and 
it was concluded that the integrity of the intestinal mucosa was not compromised by 
cyathostome infection (Love, 1990). However, further work on experimental cyathostome 
infections demonstrated an increase in urinary excretion of 51Cr-EDTA (i.e. increased 
intestinal permeability) following experimental infection of ponies with 11.5 million 
cyathostome larvae (Love et al., 1991).
Application of these techniques to the investigation of clinical disease in the horse has 
not been reported, but further work in this area may assist the detection and understanding 
of chronic equine enteropathies.
Hypoalbuminaemia/hypoproteinaemia is commonly recorded in association with numerous 
causes of chronic enteropathy in the horse. Although it is considered to be the result of a 
protein ‘leak’ through mucosa of increased permeability, absolute confirmation of protein 
losing enteropathy requires demonstration of the loss of plasma protein into the 
gastrointestinal tract. This can be shown by the use of radiolabelled tracer techniques. For 
this purpose, the use of different radioisotopes has been described, but 51Cr is the label of 
choice because it is not degraded and is not reabsorbed from the intestinal lumen (Love, 
1990). This isotope can be injected intravenously as 51CrCl3 after which it labels, in vivo, 
endogenous plasma proteins, particularly plasma albumin. By dividing the total 51Cr 
radioactivity counted in 24 hour faecal collections by the activity per ml of plasma at the 
start of the collection period, it is possible to calculate the faecal clearance of the plasma 
and so the rate of plasma protein loss into the intestine (Love, 1990). A variety of 
techniques, using this principle, have been used in the horse to investigate altered protein 
metabolism/enteric protein loss in cases of inflammatory bowel disease (Merritt, Cimprich & 
Beech, 1976; Merritt, Kohn, Ramberg, Cimprich, Reid & Bolton, 1977; Meuten et al., 
1978b), phenylbutazone toxicity (Snow et a l, 1981) and strongyle infections (Duncan & 
Dargie, 1975; Love, 1990). Similarly, radiolabelled tracer techniques have also been used 
to study red blood cell metabolism/blood loss into the gastrointestinal tract in experimental 
parasitic infections (Duncan & Dargie, 1975; Clayton, Duncan & Dargie, 1980; Love, 
1990).
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1.4.9.3 Breath hydrogen tests 
Breath hydrogen measurement is routinely used in human medicine to investigate 
gastrointestinal function. The technique is based on the fact that, when carbohydrate comes 
in contact with bacteria in the gastrointestinal tract, it is fermented and hydrogen is 
produced as a by-product of that process. A proportion of this hydrogen diffuses from the 
intestinal lumen into the portal circulation and is subsequently exhaled in breath. Because 
relatively few bacteria are present in the stomach and small intestine of healthy humans, 
hydrogen excreted in breath originates, almost entirely, from the large intestine (Levitt, 
1969). Based on this knowledge, breath hydrogen measurement has been applied 
successfully to the clinical investigation of small intestinal carbohydrate malabsorption 
(Levitt & Donaldson, 1970; Bond & Levitt, 1976), small intestinal bacterial overgrowth 
(Metz, Gassull, Drasar, Jenkins & Blendis, 1976a) and for assessment of mouth-to-caecum 
transit time (Bond & Levitt, 1975). Breath hydrogen measurement is non-invasive, safe, 
simple and relatively inexpensive to perform and, for these reasons, is an attractive 
alternative to other commonly used methods for the investigation of gastrointestinal 
function. Recently, the technique has been applied to the clinical investigation of 
gastrointestinal disorders in calves (Holland, Herdt & Refsal, 1986, 1989), dogs (Washabau, 
Strombeck, Buffington & Harrold, 1986a) and cats (Muir, Papasouliotis, Gruffydd-Jones, 
Cripps & Harbour, 1991).
To date, little is known about hydrogen production in the gastrointestinal tract and the 
patterns of breath hydrogen excretion in equidae. Zentek (1992) reported that hydrogen 
was excreted in the breath of adult horses following the ingestion of either hay and/or oats 
and Bracher, Ousey, Fazeli, Murgatroyd & Rossdale (1995) used the technique to evaluate 
developmental changes in alimentary tract function of young foals. In addition, Murphy, 
Howie & Love (1994) reported significant and transient increases in breath hydrogen 
concentration which was assumed to be a consequence of gastric fermentation, one hour 
after the administration of xylose and lactulose to a horse with pyloric stenosis. Although 
the breath hydrogen test has not yet been fully validated for use in the horse, these reports 
indicate that further studies into the diagnostic potential of this technique in equine 
gastroenterology are justified.
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1.4.10 Diagnostic imaging
1.4.10.1 Ultrasonography 
Ultrasonography, using low frequency (2 - 3.5 MHz) linear array or sector scanners, has 
become an important diagnostic aid in the investigation of internal disorders in the horse 
(Byars & Hailey, 1986) and has proved useful in the diagnosis of chronic alimentary tract 
disease, in particular, neoplasia (Hillyer, 1994). Hillyer (1994) indicated that, while random 
abdominal ultrasonography occasionally reveals a specific abnormality, it is usually 
unrewarding. Therefore, this technique should only be employed when indicated on the 
basis of either clinical and/or rectal examinations.
Abdominal neoplasia can be expected to alter the size, shape, position and internal 
architecture of an affected abdominal organ. However, occasionally specific organ 
involvement may not be detected by ultrasonography and there may only be evidence of the 
secondary effects of abdominal neoplasia, such as displacement of other organs from their 
normal anatomical position or changes to the volume or echogenicity of peritoneal fluid 
(Hillyer, 1994).
In the normal horse, the greater curvature of the stomach can be visualised by 
ultrasound on the left side of the cranial abdomen, in close apposition to the spleen 
(Rantanen, 1986). Ultrasonographic recognition of thickening and abnormal echogenicity 
of the stomach wall is consistent with a diagnosis of gastric squamous cell carcinoma 
(Traub, Bayly, Reed, Modransky & Rantanen, 1983; Rantanen, 1986). In addition, 
increased peritoneal fluid volume and/or splenic displacement and/or metastatic spread to 
other structures including the liver, spleen, intestines, omentum or diaphragm, may occur in 
association with this neoplasm.
Normal intestine is difficult to identify and evaluate ultrasonographically. However, 
Byars & Hailey (1986) indicated that gross thickening of the intestinal wall may be a 
recognisable feature in alimentary lymphosarcoma. In addition, ultrasonography was 
considered to be a useful tool in the evaluation of a case of intestinal adenocarcinoma, but 
only the secondary effects of the neoplasm (increased peritoneal fluid volume and metastatic 
spread to the liver and diaphragm) were identified (Traub et al., 1983).
Although these reports confirm that ultrasonography may be useful in the investigation 
of animals with gastrointestinal neoplasia, the definitive diagnosis in these cases must still be 
considered dependant on the cytological appearance of peritoneal fluid or histopathological 
examination of tissue samples. In this regard, ultrasonography may play a role in certain 
cases because ultrasound-guided paracentesis or needle biopsy may facilitate the collection
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of required samples (Modransky, 1986). However, ultrasound-guided biopsy is only likely 
to be feasible where lesions are in apposition/adhered to the abdominal wall. Although 
information is sparse with regard to the benefits of ultrasonography when investigating 
other than neoplastic causes of gastrointestinal tract disease, excessive peritoneal fluid and 
caudal displacement of the spleen have been recorded in a case of gastric distension due to 
pyloric stenosis (Murphy, Howie & Love, 1994).
1.4.10.2 Endoscopy
Ante mortem diagnosis of gastric disease in the adult horse is difficult due to non-specific 
clinical features and the lack of specific diagnostic techniques to evaluate the equine 
stomach. Fibreoptic endoscopic examination of the stomach and small intestine is a well 
established, valuable diagnostic aid in human, small animal and foal medicine, but the length 
of commonly available endoscopes (usually less than two metres) limits the use of this 
technique in mature horses. In addition, although several authors have described the 
diagnosis of gastric squamous cell carcinoma based on endoscopic visualisation via a 
midcervical eosophagostomy (Keirn, White, King & Tennant, 1982; Fischer, Kent Lloyd, 
Carlson & Madigan, 1986), this is an invasive procedure and carries a high risk of 
complications, in particular wound dehiscence.
Where instruments of sufficient length are available (i.e. 275-300 cm), conventional 
endoscopy, following a 24-48 hour fast, allows easy visualisation of gastric structures in the 
mature horse and has aided the diagnosis of gastric ulceration, gastric parasitism, pyloric 
stenosis and gastric neoplasia (Brown, Slocombe & Derksen, 1985; Murray, 1992a). In 
addition, Brown, Slocombe & Derksen (1985) described the use of such an instrument to 
perform duodenoscopy and obtain duodenal mucosal biopsies and suggested that this 
technique could be a valuable, relatively non-invasive tool for the investigation/diagnosis of 
chronic small intestinal disease.
1.4.10.3 Radiography
Radiography was proposed by Dik & Kalsbeek (1985) as a valuable tool in the diagnosis of 
gastric disease in the horse. These authors reported that pneumogastrography enabled 
visualisation of gastric tumours and gastric parasitism (Dik & Kalsbeek, 1985). Similarly, 
contrast radiography has been reported to be of use for the diagnosis of gastric retention 
secondary to pyloric stenosis/mass (McGill & Bolton, 1984; Church, Baker & May, 1986). 
In addition to its diagnostic potential in animals with chronic gastric disease, Bertone ei al.
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(1988) indicated that abdominal radiography may be diagnostic in animals with sand 
enteropathy: In four animals, faecal evaluation for sand was negative, but all horses had 
radiographic evidence of apparently large quantities of sand in the ventral and/or dorsal 
colons.
Although the examinations described for radiographic investigation of the 
gastrointestinal tract are simple, the technique requires powerful radiographic equipment 
and experienced interpretation, both of which will limit the availability of this technique.
1.4.10.4 Scintigraphy
In man, abdominal scintigraphy using radiolabelled leucocytes has been used successfully for 
the diagnosis of abdominal abscessation (Weldon, Joseph, French, Saverymuttu & Maxwell,
1995) and for the diagnosis and assessment of disease extent in inflammatory bowel disease 
(Weldon, Masoomi, Britten, Gane, Finlayson, Joseph & Maxwell, 1995). The technique is 
based on the fact that neutrophils migrate to the site of inflammation and increased uptake 
of the radiolabelled marker is detected by means of gamma camera imaging. Thakur, 
Coleman, Mayhall & Welch (1976) first described the use o f 11 indium-labelled autologous 
leucocytes to localise abscesses in dogs and this work was subsequently performed on 
human patients (Segal, Thakur, Arnot & Lavender, 1976). These studies, using 11 indium 
(lllIn), indicated that intense, focal increasing activity on serial images up to 24 hours was 
diagnostic of an abscess due to continued recruitment of labelled cells (Segal et al., 1976; 
Thakur et al., 1976). On the other hand, bowel inflammation results in rapid uptake and 
decreasing activity with time due to shedding of labelled cells into the bowel lumen and 
distal transit.
While abdominal scintigraphy is recognised as being a simple and safe diagnostic tool in 
human medicine, diagnosis/interpretation tends to be subjective and may be complicated by 
overlapping activity in other organs such as bone marrow, liver and spleen, which is a 
normal phenomenon. Therefore, experienced interpretation of scintigrams is essential in 
order for this technique to be accurate. Information with regard to the use of scintigraphy 
for the investigation of abdominal disorders in the horse is limited. Koblik, Lofstedt, 
Jakowski & Johnson (1985) described the use of abdominal scintigraphy as a diagnostic aid 
in a horse with chronic colic and an abdominal mass palpable per rectum. Forty-five hours 
after the intravenous administration of m In labelled leucocytes, a localised area of increased 
radioactivity was recognisable in the same region as the palpated mass. Similar localisation 
of radioactivity was not detected in scintigrams obtained from two clinically normal horses
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(Koblik et al., 1985), providing further evidence that the focal area identified in the horse 
represented leucocyte migration into an abscess.
To date, the ability of abdominal scintigraphy to diagnose CIBD in the horse has been 
evaluated in only a small number of clinical cases: While the procedure was a technical 
success, the investigator found that accurate interpretation of test results was often difficult 
(Celia Marr, personal communication). However, based on the successful application of 
this technique to the diagnosis/assessment of inflammatory bowel disease in man and an 
increase in the availability of gamma cameras in equine hospitals, further research into the 
potential of this technique for detecting chronic gastrointestinal disorders in the horse is 
justified.
1.4.10.5 Laparoscopy
Despite its widespread acceptance in human medicine, reports which document the use of 
laparoscopy in the adult horse are limited. While earlier reports provided information on 
laparoscopic technique and basic anatomical landmarks (Witherspoon, Kraemer & Seager, 
1980; Fischer et al., 1986), Galuppo, Snyder & Pascoe (1995) and Galuppo, Snyder, 
Pascoe, Stover & Morgan (1996) were first to provide a comprehensive description of the 
normal laparoscopic anatomy of the abdomen in the horse. The primary indications for 
laparoscopic examination of the equine abdomen is in clinical cases with non-specific colic 
and/or suspected abdominal neoplasia/abcessation. To date, laparoscopy has proved useful 
in the diagnosis of gastric squamous cell carcinoma (Fischer et al., 1986) and intestinal 
adenocarcinoma (Fulton, Brown & Yamini, 1990). The disadvantages of the technique are 
that an extensive knowledge of anatomical orientation is required and lesions, if present, 
may remain undetected, for example, when situated in the ventral abdomen. In addition, in 
order to enhance visualisation of abdominal structures, it is recommended that animals be 
fasted for 24-36 hours before examination to reduce the bulk of ingesta and to minimise 
gaseous distension of the bowel (Fischer et al., 1986; Galuppo, Snyder & Pascoe, 1995). 
Furthermore, inadvertent viscus rupture (Fischer et al., 1986) and subcutaneous emphysema 
(Galuppo, Snyder & Pascoe, 1995) are possible complications when performing this 
investigation. However, compared with exploratory laparotomy, wound healing following a 
laproscopic procedure is rapid and post-operative care is minimal. These advantages 
outweigh the potential disadvantages and it is likely that, as instrumentation and surgical 
experience continue to develop, more abdominal procedures will be performed via 
laparoscopy.
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1.4.11 Intestinal biopsy
Given the relatively low ante mortem diagnostic rate reported in a review of 51 cases of 
chronic diarrhoea and the fact that a diagnosis was achieved in 22 of these animals at post 
mortem examination, the authors suggested a potentially valuable role for intestinal biopsy 
in the clinical evaluation of such cases (Love, Mair & Hillyer, 1992). It is generally 
regarded that biopsy features should allow detection and characterisation of, at least, the 
unequivocal, severe inflammatory diseases, should distinguish inflammation from neoplasia, 
or should identify when the mucosal histology falls within the broad range of normal. In 
most cases, obtaining diagnostic intestinal biopsies necessitates exploratory laparotomy 
which may be of limited practical value because of financial considerations and the increased 
risks associated with abdominal surgery in debilitated and/or hypoalbuminaemic animals. 
However, in conditions where there is extensive pathological change in the large intestine, 
rectal biopsy will, occasionally, provide histopathological evidence of a specific diagnosis. 
Despite the fact that numerous authors have advocated the use of rectal biopsy as a 
diagnostic tool (Merritt, Cimprich & Beech, 1976; Meuten et al., 1978a; Traver & Thacker, 
1978; Gibson & Alders, 1987), there are relatively few studies which evaluate the diagnostic 
potential of this technique when investigating cases of chronic intestinal disease in the horse. 
Of the 51 cases of chronic diarrhoea investigated by Love, Mair & Hillyer (1992), rectal 
biopsies had been obtained from 27 and histopathological abnormalities were identified in 
specimens from 13 of these animals. However, the usefulness of rectal biopsy in the 
evaluation of these cases was generally disappointing in that two biopsies contained 
cyathostome larvae and 11 had non-specific mixed inflammatory cell infiltrates. No 
histopathological evidence of neoplasia was detected in rectal biopsies from three cases of 
alimentary lymphosarcoma (Love, Mair & Hillyer, 1992). Lindberg, Nygren & Persson 
(1996) provided the first comprehensive study of rectal biopsy diagnoses in horses with 
clinical signs of gastrointestinal disease. In the same paper, these authors described, in 
detail, the histopathological appearance of the mucosa and submucosa of the rectum in 
clinically normal horses. They noted that attaching clinical significance to histopathological 
features in animals with clinical disease can be difficult because of the subjective nature of 
biopsy interpretation and the individual variation evident in the microscopic appearance of 
rectal tissue from clinically normal horses. Therefore, it was suggested that reference to 
well defined controls is important in order to overcome diagnostic difficulties. Compared to 
rectal tissue from clinically normal horses, histopathological examination of biopsy 
specimens from 116 horses presented for investigation of enteric disease allowed detection
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of pathological changes in specimens from 60 horses. Although the majority of specimens 
were classified as having non-specific inflammatory changes, histopathological features 
were occasionally indicative of a specific disease entity. When correlated with post mortem 
findings in 40 horses, it was shown that rectal biopsy specimens permitted a definitive 
diagnosis in 6 of 12 cases of EGE, 4 of 9 cases of GE and 1 of 7 cases of alimentary 
lymphosarcoma. These results suggest that, despite its limitations, rectal biopsy is a useful 
adjunct for the investigation of chronic intestinal disease in the horse.
Proctoscopy may be helpful in evaluating involvement of rectal mucosa and is easily 
accomplished using a tube speculum (Merritt, Cimprich & Beech, 1976). However, 
Lindberg et al. (1985) reported that diagnostic histopathological changes may be present in 
rectal mucosal tissue even though the rectum appears grossly normal.
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1.5 Summary and Project Aims
Reaching a definitive diagnosis in cases of equine chronic gastrointestinal disease is often 
difficult because, regardless of the aetiology, animals often present with similar historical 
and clinical features. In addition, although many tests are available/advocated for the 
investigation of such cases, an extensive investigative ‘work-up’ may fail to differentiate 
between disease entities, thereby precluding a rational approach to therapy or management. 
Factors which contribute to the difficulties of diagnosis are numerous and include i) a 
paucity of reports which detail the relative prevalence of the different gastrointestinal 
diseases and their associated clinical and clinicopathological features, ii) a limited 
knowledge of the pathogenesis of most chronic gastrointestinal diseases, and iii) few 
specific diagnostic tests.
The present study was carried out against this background with the overall aim of improving 
objective assessment of cases of equine chronic enteropathies; The specific aims were as 
follows,
• To review the historical, clinical and clinicopathological features of confirmed 
cases of equine chronic gastro-/enteropathies, presented to a referral clinic, with 
a view to highlighting possible features which may help differentiate between 
disease entities.
• To validate a fructosamine assay for use with equine serum or plasma.
• To evaluate the use of fructosamine measurement to monitor alterations in 
protein metabolism in ponies experimentally infected with cyathostome larvae.
• To evaluate the effect of some extraintestinal factors on the oral glucose 
tolerance test in healthy ponies.
• To assess the ability of a ‘modified’ oral glucose tolerance test to detect/exclude 
a diagnosis of small intestinal pathology.
• To validate the technique of breath hydrogen measurement for use as a 
diagnostic/research tool for the investigation of pathological and/or 
physiological alterations in gastrointestinal tract function.
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Ch a pt e r  2 
G e n e r a l  M a t e r ia l s  a n d  M e t h o d s
2.1 Animals
2.1.1 Clinical material
The principal case material included in Chapter 3 and Chapter 5 comprised a series of 
horses referred by veterinary practitioners to the University of Glasgow Veterinary School 
for investigation of chronic weight loss and/or chronic diarrhoea and/or chronic colic. 
Using the Jarrogate data-base system (University of Glasgow), each horse was assigned a 
case number with the inclusion of date of presentation, breed, sex, age and owner details. 
Relevant historical details were recorded and a full physical examination was carried out. In 
all cases, blood was obtained by jugular venepuncture. The blood was collected into 
potassium ethylenediaminetetraacetic acid (EDTA) tubes (Vacutainer®, Becton Dickinson) 
for haematological examinations and lithium heparin tubes (Vacutainer®, Becton Dickinson) 
for biochemical analysis. Haematological and blood biochemical analyses were performed 
on the same day as blood collection. All or a number of the following diagnostic 
procedures were performed on each animal; faecal parasitological analysis, peritoneal fluid 
analysis, SPE, an OGTT and rectal mucosal biopsy. A definitive diagnosis was reached in 
all cases either based on historical, clinical and clinicopathological findings and/or post 
mortem examination.
2.1.2 Experimental animals
A total of 25 British native-breed ponies were used in studies on fructosamine 
measurement, OGTTs and breath hydrogen measurement (Table 2.1).
A foal/yearling group was comprised of 17 animals (7 male, 10 female) aged between 6 
and 18 months when included in the studies. These ponies were reared indoors with their 
dams. Following weaning at 4 months of age, eight animals (Pony Nos. 114 to 121, 
inclusive) were maintained on a hay and coarse mix (Spillers® Original Mix, Spillers Horse 
Feeds) diet and bedded on straw, whereas the other nine ponies (Pony Nos. 101 to 106, 
inclusive and 111, 112 and 113) received a commercially-produced pelleted ration (Spillers® 
High-Fibre Cubes, Spillers Horse Feeds) and were bedded on wood-shavings.
An adult group, comprising of eight ponies (1 male, 7 female), were aged between 5 and 13 
years when included in the studies. Three of this group (Pony Nos. 122, 126 and 129) were 
reared indoors and had been stabled since birth, whereas the other five (Pony Nos. 123,
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124, 125, 127 and 128) had been maintained at grass. All individuals in this group had been 
stabled for at least one month prior to inclusion in any investigations reported in this thesis. 
The management of animals in this group varied depending on the particular study: They 
were either maintained on a hay only diet and bedded on straw or maintained on a 
commercially-produced pelleted ration (Spillers® High-Fibre Cubes, Spillers Horse Feeds) 
and bedded on wood-shavings.
Jtudy 2 3 4 6 7 8 9
ly No.
101 X X X
102 X X X
103 X X X
104 X X
105 X X X
106 X X X
111 X X
112 X X X
113 X X X
114 X X
115 X X
116 X X
117 X X
118 X X
119 X X
120 X
121 X
122 X
123 X X X X X
124 X X X X X
125 X X X X X
126 X X X X X
127 X X X X X
128 X X X X X
129 X X X X X X
Table 2.1: Experimental animals used in individual studies; 2 = fructosamine 
assay validation, 3 = alterations in plasma fructosamine concentration following 
experimental cyathostome infection, 4 = effect of age and diet on the oral 
glucose tolerance test, 6 = breath hydrogen excretion following
ingestion/administration of a variety of test meals, 7 = effect of diet on breath 
hydrogen excretion patterns, 8 = effect of cisapride and codeine phosphate on 
breath hydrogen excretion patterns, 9 = pharmacokenetics of lactulose in 
ponies.
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Prior to inclusion in these studies, all animals were considered to be healthy based on 
clinical examinations. All experimental ponies were housed in individual loose boxes which 
were cleaned out daily. Animals were fed twice daily at 08:00 and 16:00 hours and had ad 
libitum access to water. They were regularly turned out to exercise in concrete yards.
2.2 Investigative Techniques 
2.2.1 Haematological analysis
A complete blood count was obtained using an ABX Minos ST Vet (ABX) haematology 
analyser. Isotonic saline was used as a diluent and potassium cyanide as a lysing agent as 
described by the manufacturer. The parameters evaluated included red and white cell and 
platelet counts, haemaglobin concentration and haematocrit. For the differential white cell 
count, blood films were fixed and stained with a standard May-Grunwald Giemsa stain, and 
200 cells counted under oil immersion microscopy.
2.2.2 Biochemical analyses
Plasma concentrations of urea, creatinine, bilirubin, AP, GGT, glutamyl dehydrogenase 
(GLDH), albumin, total protein, sodium, potassium, chloride, calcium and magnesium were 
measured on discrete clinical chemistry analysers. The commercial reagent kits, 
manufacturers and their methods are listed in Table 2.2. Plasma globulin concentrations 
were estimated by subtraction of albumin from total protein concentrations.
Quality assurance was guaranteed using commercially available control sera (Pathonorm™ 
H, Nycomed). Quality control was monitored by the Scottish Quality Assessment Scheme 
and UKEQAS for general clinical chemistry.
Fructosamine measurement in equine serum and plasma was performed as outlined in 
Chapter 4.
2.2.3 Oral glucose tolerance test
Following a 14-16 hour fast, lg anhydrous glucose (Sigma-Aldrich Company Ltd) per kg 
bodyweight (bwt) was administered, as a 20% w/v warm solution, by stomach tube 
(Roberts & Hill, 1973). Blood, obtained by jugular venepuncture at zero min (i.e. pre-test) 
and at times 30, 60, 90, 120, 150, 180, 240, 300 and 360 min, was collected into fluoride 
oxalate glass vacutainers (Vacutainer®, Becton Dickinson). Animals under test had access 
to water at all times and access to food was denied until the end of the sampling period. All 
samples were analysed on the day of collection for glucose concentration.
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Parameter Reagent Kit Method
Albumin1 T01-1377-A4, Bayer Diagnostics Bromocresol green method
AP1 T01-3349-A4, Bayer Diagnostics Enzymatic colorimetric test with p- 
nitrophenyl phosphate using DEA 
buffer
Bilirubin1 T01-1963-A4, Bayer Diagnostics Colorimetric test using a blanked 
diazo
Calcium1 T01-1476-A8, Bayer Diagnostics Colorimetric test using 
cresolphthalein
Chloride1 T01-1474-A4, Bayer Diagnostics Colorimetric test using mercuric 
thiocyanate
Creatinine1 T01-1927-A4, Bayer Diagnostics Colorimetric test with alkaline picrate
GGT1 T01-1916-A4, Bayer Diagnostics Enzymatic colorimetric test using y- 
glutamyl-p-nitroanalide
GLDH2 GL441, Randox Laboratories Enzymatic colorimetric test using a -  
oxogluterate
Glucose1 T01-1833-A4, Bayer Diagnostics Colorimetric test using the combined 
hexokinase and glucose-6- 
dehydrogenase method
Magnesium1 TO 1-2878-02, Bayer Diagnostics Colorimetric test using xylidyl blue
Potassium1 - Indirect ion-selective electrode
Sodium1 - Indirect ion-selective electrode
Total protein1 T01-1301-A4, Bayer Diagnostics Modified Biuret method
Urea1 T01 1823-A4, Bayer Diagnostics Enzymatic UV test with urease and 
glutamate-dehydrogenase
Table 2.2: Commercial reagent kits, manufacturers and methods used for 
analysing biochemical parameters on the Technicon AXON (Bayer 
Diagnostics)1 and Cobas MIRA (Roche)2 clinical chemistry analysers. DEA = 
Diethanolamine, UV = ultraviolet.
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2.2.4 Breath tests
2.2.4.1 Protocol and breath collection 
Following an overnight fast (14-16 hours), the pattern of hydrogen excretion in the breath 
of animals under test was determined after the administration/ingestion of a test 
meal/substrate, the specific details of which are outlined in the relevant sections. End- 
expiratory breath samples were collected, in duplicate, at zero minutes (0 min) and at 
regular intervals thereafter for either 8 or 10 hours. Breath samples were collected using a 
plastic tube (nasal tube) (40 cm long, internal diameter 12 mm) with a valve attached at one 
end, two centimeters from which was situated a side exit port (8FG Dog Catheter, Rocket 
of London) (Fig. 2.1). For breath collection, the nasal tube was inserted through the nostril 
into the ventral nasal meatus of the pony (Fig. 2.2). The animal was allowed to breath 
through the tube on a number of occasions and the valve at its distal end served as an 
indicator of the breathing pattern, closing during inspiration and opening during expiration. 
Samples of breath were collected towards the end of expiration by aspirating, from the side 
exit port, into a 20 ml syringe (Plastipak, Becton Dickinson), via a three-way tap (Rocket 
of London). The breath samples were sealed in the syringes by closing the three-way tap 
and were stored in this manner at room temperature.
Fig. 2.1: Equipment for breath collection
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Fig. 2.2 : Breath collection procedure
2. 2. 4.2 Breath hydrogen analysis 
All samples were analysed within 30 minutes of collection using an Exhaled Hydrogen 
Monitor (GMI Medical Ltd) (Fig. 2.3). This instrument measures hydrogen concentration 
by means of a sensitive, selective electrochemical cell. This consists of a metallised 
membrane working electrode, which is held at a constant potential with reference to a 
reference electrode. Hydrogen diffuses through the metallised membrane and yields 
electrons to the electrode. This generates an electric current, the magnitude of which is 
proportional to the partial pressure of hydrogen, which can be read in parts per million 
(ppm) on a digital display. With this instrument, it is possible to obtain a direct 
measurement of breath hydrogen concentration within 10 seconds. The response of the 
electrode is reproducible and linear over a range from 1 to 250 ppm, can detect changes in 
hydrogen concentration of as little as 1 ppm and the method correlates well with hydrogen 
measurement by thermal conductivity detectors. Although the electrodes are highly
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selective for hydrogen they also respond to changes in the oxygen and carbon monoxide 
tension in expired air. However, the differences of oxygen and carbon monoxide normally 
encountered in expired air should not account for more than 3 ppm in the output of the 
instrument (Corbett, Thomas, Read, Hobson, Bergman & Hodsworth, 1981).
E X H A L E D  HYOROGEN M O N ITO R
Fig. 2.3: Exhaled Hydrogen Monitor (GMI Medical Ltd).
2.3 Data Organisation and Statistical Analysis
Data organisation and presentation were facilitated by use of a number of computer 
software packages including: Microsoft Word for Windows 95 version 7.0, Microsoft 
Excel for Windows 95 version 7.0 and Microsoft Powerpoint for Windows 95 version 7.0 
(Microsoft Corporation) and Harvard Graphics 2.0 for Windows (Software Publishing 
Corporation).
Statistical analyses were performed using Microsoft Excel for Windows 95 version 7.0 
(Microsoft Corporation) and MINITAB for Windows, release 9 (Minitab Incorporated).
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C h a p t e r  3
Ch r o n ic  G a st r o in t e st in a l  D ise a se  in  th e  H o r se : H ist o r ic a l , C l in ic a l  and  
C l in ic o p a t h o l o g ic a l  Fe a t u r e s  of  29 C a ses
3.1 Introduction
The known causes of chronic gastrointestinal disease in the horse are both numerous and 
diverse and, as summarised within Chapter 1, many reports have been published which 
document the clinical, clinicopathological and pathological features of specific disease 
entities. Surprisingly, there are relatively few reports which provide details about series of 
such cases, therefore there is only limited information available on the relative prevalence of 
these conditions and the relative occurrence of clinical features which may help differentiate 
between them.
Stu d y  1
3.2 Aim of Study
The aim of the study was to review historical, clinical and clinicopathological features of 29 
confirmed cases of chronic gastro-/enteropathy in the horse, with a view to highlighting 
possible features which may aid diagnosis.
3.3 Materials and Methods
3.3.1 Control population
In order to determine whether either breed and/or age and/or gender were important factors 
predisposing to the development of specific chronic diseases of the gastrointestinal tract, it 
was necessary to generate a control population with which comparisons could be made. 
This control population was established by selecting all new equine cases (excluding 
confirmed cases of chronic gastrointestinal disease) presented to the University of Glasgow 
Veterinary School between 3/1/96 and 3/1/97 and, for this population, the overall 
breed/type distribution, age distribution and gender distribution were determined. Because 
of the variety of breed/type categories and the potential for overlap between categories, 
these descriptions were further simplified to record either horse, pony or donkey. 
Subsequently, it was necessary to determine if the control population was uniform, with 
respect to age, breed/type and gender, across referral groups (i.e. medical referrals versus 
surgery (orthopaedic) referrals) or whether referral groups were sources of bias in the 
control population. Using Yate’s corrected Chi-square analysis (r x c contingency tables), 
both referral groups were investigated for differences in age, breed/type and gender
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distribution: No significant differences were found and it was concluded that the overall 
group data were not markedly biased by a particular referral group.
Where appropriate, this same method of statistical analysis was used to test for 
associations between the presence of a factor (e.g. age <5 years) and a disease classification 
(e.g. cyathostomosis). Two-by-two contingency tables were used to test for the effects of 
either gender (i.e. either female or male (including both entire and gelded)) or type (i.e. 
horse or pony). Similarly, 2 x 2  contingency tables were used to test for an association 
between age and a particular disease. Age was divided into the categories 0-5, 6-10, 11-15 
and >15 years and depending on the disease being investigated different age categories were 
collapsed: For example, animals may have been grouped as i) either 0-5 years or >5 years or 
ii) either 0-10 years or >10 years. Significance levels of less than 5 % were considered 
statistically significant.
3.3.2 Chronic gastro-/enteropathies
The principal clinical cases included in this study were adult (> one year old) horses and 
ponies presented for investigation of weight loss and/or diarrhoea and/or colic (minimum 
duration 7 days). A definitive diagnosis of a primary gastrointestinal disease was reached in 
all cases on the basis of ante mortem clinicopathological findings and/or necropsy findings.
Detailed clinical histories were obtained from the owner of each animal and a full 
clinical examination was performed at admission, then at least daily thereafter. In all cases, 
blood samples were submitted on one or several occasions for haematological and 
biochemical analyses. Faeces from all animals were examined for worm eggs by the 
modified McMaster technique and samples diluted in water were examined under the 
microscope for parasitic larvae. In addition, faeces from eight animals were submitted for 
bacteriological examination. Serum protein electrophoresis (Blackmore, Henley & Mapp, 
1983) was performed on blood obtained from 15 cases. Peritoneal fluid, obtained by 
abdominocentesis from 20 animals, was submitted for cytological and biochemical analysis 
and an OGTT was performed on 20 animals. Rectal biopsy samples were obtained, by 
means of a sow uterine biopsy instrument, from 16 animals and submitted, in 10 % 
formalised saline, for histopathological examination. Multiple intestinal biopsies were 
obtained, via laparotomy, from one individual.
The horses were either discharged following full recovery or euthanased on humane 
grounds or at the owners’ requests. One case died naturally. Full post mortem and 
histopathological examinations were performed on 23 animals.
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3.4 Results
3.4.1 Control population
The total number of animals presented, for the first time, to the University of Glasgow 
Veterinary School for the period 3/1/96 to 3/1/97 was 290 (excluding confirmed cases of 
chronic gastrointestinal disease). The distribution of the general type classifications (i.e. 
horse, pony or donkey), together with the age and gender distribution for all animals are 
shown in Table 3.1. These data and the hospital case numbers assigned to individual 
animals are presented in detail in Appendix 3.
Overall (n=290)
Reasons for referral 
Medicine (n=l 15) Surgery (n=175)
Age
Mean 9.51 11.08 8.45
SD 6.04 7.23 4.83
Median 8 8 8
Range 1 month - 33 years 4 months - 33 years 1 month - 21 years
Not recorded 6 1 5
Sex
Female 124 55 69
Male (gelded) 149 56 93
Male (entire) 16 3 13
Not recorded 1 1 0
Type
Horse 184 66 118
Pony 98 44 54
Donkey 3 3 0
Not recorded 5 2 3
Table 3.1: Age, type and sex distribution of new equine cases (excluding 
confirmed cases of chronic gastrointestinal disease) presented to the University 
of Glasgow Veterinary School between 3/1/96 and 3/1/97.
3.4.2 Chronic gastro-/enteropathies
3.4.2.1 Diagnoses
Historical, clinical and laboratory data were obtained from 29 cases with confirmed chronic 
gastrointestinal disease. These animals ranged in age from 1.5 to 20+ years and comprised 
21 mares, 6 geldings and 2 entire males. There were 15 ponies and 14 horses. The hospital 
case numbers assigned to individual animals are listed in Appendix 2.
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The diagnoses reached were CIBD (11 cases), cyathostomosis (9 cases), alimentary 
lymphosarcoma (7 cases), gastric ulceration/pyloric stenosis (1 case) and Eimeria leukarti 
enteropathy (1 case) (Table 3.2). Five cases of cyathostomosis were discharged following 
full recovery. A definitive diagnosis was achieved ante mortem in 8 cases of 
cyathostomosis by demonstrating the presence of large numbers of cyathostome larvae in 
faeces (in five cases, larvae were grossly visible on the rectal glove following rectal 
examination). Two cases of lymphosarcoma were diagnosed by demonstrating 
characteristic pathological changes in the rectal tissue obtained by biopsy. A diagnosis of 
CIBD was made in one animal based on histopathological examination of intestinal biopsies. 
In all other cases (n=18, 62.1 %), the diagnosis was reached at post mortem examination.
Diagnosis Number of animals Identification numbers
Cyathostomosis 9 1-9
Alimentary Lymphosarcoma 7 10-16
Chronic inflammatory bowel disease 11 17-27
Eosinophilic enteritis (2)
Granulomatous enteritis (2)
Lymphocytic-plasmacytic enteritis (2)
Lymphocytic enteritis (1)
No specific classification (4)
Eimeria 1 28
Pyloric stenosis 1 29
Table 3.2: Post mortem diagnoses in 29 confirmed cases of chronic
gastrointestinal tract disease in adult horses.
3.4.2.2 Pathological features
3.4.2.2.1 Cyathostomosis 
The gross pathological features of cyathostomosis included typhilitis and/or colitis of 
variable severity. In the patients which died or those that were euthanased after a short 
duration of illness, there was marked mucosal congestion, haemorrhage, ulceration and/or 
necrosis; whereas, in the case which was euthanased after a protracted illness, intestinal 
pathology was not as marked and included mucosal oedema and irregular areas of 
congestion. In all cases, careful inspection of the mucosa allowed detection of numerous 
small strongyle larvae in the mucosa, which often gave the mucosa a ‘peppered’ 
appearance. One animal with cyathostomosis, euthanased because of the development of
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severe colic associated with abdominal distension had a markedly dilated caecum. The 
histopathological features of cyathostomosis cases included mucosal distortion, mucosal 
oedema, dilatation of crypts and a diffuse cellular infiltrate (mononuclear and/or 
eosinophilic) in the submucosa, which was very intense around the larvae in the submucosa.
3.4.2.2.2 Alimentary lymphosarcoma
In five of the seven cases confirmed as alimentary lymphosarcoma, pathological changes 
were evident in both the large and small intestine. In one case, there was involvement of the 
small intestine only and in the other, the primary pathology was detected in the large 
intestine. In all cases, the intestinal lesions were considered to be diffuse. Typical gross 
pathological features included mucosal oedema/thickening, raised mucosal plaques and 
mucosal ulceration. In some cases serosal plaques were present, which on occasion were 
associated with transmural extension of the pathological process. Enlarged/oedematous 
ileocaecocolic lymph nodes were common. In all cases, microscopic examination at 
numerous sites of the intestinal tract showed diffuse infiltration by lymphoreticular cells 
resulting in distortion of the normal mucosal architecture, characterised by villus stunting, 
obliteration of crypts and mucosal oedema. At the different sites, in each individual, there 
was variation in the density of infiltration and in the extent of invasion of the deeper layers. 
On occasion, the neoplastic infiltrate was noted to invade the epithelium. The neoplastic 
infiltrate was often accompanied by a pronounced fibrous reaction, particularly in the 
submucosa. In one case, lymphosarcomatous spread to the liver was detected.
3.4.2.2.3 Chronic inflammatory bowel disease
The term CIBD is used to describe the intestinal pathology detected in 11 cases in this 
series. The typical gross pathological features of which were similar to those described for 
alimentary lymphosarcoma and histopathology was necessary in all cases to differentiate 
between inflammatory and neoplastic lesions. In cases of CIBD, the histopathological 
appearance of the lesions was characterised by severe focal or diffuse inflammatory cell 
infiltrates, of predominantly one or a mixture of cell types, into the lamina propria, 
submucosa or entire wall of a region or throughout the whole intestine. In a number of 
cases, the gross and histopathological features were consistent with reported descriptions of 
recognised pathological entities such as GE (2 cases) (Merritt, Cimprich & Beech, 1976; 
Lindberg, 1984), EGE (2 cases) (Pass & Bolton, 1982), lymphocytic-plasmacytic enteritis 
(2 cases) (MacAllister, Mosier, Qualls & Cowell, 1990) and lymphocytic enteritis (one case)
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(Clark, Morris, Allen & Tyler, 1988). In the other cases, the mixed inflammatory infiltrates 
(lymphocytes and/or plasma cells and/or macrophages and/or eosinophils and/or globule 
leukocytes) lacked a precise pattern and/or features were inconsistent with recognised 
entities. As with alimentary lymphosarcoma, involvement of ileocaecocolic lymph nodes 
was common in animals with CIBD. In addition, in both animals in which the intestinal 
lesions were categorised as EGE, eosinophilic granulomata were present in the pancreas and 
there was dilatation and fibrosis of both the bile and pancreatic ducts. In the two cases 
classified as GE, the serosal surface of the intestine was affected by the pathological process 
and there were associated omental adhesions.
3.4.2.2.4 Other diagnoses 
One animal in the present series was diagnosed at post mortem examination as a case of 
coccidial enteropathy. In this case, the small intestinal mucosa, particularly the ileum, was 
grossly thickened throughout and large numbers of microgametocytes and macrogametes 
were detected, by microscopy, in the lamina propria. There was evidence of villus stunting 
and, while a marked cellular reaction to the presence of these parasites was not evident, 
increased numbers of macrophages were apparent in the region of the villus tips.
Only one animal in this series had primary gastric disease. In this case, the stomach 
was grossly dilated. On opening into the stomach, it was apparent that the pyloric outlet 
was narrowed due to extensive thickening of the pyloric wall associated with a large ulcer 
(6 cm x 8 cm) proximal to the pyloric sphincter. There was a second large, deep ulcer (15 
cm x 7 cm) in the squamous zone adjacent to the mar go plicatus with additional smaller 
ulcers present in both the squamous and glandular regions. Histopathological examination 
of the pyloric lesion revealed extensive granulation tissue with proteinaceous and cellular 
debris adherent to the surface of the ulcer.
3.4.2.3 Historical features 
The historical features of the 29 cases are summarised in Table 3.3. All animals were 
presented for investigation of weight loss and/or diarrhoea and/or colic. All cases of 
cyathostomosis were presented between November and March and young animals (0-5 
years) were significantly over-represented within this disease category when compared to 
the control population (p<0.01) (seven of the animals with cyathostomosis were three years 
or less). By contrast, the age distribution of animals in the CIBD (p<0.01) and alimentary
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lymphosarcoma (p<0.01) disease groups were significantly older when compared to the 
control population and cases were seen throughout the year.
Seventy five percent of all animals diagnosed as cyathostomosis or alimentary 
lymphosarcoma were ponies, compared with the fact that ponies accounted for only 33 .8 % 
of the total equine control population (i.e. ponies were significantly over-represented within 
each of these two disease categories (p<0.05)). A significant association between animal 
type and a diagnosis of CIBD was not detected.
Compared to the control population, females were significantly over-represented 
(p<0.05) within the CIBD disease group and the association between being female and a 
diagnosis of alimentary lymphosarcoma approached significance (p=0.06): 85 % of animals 
diagnosed as either CIBD or alimentary lymphosarcoma were female compared with the 
statistic that the majority of animals in the control population were male (56.9 %).
Three of the animals diagnosed as cyathostomosis had received anthelmintics, as part of 
a parasite prophylaxis programme, within the ten days prior to the onset of illness. No 
similar historical feature was recorded for any animal in the other two major disease 
categories.
3.4.2.4 Clinical features 
Generally, the time course of cyathostomosis was relatively short, with 66 % of cases 
exhibiting signs for 2 weeks or less prior to presentation, compared with the time-course for 
CIBD and alimentary lymphosarcoma, with 66 % of these cases exhibiting signs for 4 weeks 
or more (Table 3.4) At the time of presentation, poor body condition was a feature of all 
cases included in this study, and varied from mild to marked in all major disease categories. 
Diarrhoea was most commonly associated with cyathostomosis (89 %) and alimentary 
lymphosarcoma cases (86 %), but was not a totally consistent feature of either disease 
entity. Similarly, peripheral oedema occurred with equal frequency in cases with 
cyathostomosis (44 %) and alimentary lymphosarcoma (43 %) and was less common in 
animals with CIBD. Only one animal with CIBD exhibited signs of abdominal discomfort at 
initial presentation but during hospitalisation, recurrent low grade abdominal pain was 
observed in a number of other animals in each disease category. One case of 
cyathostomosis developed severe colic associated with caecal tympany/dilatation and was 
euthanased on humane grounds. Five cases of cyathostomosis were pyrexic (rectal 
temperature greater than 38.3°C) when initially presented and two additional cases were 
pyrexic at some stage during their hospitalisation. By contrast, pyrexia was not a feature of
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alimentary lymphosarcoma cases and was only infrequently detected in animals with CIBD. 
Five of the 29 animals in this study did not exhibit any abnormality apart from weight loss at 
initial presentation. Ptyalism and intermittent, low grade colic were the principle clinical 
features of one case with gastric disease.
No palpable abnormalities were detected, per rectum, in any of the cases included in 
this study. However, an incidental finding following rectal examination was visualisation of 
cyathostome larvae on the rectal sleeve in 5 cases (56 %) of cyathostomosis.
3.4.2.5 Clinicopathological features 
The significant laboratory findings for the 29 cases are summarised in Table 3.5. The 
haematological and biochemical abnormalities commonly identified were hypoalbuminaemia 
( <30  g/L) (24 cases), neutrophilia (> 6.8 x 109/L) (20 cases) and increased serum AP 
concentrations (>310 U/L) (22 cases). Although these abnormalities were not specific for 
a particular diagnosis, all cases of cyathostomosis had a neutrophilia which in the majority 
of cases was marked (median neutrophil count - 17.4 x 109/L). The only other 
haematological abnormality detected was a mild anaemia in five cases (two of 
cyathostomosis and three of CIBD). All cases of cyathostomosis and alimentary 
lymphosarcoma were hypoalbuminaemic. Increases in plasma urea and creatinine 
concentrations and decreases in electrolyte concentrations associated with dehydration were 
detected in three cases of cyathostomosis and one case of CIBD. Increases in GGT 
concentration were detected in two cases of alimentary lymphosarcoma, both of which had 
evidence of liver pathology at post mortem examination.
Faeces submitted for parasitological evaluation yielded faecal worm egg counts ranging 
from 50 to 300 eggs per gram in 6 cases. Faeces from all cases of cyathostomosis were 
negative for worm eggs, but large numbers of cyathostome larvae were present in faeces 
from 8 cases. Campylobacter spp. and Salmonella typhimurium were cultured from the 
faeces of three cases and one individual case, respectively.
Bacteriological analysis of peritoneal fluid yielded no significant abnormalities in any of 
the cases from which peritoneal fluid was obtained. However, increases in white cell count 
and total protein were detected in the peritoneal fluid of three horses, two of which were 
subsequently confirmed as GE with serosal involvement. The cause of the increase in the 
total protein concentration of peritoneal fluid in the other case with CIBD was not identified 
at post mortem examination.
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Abnormal serum globulin profiles were detected, by SPE, in five of eight cases 
diagnosed as cyathostomosis and two of three cases with alimentary lymphosarcoma. In 
two animals with cyathostomosis, marked increases in the relative proportions of both a -  
and (3-globulin fractions were evident, whereas in the other three cases moderate increases 
in a2-globulin fraction only were detected. In the two cases of alimentary lymphosarcoma, 
abnormalities of either the (31- (markedly increased) or (32- (moderately increased) globulin 
fractions only were apparent. Serum globulin profiles in three animals with cyathostomosis 
and three animals with CIBD were normal.
The results of OGTT’s were recorded as either normal (6 cases), partial malabsorption 
(11 cases) or total malabsorption (2 cases), as defined by Mair et al. (1991). The OGTT 
from one case was uninterpretable due to a high BGC. Two cases of cyathostomosis had 
normal OGTT results, the test in another case being classified as evidence of partial 
malabsorption (the glucose concentration at 60 min was 178 % of BGC). Both animals 
which had test results indicative of total malabsorption were confirmed as cases of 
alimentary lymphosarcoma.
Rectal biopsies were obtained from 16 animals in the present series and 
histopathological abnormalities were identified in seven of these specimens. Pathological 
change characteristic for alimentary lymphosarcoma was detected in rectal tissue obtained 
from two animals, and this diagnosis was subsequently confirmed at necropsy. In another 
case, which was confirmed as alimentary lymphosarcoma at post mortem examination, a 
marked lymphocytic infiltrate was evident in the rectal lamina propria. Histopathological 
examination of biopsied rectal tissue from another two animals detected severe 
inflammatory lesions: Both of these animals were subsequently diagnosed as cases of CIBD. 
In the remaining two cases, there was a moderate increase in cellularity in the lamina propria 
of the rectal tissue which was interpreted as non-specific proctitis.
3.5 Discussion
Chronic inflammatory bowel disease, cyathostomosis and alimentary lymphosarcoma 
accounted for the majority of confirmed cases of chronic equine gastrointestinal disease in 
the present series. These findings are similar to the observations of Love, Mair & Hillyer 
(1992) who reported that of 51 cases of chronic diarrhoea, a specific diagnosis was 
achieved in 37 horses, and of these, 28 (78 %) were diagnosed as either cyathostomosis (14 
cases), idiopathic chronic colitis (9 cases) or alimentary lymphosarcoma (5 cases).
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In the present series, the pathological features of cyathostomosis were comparable to 
previous descriptions of the condition (Giles, Urquhart & Longstaffe, 1985). In addition, 
the gross and histopathological intestinal features of the majority of cases of CIBD were 
consistent with reported descriptions of recognised pathological entities (Merritt, Cimprich 
& Beech, 1976; Pass & Bolton, 1982; Lindberg, 1984; Clark et al., 1988; MacAllister et al.? 
1990), all other cases having severe mixed inflammatory infiltrates lacking a precise pattern. 
No obvious cause of the chronic inflammatory change in these cases was identified. 
Although the histopathology of alimentary lymphosarcoma cases was similar to that 
described by Platt (1987), the extent of the intestinal involvement was different from 
previous reports: In all cases in this series, the lesions were classified as diffuse and 
pathological change in the large intestine was a feature in six of the seven cases. By 
contrast, Platt (1987) reporting on the pathological features of nine cases of alimentary 
lymphosarcoma, described diffuse lymphosarcomatous change in the small intestine only. 
Furthermore, Mair & Hillyer (1991), when describing the clinical features of 
lymphosarcoma in the horse, reported that in animals with intestinal lymphosarcoma, the 
small intestine only was involved in the majority of cases and that focal lesions were more 
common than diffuse intestinal lesions. The factors which influence the extent of intestinal 
involvement in cases of alimentary lymphosarcoma are unknown.
Both coccidial enteropathy and pyloric stenosis secondary to gastric ulceration, 
diagnosed in single cases in the present series, are uncommon conditions of the adult horse. 
Eimeria leukarti has been reported as a cause of equine chronic diarrhoea and the 
pathological features of this case are similar to those described previously (Wheeldon & 
Greig, 1977). However, based on a paucity of clinical reports and the failure to produce 
disease by experimental infections (Laufenstein-Duffy, 1969), this parasite is currently 
considered to be of slight pathogenic significance in horses (Love, 1992).
Interestingly, primary gastric disease was a feature of only this single case in the present 
series, emphasising the point that chronic disease of the equine stomach is uncommon. In 
fact, pyloric obstruction as a sequel to gastric ulceration has been reported in mature horses 
on only two previous occasions (Church, Baker & May, 1986; Laing & Hutchings, 1992). 
Furthermore, the results of this study indicate that in our population, alimentary 
lymphosarcoma was the most common neoplasm of the equine gastrointestinal tract and not 
gastric squamous cell carcinoma as had been suggested by Boulton (1987). The case of 
chronic gastric disease described in this report was characterised clinically by ptyalism and 
chronic, low grade colic which should be interpreted as evidence of possible gastric
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dysfunction. While endoscopy may aid the ante mortem diagnosis of gastric disease in the 
adult horse (Murray, 1992a), an instrument of sufficient length was not available for use in 
the investigation of this case.
The historical features of cyathostomosis cases in the present study are similar to 
previous reports (Reid et al., 1995) in that, typically, affected animals are young adults and 
present in winter or early spring. In addition, the clinical presentation is characterised by 
sudden onset diarrhoea and rapid weight loss. By contrast, CEBD and alimentary 
lymphosarcoma tended to be diagnosed in older animals and, in general, for both conditions, 
the duration of clinical signs prior to presentation at the referral centre was longer than that 
recorded for cyathostomosis. While these features may be useful for differentiating cases of 
cyathostomosis from other causes of chronic gastrointestinal tract disease, it is important to 
acknowledge that not all cases of cyathostomosis have the ‘classical’ history: For example, 
one animal in the present series was aged (20 years), another presented because of rapid 
weight loss in the absence of diarrhoea and another exhibited chronic ill-thrift. Similarly, 
neither CIBD nor alimentary lymphosarcoma are confined to the older horse (Lindberg et 
al., 1985; Platt, 1987; Mair & Hillyer, 1991). In fact, the majority of cases of either GE or 
EGE reported in the literature were adult animals of 5 years of age or less (Lindberg et al., 
1985; Platt, 1986) and Platt (1987) described the pathological features of alimentary 
lymphosarcoma in nine animals all aged between 1 and 6 years.
Comparison of animal type and sex distribution data from the clinical cases with similar 
data from the control population yielded some interesting results: It appears that ponies are 
at a greater risk of developing either cyathostomosis or alimentary lymphosarcoma than 
horses, and that female animals are at greater risk of developing CIBD and may be at a 
greater risk of developing alimentary lymphosarcoma than males. Although these 
associations appear to be significant in the present study they are not supported by previous 
reports of these conditions. Gender and type of animal were not identified as important risk 
factors for the development of cyathostomosis (Reid et al., 1995). Similarly, Mair & 
Hillyer (1991), providing details of a greater number of cases, reported that alimentary 
lymphosarcoma occurred with equal frequency in both horses and ponies and was diagnosed 
more often in male animals, but in that study the relative prevalence of these conditions 
within a gender or type group (i.e. statistical comparison to a control population) was not 
investigated. Certain inflammatory enteropathies (most notably GE and EGE) have been 
reported almost exclusively in horses, in particular in Standardbreds, but CIBD was 
diagnosed in three ponies in the present series. Furthermore, when compared to data from
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our control population, horses were not over represented in this disease category (i.e type 
distribution was similar for both the control group and the CIBD category).
Anthelmintic treatments preceded the onset of illness in three cases of cyathostomosis 
and preceded the onset of diarrhoea in another case presented because of chronic ill-thrift. 
A comparable association between anthelmintic treatments and the onset of illness was not 
recorded for either of the other two major disease categories, supporting the hypothesis that 
anthelmintic treatments may precipitate clinical disease in animals with a heavy mucosal 
cyathostome burden (Gibson, 1953; Reid et al., 1995).
The results of the present study highlight the difficulty in reaching a diagnosis in 
animals with chronic gastrointestinal disease based on clinical features alone: Reported 
weight loss was a feature of all cases and a number of animals in each of the major disease 
categories exhibited additional signs such as diarrhoea and/or peripheral oedema and/or 
colic. The non-specific nature of the clinical presentation was further emphasised by the 
fact that five animals exhibited no abnormality apart from poor body condition/reported 
weight loss at the time of initial presentation. Diarrhoea was recorded with a greater 
frequency in cases of alimentary lymphosarcoma in this study compared to the incidence of 
that clinical feature in other reports of the condition (Platt, 1987; Mair & Hillyer, 1991), 
and was considered to reflect the frequency of extensive pathological involvement of the 
large intestine. In the present series, pyrexia was identified as the most useful clinical 
feature for differentiating cyathostomosis from other causes of chronic gastrointestinal 
disease. However, the greater frequency with which pyrexia was detected in cases of 
alimentary lymphosarcoma (Mair & Hillyer, 1991) and CIBD (Lindberg et a l , 1985) in 
other case series indicates that the differentiating ability of this clinical feature is 
questionable.
An interesting aspect of the present series is the variety of clinical presentations (such 
as chronic weight loss, rapid weight loss in the absence of diarrhoea and severe colic) 
recorded for animals with cyathostomosis. In recent years, numerous reports describe a 
variety of cyathostome-associated diseases, with clinical presentations distinct from the 
‘classical’ features of sudden onset diarrhoea, which becomes chronic, and rapid weight 
loss. Mair (1993) described a previously unrecorded syndrome of cyathostome-related 
recurrent diarrhoea in five aged ponies. In addition, Mair (1994), when documenting an 
outbreak of cyathostomosis in a group of five young horses, described rapid weight loss, 
severe peripheral oedema and pyrexia, without diarrhoea, in four of those animals: A similar 
weight loss syndrome has been increasingly observed in weanlings during the autumn
Chapter 3 58
grazing period (S. Love, personal communication). Reilly, Cassidy & Taylor (1993) 
reported chronic weight loss/ill-thrift of several months duration prior to cyathostome- 
associated sudden onset diarrhoea: a history similar to that of Case 2 in the present series. 
Cyathostomes have also been incriminated as the cause of a seasonal (late autumn-spring) 
‘malaise syndrome’ in adult horses which is characterised by reduced appetite, lethargy, 
weight loss with variable faecal consistency and which responds to anthelmintic therapy 
(Matthews & Morris, 1995). In addition, cyathostome infection is increasingly recognised as 
an important cause of equine colic: The results of a study which compared the effect of 
different anthelmintic programmes on the incidence of colic demonstrated a marked 
decrease in colic incidence on farms on which effective cyathostome control was achieved 
compared with that recorded on farms where cyathostome control failed (Uhlinger, 1990). 
Furthermore, cyathostomes have been identified as a cause of caecocaecal intussusception 
(Lyons et al., 1994; S. Love, personal communication) and also non-strangulating intestinal 
infarction (Mair & Pearson, 1995). Mechanisms which may contribute to the occurrence of 
cyathostome-associated colic include intestinal mucosal oedema and/or vasoconstriction 
induced by the local production of vasoactive substances in response to the presence of 
cyathostome mucosal stages (Mair & Pearson, 1995). In addition, a disruption to normal 
intestinal motility has been observed following experimental cyathostome infection (Bueno, 
Ruckebusch & Dorchies, 1979) and it is possible that altered intestinal motility may 
contribute to the development of intussusceptions and may have resulted in caecal tympany 
which developed in one animal (Case 9) described in the present report.
The most useful diagnostic aid in the present series was faecal analysis: Eight cases of 
cyathostomosis (89 %) were diagnosed by detecting large numbers of cyathostome larvae in 
faeces and in five of these cases larvae were visible grossly, facilitating a rapid diagnosis. 
Love, Mair & Hillyer (1992) reported an ante mortem diagnosis rate of 50 % for 
cyathostomosis, simply by observing larvae in faeces, whereas the remaining cases could 
only be confirmed at post mortem examination which emphasises the fact that the absence 
of larvae from faeces makes conformation of a diagnosis, ante mortem, difficult. Although 
blood analyses are important for case assessment and may fashion approach to treatment, it 
is generally considered that such analyses have limited diagnostic value when investigating 
cases of chronic gastrointestinal disease in the horse. However, while neutrophilia was 
detected in animals in each of the three main disease categories, it was a consistent feature 
of cyathostomosis cases such that absence of neutrophilia in an animal presented for 
investigation of weight loss and/or diarrhoea would be suggestive of a diagnosis other than
Chapter 3 59
cyathostomosis. This observation is supported by the results of previous reports which 
indicate that leucocytosis due to neutrophilia is a common feature of cyathostome- 
associated illness (Giles, Urquhart & Longstaffe, 1985; Uhlinger, 1991; Kelly & Fogarty, 
1993; Mair, 1994). Hyperbetaglobulinaemia, which has been described as characteristic of 
cyathostome infection (Giles, Urquhart & Longstaffe, 1985; Kelly & Fogarty, 1993), was 
detected in only two of eight cases of cyathostomosis in the present series. In three other 
cases, moderate increases in a2-globulin fraction only were detected, whereas in the 
remainder (3 cases) no abnormality in serum globulin profile was detected. Moreover, a 
marked increase in (31-globulin was detected in one of three animals with alimentary 
lymphosarcoma. Consequently, the detection of hyperbetaglobulinaemia was an 
inconsistent feature of cyathostome infection and had poor diagnostic specificity. Mair et 
al. (1993), when investigating the usefulness of SPE to help differentiate between 
cyathostomosis and other causes of chronic diarrhoea, reported that a marked increase in 
pi-globulin fraction was suggestive of cyathostomosis, but it was considered that the 
absence of that feature could not preclude that diagnosis.
On the basis of the OGTT results, two animals in the present series exhibited evidence 
of total glucose malabsorption and both of these cases were subsequently diagnosed as 
alimentary lymphosarcoma. This finding supports the observation of Mair et a l (1991) that 
evidence of total malabsorption suggests a diagnosis of either alimentary lymphosarcoma or 
CIBD. The test results in another 11 cases were classified as evidence of partial 
malabsorption: Specific interpretation of these results was not possible because this 
category included at least two cases which did not have primary small intestinal disease (i.e. 
one case of cyathostomosis and the case of chronic gastric ulceration). A more detailed 
analysis of the OGTT as a diagnostic test is presented in Chapter 5 (Study 5).
Marked pathological change suggestive of a severe enteropathy was evident in biopsied 
tissue obtained from five of the 16 animals from which specimens were obtained (31 %), 
and the findings permitted a definitive diagnosis in two cases of alimentary lymphosarcoma. 
These results compare favourably with those of Lindberg, Nygren & Persson (1996) who 
reported that rectal biopsy findings were diagnostic in 11 of 40 (27.5 %) cases of chronic 
gastrointestinal disease which were confirmed at necropsy. The findings of the present 
study and that described by Lindberg, Nygren & Persson (1996) confirm that rectal biopsy 
is a simple, safe and useful adjunct for the investigation of chronic intestinal disease in the 
horse.
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In conclusion, this study demonstrates that the most frequently identified causes of 
chronic gastrointestinal disease in the adult horse are cyathostomosis, CIBD and alimentary 
lymphosarcoma and that, for the latter two conditions in particular, a definitive diagnosis is 
often difficult to achieve. While history and certain clinical features were considered as 
being useful for differentiating cyathostomosis from other causes of chronic gastrointestinal 
disease, the only specific diagnostic tests identified in this study were either faecal analysis 
for parasitic larvae or histopathological examination of biopsied rectal tissue. In fact, in 
addition to the limited diagnostic specificity of clinicopathological findings in cases of 
chronic gastrointestinal disease, there were numerous opportunities for misdiagnosis in the 
present study; the markedly elevated plasma GGT and AP concentrations detected in one 
animal with alimentary lymphosarcoma may have been misinterpreted as evidence of 
primary hepatic disease; demonstration of increased WCC and total protein concentrations 
in the peritoneal fluid of two animals diagnosed as GE with serosal involvement may have 
led to a misdiagnosis of peritonitis as the primary disease process; and, the culture of 
Salmonella and Campylobacter from the faeces of a number of cases may have been 
incorrectly interpreted as evidence of intestinal disease with a primary bacterial aetiology. 
These findings emphasise the importance of cautious interpretation of clinicopathological 
data.
Finally, although it is recognised that chronic gastrointestinal tract diseases are 
uncommon in adult equine animals, they are an important category of conditions because 
they can be severely debilitating. Reaching a definitive diagnosis in such cases is important, 
in that it allows for a rational approach to therapy/case management, but is often difficult 
because of the apparent overlap in clinical features between disease entities and a lack of 
specific diagnostic tests. Therefore, it is necessary that the information base on these 
conditions be expanded by seeking input from colleagues in general practice and other 
referral institutions to furnish more detailed epidemiological, clinical and clinicopathological 
data. In addition, this study serves to emphasise that further study should be directed 
towards developing/evaluating diagnostic techniques which may provide more objective 
information on gastrointestinal function in the horse.
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C h a p t e r  4
Fr u c t o sa m in e  M e a su r e m e n t  in  P o n ie s: Va l id a t io n  a n d  R e spo n se  F o l l o w in g  
E x p e r im e n t a l  C y a t h o st o m e  In f e c t io n
4.1 Introduction
4.1.1 Fructosamine formation
Fructosamine is a stable ketoamine compound. It is formed when a glucose molecule in the 
open chain form reacts non-enzymatically with the free amino groups of a protein molecule 
to create an unstable aldimine compound; aldimine may either dissociate back into glucose 
and protein or undergo spontaneous transformation, by amadori rearrangement, into a 
stable (i.e. irreversible) ketoamine (Dominiczak, 1991). The fructosamine concentration in 
peripheral blood is a measure of the glycation of all serum proteins, approximately 80-90 % 
of which, in man, is attributable to glycated albumin (Johnson, Metcalf & Baker, 1982; 
Kennedy, 1992). Consequently, the principal factors which influence fructosamine 
formation are the half-life of serum albumin (which is reported to be 19 days in horses 
(Mattheeuws, Kaneko, Loy, Cornelius & Wheat, 1966)) and the average glucose 
concentration to which the albumin is exposed while in circulation. Therefore, fructosamine 
concentration in peripheral blood varies according to the long-term glycaemic status and/or 
protein metabolism of an individual.
4.1.2 Clinical applications of fructosamine measurement in human and veterinary 
medicine
To date, the most common application of fructosamine measurement, in human medicine, is 
as an indicator of long-term glycaemic status in diabetic patients (Rowe & Dominiczak, 
1989). For this purpose fructosamine measurement has a major advantage over blood 
glucose estimation in that it reflects the average blood glucose concentration over the 
preceding 2-4 weeks and is unaffected by transient hyperglycaemia. Recently, a number of 
researchers in veterinary medicine have reported the successful use of fructosamine 
measurement to monitor therapeutic control of the hyperglycaemia of diabetes mellitus in 
dogs (Jensen, 1992; Reusch, Liehs, Hoyer & Vochezer, 1993; Graham, 1995) and cats 
(Kaneko, Kawamoto, Heusner, Feldman & Koizumi, 1992; Reusch et al., 1993). 
Conversely, Cantley, Ford & Heath (1991) reported that serum fructosamine concentrations 
are decreased in sheep with pregnancy toxaemia, which was considered to be a consequence 
of prolonged hypoglycaemia. In addition to its application in the monitoring of glycaemic
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status, it has been proposed that fructosamine measurement will reflect alterations in the 
rate of protein turnover: alterations in fructosamine concentration occur in patients with 
thyroid dysfunction (Lloyd & Marples, 1986; Waterson & Mills, 1988) in the absence of 
alterations in serum protein or glucose concentrations and are assumed to reflect changes in 
the rate of protein turnover.
4.1.3 Aim of studies
The aim of this study was to validate a fructosamine assay for use on equine serum and 
plasma and to evaluate the use of fructosamine measurement to monitor alterations in 
protein metabolism using, as a ‘model’, experimental cyathostome infections, which have 
been shown to result in enteric protein loss (Love et a l, 1991).
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St u d y  2
4.2 Fructosamine Validation
4.2.1 Background
The initial stage in the evaluation of a laboratory test, before it can be applied to a clinical 
setting, is to define the performance characteristics of the test within the analytical 
laboratory. While the validity of laboratory methods for the measurement of serum/plasma 
fructosamine have been studied and reported both in the dog (Jensen, 1992; Graham, 1995) 
and in the cat (Reusch et a l , 1993), a fructosamine assay has not yet been validated for use 
on equine serum or plasma.
4.2.2 Experimental objective
The objective of the study was to validate a fructosamine assay for use on equine serum and 
plasma.
4.2.3 Materials and methods
4.2.3.1 Animals and sample collection 
Twenty four British native-breed ponies were used in this study and were grouped 
according to age and diet (Table 4.1). All animals were stabled for the duration of the 
study and bedded on straw (Group A and B) or wood shavings (Group C) and were 
considered to be healthy based on clinical examinations. Blood was collected from these 
animals, into heparinised (Groups A, B and C) and plain (Groups A and B) vacutainers 
(Becton-Dickinson), once weekly for five weeks, by jugular venepuncture. Plasma and 
serum analyses were performed on the day of sample collection unless otherwise stated.
n Age Sex Diet
Group A 7 5-11 years old 1 male, 6 female hay only
Group B 8 9-12 months old 4 male, 4 female hay and coarse mix3
Group C 9 9-12 months old 3 male, 6 female high-fibre cubesb
Table 4.1: Age, sex and diet of three groups of ponies used to validate the 
fructosamine assay, n = number of animals.
a Spillers® Original Mix,b Spillers® High-Fibre Cubes (Spillers Horse Feeds).
Chapter 4 64
4.2.3.2 Fructosamine analysis
Plasma and serum fructosamine concentrations were measured using a commercial 
colorimetric test kit based on the ability of ketoamine to reduce nitroblue tetrazolium (NBT) 
in alkaline conditions (Unimate Fructosamine, Roche). The production of formazan forms 
of NBT is proportional to the concentration of fructosamine and was measured 
photometrically using an autoanalyser (Cobas Mira, Roche). Fructosamine measurements 
are made against a calibrator solution based on glycated polylysine supplied by the kit 
manufacturer (Fructosamine Calibrator, Roche).
4.2.3.3 Data analyses
Using a paired t-test and linear regression analysis, the effect of using either serum or 
plasma for fructosamine measurement was assessed by comparing the serum fructosamine 
concentrations with the plasma fructosamine concentrations which were measured in pony 
Groups A and B for five consecutive weeks.
The within-run variation was assessed by determining the coefficient of variation (CV) 
of 10 replicate measurements of fructosamine in two pony plasma samples (Group A pooled 
plasma, Group B pooled plasma). The between-day variation was assessed by determining 
the CV of five replicate measurements of fructosamine concentrations in two pony plasma 
samples (Group A pooled plasma, Group B pooled plasma), each stored at -20°C in five 
separate vials, of which one was thawed and assayed each day.
In order to determine the accuracy of the assay for measuring fructosamine at low 
concentrations, a plasma sample with an initial fructosamine concentration of 255 pmol/1 
was diluted 1/1.5, 1/2, 1/4 and 1/8 with physiological (0.9 %) saline. To evaluate the 
stability of fructosamine during storage, blood was collected from 13 animals (all Group A 
and six ponies in Group B) into heparinised vacutainers, and plasma fructosamine was 
measured i) immediately, ii) following storage of whole blood for 72 hours at room 
temperature, iii) following storage of plasma for 7 days at 4°C and iv) following storage of 
plasma for 28 days at -20°C.
To assess the effect of diet and age on fructosamine measurement in plasma, the means 
of animals (mean of five observations per animal) in Group B were compared to those of 
Group C and the means of Group A were compared to those of Groups B and C combined. 
Both factors were evaluated using the Mann Whitney U test. A probability of less than 5% 
(p<0.05) was taken to infer the presence of statistically significant differences.
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A reference range for fructosamine in pony plasma was calculated based on the mean of 
five observations per animal (n=24) (reference range = mean ± 2sd).
4.2.4 Results
Data which contributed to the results presented in this section are detailed in Appendices 4, 
5, 6, 7, 8 and 9.
Paired plasma and serum fructosamine measurements (n=75) were highly correlated 
(p<0.001) (Fig. 4.1). The mean serum fructosamine concentration and associated standard 
deviation (270.4 ±37.7 pmol/L) was greater than that calculated for plasma fructosamine 
concentration (263.3 ± 29.1 pmol/L). However, both sets of results were not statistically 
different (p=0.20). Because greater variation in serum fructosamine concentrations were 
observed, measurement of fructosamine in equine plasma was considered to be more 
appropriate, therefore validation results for plasma only are reported.
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Fig. 4.1 : Scatter plot demonstrating the correlation between plasma 
fructosamine concentration and serum fructosamine concentration based on 
measurements made following repeated sampling of ponies in Groups A and B.
Total number of paired samples assessed was 75.
The intra-assay coefficients of variation were 1.60 and 1.52 % for Group A plasma 
pool and Group B plasma pool, respectively, giving a mean CV of 1.56 %. The inter-assay 
coefficients of variation were 4.77 and 3.94 % for Group A plasma pool and Group B
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plasma pool, respectively, giving a mean CV of 4.35 % (Table 4.2). Linearity, expressed as 
a percentage of the initial fructosamine concentration in a serially diluted plasma sample, is 
shown in Figure 4.2. Deviation from linearity is observed in all diluted samples, the 
analysis tending to overestimate the predicted fructosamine concentration. However, the 
measured fructosamine concentrations did not differ markedly from the predicted 
fructosamine concentrations.
Intra- 
Group A
•assay
Group B
Inter-assay 
Group A Group B
n 10 10 5 5
mean 257.3 248.3 252.5 243
SD 4.11 3.77 12.03 9.57
CV% 1.6 1.52 4.77 3.94
Table 4.2: Intra-assay and inter-assay variations in equine plasma fructosamine 
concentrations (pmol/L). n = number of replicates, SD= standard deviation, CV 
= coefficient of variation.
300 n
so
u
■i->
Causou
250 -
200 -
c
g 150 -at
0
1  100 -
C3
I 50 - 
51
75 50 25 12.5 0100
Dilution %
Fig. 4.2: Quantitative recovery of fructosamine in a diluted equine plasma 
sample.
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Assessment of stability during storage (Fig. 4.3) indicated that fructosamine 
concentrations in whole blood stored for 72 hours (mean ± SD, 264 + 18.23 pmol/L) were 
significantly less (p<0.001) than those recorded immediately following sample collection 
(311.85 + 18.94 pmol/L). Although no significant difference was observed between 
immediate analysis and measurement of fructosamine after plasma storage for seven days at 
4°C (301 + 20.54, p=0.21), storage for 28 days at -20°C resulted in a significant decrease 
(296.3 ± 18.26, p=0.044).
No statistically significant differences between groups was recorded due to the effect of 
either diet (p=0.6) or age (p=0.145) on plasma fructosamine concentrations. The reference 
range for fructosamine in pony plasma, based on data from the 24 animals in this study, was 
calculated to be 256.88 + 53.04 pmol/L (203-310 pmol/L).
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Fig. 4.3: The effect of storage on plasma fructosamine concentrations (p,mol/L). 
Day 1 = immediate analysis, Day 3 = whole blood stored at room temperature 
for 72 hours, Day 7 = plasma stored at 4°C for 7 days, Day 28 = plasma stored 
at -20°C for 28 days.
4.2.5 Discussion
Fructosamines can be measured easily and rapidly, in equine serum or plasma, using the 
method outlined in this study. Simultaneous serum and plasma measurements were well 
correlated and not statistically different. However, because greater variation in serum 
fructosamine concentrations were observed (i.e. greater SD), measurement of fructosamine 
in equine plasma was considered to be more appropriate. The precision of the fructosamine 
assay, for use in equine plasma, as judged by intra- and inter-assay coefficients of variation
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was similar to that previously reported in both human (Kruse-Jarres, Jarausch, Lehmann, 
Vogt & Rietz, 1989) and animal validation studies (Jensen, 1992; Reusch et a l , 1993; 
Graham, 1995). Based on the dilution studies (linearity), the assay method was shown to be 
acceptably accurate for measuring low concentrations of fructosamine in equine plasma. In 
addition, the detection limit for this analytical method, based on analysis of 20 samples of 
physiological saline, was calculated to be 7 p,mol/L (mean ± 2 .6s d ) (Graham, 1995). Jensen 
(1992) reported that fructosamine was stable in canine serum when stored at 4°C and 25°C 
for five days and at -20°C for one month. Similarly, Graham (1995) demonstrated that 
fructosamine is stable in whole blood, at room temperature, for 48 hours. The results of the 
present study indicate that a significant and unacceptable reduction in plasma fructosamine 
occurs when equine whole blood is stored at room temperature for 72 hours, however, it is 
stable for one week when the plasma is separated and stored at 4°C. In addition, although a 
significant decrease in plasma fructosamine concentration was observed following sample 
storage for one month at -20°C, the variation from immediate analysis was less than 5 % 
and may, in part, be explained by inter-assay variation. Therefore, it was considered that 
storage of equine plasma samples for up to one week at 4°C and up to one month at -20°C 
is acceptable for fructosamine determination. Although possible interference by other 
plasma constituents was not investigated, the assay method/protocol (reaction pH and time 
course) ensure negligible interference by other reducing substances such as creatinine and 
glucose (Johnson, Metcalf & Baker, 1982). In addition, Kruse-Jarres et al. (1989) observed 
no interference due to anticoagulants and Reusch et a l (1993) reported that fructosamine 
measurement was unaffected by transient hyperglycaemia.
Analysis of data for the different groups of ponies showed no significant effect due to 
diet or age. However, because the effect of age approached significance (p=0.145), this 
factor should ideally be re-evaluated using larger groups of animals.
The reference range, calculated after combining data from all ponies included in this 
validation study (203-310 fimol/L) is ‘narrower’ than reference ranges reported for other 
species (Reusch et a l , 1993; Graham, 1995) and may be a reflection of the single breed 
type used in this study and the similar background of those animals (i.e. all stabled). 
Interestingly, Jensen & Aaes (1992) reported a narrow reference range of 258.6-343.8 
p.mol/L for fructosamine concentrations in canine serum, however, it was based on data 
from 29 adult Beagle dogs maintained under similar conditions.
The validation study indicates that the assay is rapid and precise and accurate for 
measuring low concentrations of fructosamine in equine plasma.
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4.3 Fructosamine Response Following Experimental Cyathostome Infection
4.3.1 Background
The detection of hypoalbuminaemia, in animals with chronic gastro-/enteropathies, indicates 
that severe intestinal pathology exists. In mild or subclinical disease, protein loss and/or 
increases in protein catabolism may be compensated for by increased synthesis such that 
measurement of albumin concentrations give results within the normal range. Thus, 
measurement of albumin concentrations alone is a relatively unreliable/crude indicator of 
altered protein metabolism and it is considered that measurement of the rate of protein 
turnover would be more informative: This has only been accurately achieved in the horse 
using radioisotope tracer techniques (Duncan & Dargie, 1975; Love, 1990). However, in 
recent years, studies in man have indicated that serum fructosamine measurement may prove 
to be a simple, sensitive method of assessing altered protein metabolism (Lloyd & Marples, 
1986; Waterson & Mills, 1988).
4.3.2 Experimental objective
The specific objective of the study was to evaluate the use of fructosamine measurement to 
monitor alterations in protein metabolism using, as a ‘model’, experimental cyathostome 
infections.
4.3.3 Materials and methods
4.3.3.1 Animals, experimental infections and sampling 
The animals used in this study were nine British native-breed ponies, the details of which are 
outlined in Table 4.1 (Group C). All animals, reared indoors with their dams, were 
considered to be helminth-naive prior to experimental infection. The ponies were randomly 
allocated to one of three groups; Infected Group 1 (Pony Nos. 101,104 and 105), Infected 
Group 2 (Pony Nos. I l l ,  112 and 113) and an Uninfected Control Group 3 (Pony Nos. 
102, 103 and 106).
Cyathostome third-stage larvae (L3) were cultured and harvested from faeces obtained 
from two ponies which had naturally acquired a cyathostome infection by grazing the same 
pasture. The larvae were stored for 6-10 weeks at 4°C (i.e. cold-conditioned) and given as 
a ‘trickle’ infection, with doses of 150,000 L3 administered by nasogastric tube three times 
weekly. Infected Group 1 received a total of 3.9 million L3 over a nine week period and 
infected Group 2 received a total of 3.15 million L3 over seven weeks.
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From four weeks prior to infection, blood was obtained once weekly, from all animals, 
for blood biochemical analyses (plasma fructosamine, plasma albumin and SPE). In addition, 
from eight weeks prior to infection all animals were weighed weekly. Post infection, each 
pony was monitored daily for alterations in demeanor, appetite and faecal consistency.
4.3.3.2 Laboratory analyses
Plasma fructosamine was measured using the method outlined above (Section 4.2.3.2). 
Total plasma protein and plasma albumin were analysed using a modified Biuret and 
bromocresol green methods, respectively. Electrophoretic separation of the serum proteins 
was achieved in an integrated system (Paragon Electrophoresis System, Beckman 
Instruments Inc.) on thin layered, buffered agrose gels (Paragon SPE kit, PN 655900, 
Beckman Instruments Inc.). The protein fractions were quantified by densitometry 
(Appraise Densitometer System, Beckman Instruments Inc.) and calculated from total 
protein.
4.3.3.3 Data analyses
The effects of experimental group, time and animal on weight change (kg), plasma 
fructosamine concentration (fimol/L), plasma albumin concentration (g/L) and serum 
globulin fractions (a2, pi, p2 and y) (g/L) were assessed. Although the group sizes in this 
experiment are too small to comment on anything other than trends, statistical analysis using 
analysis of variance (ANOVA) techniques were performed to support observations. For 
this purpose, the data for each parameter up to the time of infection were analysed 
separately from data collected after infection. Where there was no significant difference 
among groups prior to infection, the raw post infection data were analysed. Where there 
was a significant difference among groups prior to infection, the post-infection data were 
adjusted by subtracting the mean of the pre-values from each of the post-values for each 
animal (i.e. the dependent variable in the ANOVA equation was the change in the measured 
parameter rather than the absolute value). Significance was set at the 5 % level.
4.3.4 Results
The results, presented below, are based on pre-infection data and that obtained during the 
first 20 weeks post-infection and are detailed in Appendices 10, 11, 12 and 13. Full clinical, 
haematological, blood biochemical and parasitological findings for this study are recorded 
elsewhere (Murphy & Love, 1997).
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4.3.4.1 Clinical observations 
Following initial infection, the weight gain of ponies in both infected groups was reduced, 
relative to the control animals. This effect was observed in all infected animals by five 
weeks post infection (PI) (Fig. 4.4).
One pony in infected Group 2 became dull, intermittently diarrhoeic and had a reduced 
appetite 51 days PI. Due to a gradual worsening of these clinical features and the 
development of colic, this pony was euthanased 66 days PI: At post mortem examination 
cyathostome-induced typhlitis/colitis was evident. The remaining animals in Group 1 and 
Group 2 remained bright, appetant and demonstrated no clinical evidence of intestinal 
disease during the 20 week PI period.
Weight Gain Weight Gain (%)
Group 2Group 1
-20
8 -4 0 4 8 12 16 208 -4 0 4 8 12 16 20
Time (weeks)
-^-Control ■♦■101 * 1 0 4
Time (weeks) 
105 *-111 0 1 1 2  * 1 1 3
Fig. 4.4: Weight changes (expressed as a percentage of individual weights at 8 
weeks pre-infection) of individual ponies following experimental cyathostome 
infection compared with Control Group mean (±SD).
4.3.4.2 Blood biochemistry 
Plasma fructosamine concentrations increased in the control ponies during the course of this 
study (mean ± SD, 216 + 32.5 pmol/L at day 0 to 312 + 17 pmol/L at 20 weeks PI), but 
decreased, relative to the controls, in both infected groups (Fig. 4.5). In the infected 
groups, fructosamine concentrations, in five ponies, fell below the lowest limit of the
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Fig. 4.5: Plasma fructosamine concentrations (pmol/L) in individual ponies 
following experimental cyathostome infection compared with Control Group 
mean (±SD).
Plasma albumin
Group 1
■4 0 4 8 12 16 20
Plasma albumin
Group 2
•4 0 4 8 12 16 20
Time (weeks)
♦  Control ♦ 1 0 1 104
Time (weeks) 
105 -A- 111 44112 44113
Fig. 4.6: Plasma albumin concentrations (g/L) in individual ponies following 
experimental cyathostome infection compared with Control Group mean (±SD).
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reference range (i.e. 203.8 pmol/L) between 13 and 18 weeks PI. Similarly, plasma albumin 
concentrations increased in the control group during this study period (mean + SD, 21 + 4 . 6  
g/L at day 0 to 33 + 0 g/L at 20 weeks PI). Visual assessment of Figure 4.6 shows that 
changes in plasma albumin concentration were more marked in Group I compared with 
those in Group 2. Notably, no obvious decrease in plasma albumin concentration was 
detected in pony 111 prior to euthanasia (3 lg/L).
Increases in a2- (four ponies), (32- (five ponies) and y-globulin fractions (six ponies) 
were observed from 4-6 weeks PI, whereas increases in (31-globulin were observed in five 
animals at a later stage (10-12 weeks PI) in the course of these infections (Fig. 4.7).
For all measured parameters, the observed differences in trends were supported by the 
statistical analyses (p<0.001).
16 20 12 16 20
16 20 -4 0 
Time (weeks)
Group 1 mean Group 2 mean -fr Group 3 mean
Fig. 4.7: Group mean alterations in serum globulin fractions (a, (31, (32 and y) 
(g/L) following experimental cyathostome infection.
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4.3.5 Discussion
Parasitism, in particular disease due to cyathostome infection, is recognised as an important 
cause of gastrointestinal dysfunction in equine animals, which may manifest clinically as 
weight loss and/or colic and/or diarrhoea (Mair et a l, 1990; Uhlinger, 1990; Love, Mair & 
Hillyer, 1992). The results of the present study demonstrate that cyathostomes are 
pathogenic to ponies when administered in conditions and at rates considered likely to 
mimic the uptake of infective larvae by the grazing animal. All infected ponies failed to gain 
weight at the same rate as the control animals and one pony developed clinical signs 
attributable to gastrointestinal disease within the 20 week PI study period. In addition, 
infection resulted in significant changes in numerous constituents of peripheral blood within 
the first 4-6 weeks of infection indicating that mucosal penetration may contribute to the 
pathogenic effects which have traditionally been attributed to larval emergence. Although, 
from the present study, it was not possible to confirm the pathophysiological mechanism of 
these changes, it is likely that they reflect intestinal mucosal inflammation.
A decrease in plasma fructosamine concentration was detected in both infected groups 
and became apparent in all animals 4-6 weeks PI. Based on our knowledge of fructosamine 
formation, the factors which may be responsible for a decrease in plasma fructosamine 
concentration include increased protein turnover and/or protein loss and/or altered 
composition of serum proteins and/or prolonged hypoglycaemia. Hypoalbuminaemia is a 
frequent, but not consistent, feature of naturally-occurring cyathostome infections 
(Uhlinger, 1991; Love, Mair & Hillyer, 1992), and is assumed to be a consequence of 
increased intestinal permeability and enteric protein loss (Love et al., 1991). In the present 
study, there was a decrease in plasma albumin concentration in both infected groups, 
relative to the control animals, and this feature is likely to have been a major influencing 
factor on the observed decrease in fructosamine concentration.
In studies in man, alterations in fructosamine concentration occur in patients with 
thyroid dysfunction in the absence of alterations in serum protein or glucose concentrations 
and are assumed to reflect changes in the rate of protein turnover (Lloyd & Marples, 1986; 
Waterson & Mills, 1988). Based on this observation, Heath & Connan (1991) investigated 
the usefulness of fructosamine measurement as a means of monitoring alterations in protein 
metabolism in ovine gastrointestinal parasitism, but their findings were not conclusive and 
the decreases in fructosamine concentrations which they detected could have been due to 
factors other than increased plasma protein turnover. It is known that in ovine 
gastrointestinal parasitism marked increases in enteric protein loss and the rate of albumin
Chapter 4 75
turnover may occur in the absence of a marked decrease in serum albumin suggesting that 
increases in the catabolism of albumin may be compensated for by increased synthesis 
(Holmes & MacLean, 1971). On this basis, the straight forward measurement of albumin 
concentrations can give results within normal ranges such that they are relatively unreliable 
indicators of underlying dynamic intestinal pathogenic processes in sheep. From the results 
of individual animals in the present study, it would appear that similar effects may arise in 
equine intestinal parasitism. For example, in pony 111 (Group 2), an obvious decrease in 
fructosamine concentration was observed PI, suggesting significant disturbances in protein 
metabolism, however, no concurrent alteration in plasma albumin concentration was 
detected in this animal. In addition, for the other two animals in Group 2, decreases in 
plasma albumin concentration were relatively mild compared with the observed decreases in 
plasma fructosamine concentration.
Much of the data available on changes in serum globulin fractions in cyathostome 
infections are conflicting. In experimental infections, Love et al. (1991) detected no 
noticeable changes in values of any serum globulin fractions in ponies which received 
greater numbers of infective cyathostome larvae, whereas Round (1970) detected elevations 
in (3-globulin fraction. Similarly, in natural infections, Giles, Urquhart & Longstaffe (1985) 
reported increased a- and (3-globulin fractions, whereas Mair, Cripps & Ricketts (1993) 
detected significantly higher values for (31-globulin fraction in horses with acute larval 
cyathostomosis when compared with horses which were diarrhoeic for other reasons. The 
results of this study demonstrate that marked alterations in serum globulin composition may 
occur in animals with cyathostome infection. This feature, presumed to be a consequence 
of an intestinal inflammatory response, may have an effect on fructosamine concentration, 
because it is known that certain classes of globulins are more potent glycators than others 
(Handley, Johnson & Peel, 1993).
Although fructosamine concentrations have been shown to decrease in medical 
conditions associated with prolonged hypoglycaemia (Cantley, Ford & Heath, 1991), no 
data is available on possible alterations in the glycaemic status of the infected ponies in the 
present study. Therefore, the influence of this potential variable on fructosamine 
concentrations following experimental cyathostome infection is unknown.
In conclusion, the results of this study confirm that cyathostomes are pathogenic to 
young ponies and that it is possible to assess these effects by sequential clinical 
measurements. With regard to the use of fructosamine for monitoring alterations in protein 
turnover, it is possible that it may be a more effective means, than albumin measurement, for
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monitoring relatively subtle effects of experimental cyathostome infections which might 
occur after administration of relatively small inocula of larvae (i.e. low level infection). 
Similarly, since a proportion of animals with naturally-acquired cyathostomiasis are 
normoalbuminaemic, it is possible that fructosamine measurement may be a more sensitive 
indicator than albumin measurement for the purposes of detecting altered protein 
metabolism in these individuals. Finally, it is possible that fructosamine measurement could 
be utilised for assessment and/or clinical monitoring of other equine chronic enteropathies.
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C h a p t e r  5
St u d ie s  o n  t h e  Or a l  G l u c o se  T o l e r a n c e  Te st  in  th e  H orse
5.1 Introduction
5.1.1 The oral glucose tolerance test in equine gastroenterology
Carbohydrate absorption studies were first introduced to equine gastroenterology in the 
early 1970s as a means of evaluating small intestinal function. Loeb, McKenzie & Hoffsis
(1972) described the use of a carbohydrate digestion/absorption test for assessment of 
upper gastrointestinal tract and/or pancreatic function. Following an overnight fast, animals 
under test were administered 2 lbs of corn starch in four litres of water. Serial blood 
samples were obtained pretest and hourly for four hours thereafter and analysed for glucose 
concentration. For normal individuals, a mean peak increase of approximately 40 % above 
mean basal glucose concentrations was detected one hour post starch administration. 
Consequently, it was hypothesised that failure to detect an increase in plasma glucose 
concentration was indicative of either pancreatic disease with decreased amylase 
secretion/activity or small intestinal malabsorption. In addition, it was suggested that 
performing an OGTT would facilitate differentiation between pancreatic and small intestinal 
disease (Loeb, McKenzie & Hoffsis, 1972). Roberts & Hill (1973) described an OGTT for 
use in the horse and demonstrated its potential for detecting small intestinal malabsorption. 
In those studies, following an overnight fast, 1 g anhydrous glucose per kg bwt was 
administered by stomach tube as a 20 % w/v solution. Blood samples were collected at 
zero, 30, 60, 90, 120, 180, 240, 300 and 360 min and analysed for glucose concentration. 
In normal individuals, plasma glucose concentrations increased to approximately 200 % of 
the BGC within 120 min of oral glucose loading and subsequently decreased to pretest 
concentrations within the six hours sampling period (Roberts & Hill, 1973).
The absorption of glucose by the small intestine is a highly efficient process, whereby 
the molecule is actively transported against a concentration gradient by the combination of a 
sodium dependent glucose-galactose specific carrier and an energy dependent sodium pump 
(Freeman & Quamme, 1986). Therefore, it is assumed that a suboptimal plasma glucose 
tolerance curve suggests a defect in specific nutrient absorption due to marked 
morphological and/or functional damage to the small intestinal mucosa. When Roberts & 
Hill (1973) performed an OGTT on two horses with clinical signs of gastrointestinal tract 
dysfunction, minimal increases in plasma glucose concentrations were detected and these
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animals were subsequently confirmed, at necropsy, as having severe small intestinal 
pathology.
Only one report has been published which correlates the plasma glucose response in 
individual horses with post mortem findings (Mair et a l , 1991). In that study, OGTTs were 
performed as described by Roberts & Hill (1973) and the results were classified as either 
normal or evidence of either partial malabsorption or total malabsorption (Mair et al.,
1991). Normal glucose response was defined as tests where the plasma glucose 
concentration at 60 or 120 min was greater than 185 % of the BGC, whereas a total 
malabsorption was defined as tests where plasma glucose concentrations at 60 and 120 min 
showed a lower than 15 % increase above BGC. All horses which exhibited a total 
malabsorption had small intestinal disease (either alimentary lymphosarcoma or GE) when 
examined at necropsy (i.e. the test was 100 % specific). However, in a report published at 
roughly the same time the ability of the OGTT to differentiate between large and small 
intestinal disease processes was questioned, based on the fact that several horses with 
confirmed cyathostomosis exhibited carbohydrate malabsorption (Love, Mair & Hillyer,
1992).
5.1.2 Factors which influence the oral glucose tolerance test
It is recognised that a variety of factors, apart from malabsorption, may influence plasma 
glucose concentrations after oral glucose loading and compromise interpretation of test 
results. Breukink (1974) emphasised the need to use a standardised test protocol because 
quantity and concentration of glucose administered and length of starvation prior to the test 
affect the glucose absorption curve. Food deprivation for 24 to 36 hours was found to 
reduce glucose absorption in ponies (Breukink, 1974). Although the physiological 
mechanism(s) responsible for this are unclear, they may involve altered gastrointestinal 
motility, decreased efficiency of mucosal transport systems or altered insulin function 
(Freeman, Ferrante, Kronfeld & Chalupa, 1989). Regardless of the precise mechanism 
involved, it is possible that the results of carbohydrate absorption studies performed in 
animals deprived of food/anorexic animals, without gastrointestinal disease, could resemble 
the absorption curves of horses with primary malabsorption syndromes (Freeman et al., 
1989). Similarly, it has been demonstrated that maintenance diet may influence the glucose 
absorption curve. Jacobs & Bolton (1982) detected substantially lower glucose absorption 
curves in horses fed a stable diet comprised of hay, chaff and a commercial complete feed, 
when compared with those obtained for pasture-fed horses. These findings prompted the
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authors to suggest that the OGTT should be further standardised by feeding a standard diet 
for 1 week prior to performing the test. Based on the observations of Jeffcott, Field, 
McLean & O’Dea (1986), it is known that breed/endocrine status will influence glucose 
metabolism and therefore plasma glucose concentrations post oral glucose loading. These 
authors noted that higher plasma glucose concentrations were achieved in normal ponies 
when compared to Standardbreds, with glucose concentrations for both groups returning to 
pretest concentrations within 360 min. When the OGTTs were performed on ponies which 
were obese and/or laminitic peak plasma glucose concentrations were higher than those 
achieved in Standardbreds and glucose levels remained elevated for the remainder of the 
sampling period. These findings were considered indicative of innate insulin resistance in 
ponies (Jeffcott et a l,  1986) and suggest that separate reference ranges for normal plasma 
glucose response in horses and ponies should be established.
5.1.3 Other carbohydrate absorption tests in equine gastroenterology
Breukink (1974) and Roberts (1975) documented studies, using a variety of oral 
disaccharide and monosaccharide tolerance tests, designed to evaluate the efficiency of 
specific disaccharidase enzymes and sugar transport mechanisms in the equine small 
intestine. Of these tests, it was considered that the lactose tolerance test was potentially of 
most clinical value in that it may allow detection of lactase deficiency/small intestinal 
mucosal damage in diarrhoeic foals. It is recognised that the ability to hydrolyse lactose is 
severely affected in humans with diffuse intestinal mucosal damage, lactase activity being 
depressed more than the other disaccharidases and is the last to recover (Roberts, 1975). 
Therefore, it has been suggested that a reduced tolerance curve may indicate the need to 
restrict/prevent access to milk for a period to avoid osmotic diarrhoea (Roberts, 1985). As 
horses mature they lose the ability to hydrolyse lactose, being lactase deficient from 2.5 to 3 
years of age (Breukink, 1974: Roberts, 1975) and, therefore, this test procedure is of no 
diagnostic relevance in the adult equine animal.
The oral D-xylose tolerance test has also been adapted for use in the horse (Roberts,
1974). This test is based on the same principle as the OGTT, in that evidence of abnormal 
xylose absorption is suggestive of small intestinal pathology (Bolton et al., 1976; Roberts & 
Norman, 1979). Compared to small intestinal transport of glucose, D-xylose has a low 
affinity for active transport systems in small intestinal mucosa, which become saturated at 
low intra-luminal concentrations of xylose (Freeman, 1993). Based on this knowledge, 
Freeman (1993) indicates that the xylose absorption test should be regarded as a measure of
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intestinal mucosal surface area and mucosal permeability rather than as a specific measure of 
nutrient carbohydrate absorption. Therefore, absorption of this sugar would be expected to 
occur predominantly by passive mechanisms under conditions of the D-xylose absorption 
test. Information regarding the clinical value of the xylose absorption test is limited. 
Merritt, Mallonee & Merritt (1986), extrapolating from studies in other species suggested 
that assessment of xylose absorptive capacity was a more sensitive indicator of small 
intestinal disease than the OGTT. Although Brown (1992) reported that the results of the 
D-xylose tolerance test correlated well with necropsy findings in 11 animals (five horses 
with normal xylose absorption had no lesions of the small intestine, whereas five of six 
horses with evidence of xylose malabsorption had either lymphocytic-plasmacytic enteritis 
or alimentary lymphosarcoma with small intestinal involvement), no data has been published 
which compares the efficacy of both the OGTT and the oral xylose tolerance test for 
detecting small intestinal pathology. Furthermore, it has been suggested that xylose is 
preferable to glucose as a test substrate in carbohydrate absorption studies because it is not 
normally present in plasma and it is not subject to individual variation in glucose metabolism 
(Mair et a l , 1991). However, the cost of xylose is greater than that of glucose and the 
availability of xylose analysis is limited such that the OGTT is more commonly employed for 
the investigation of small intestinal malabsorption.
5.1.4 Aim of studies
The aim of the studies reported in this Chapter was to investigate some of the factors which 
may influence the OGTT and to assess the efficacy of this technique for detecting small 
intestinal pathology in the horse.
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5.2 The Effect of Age and Diet on the Oral Glucose Tolerance Test in Ponies
5.2.1 Background
It is generally accepted that factors other than reduced absorptive capacity, due to small 
intestinal pathology, may influence the plasma glucose response following oral glucose 
loading. A number of these factors have been investigated previously and include, glucose 
dose and concentration (Roberts & Hill, 1973), period of starvation prior to the test 
(Breukink, 1974), breed/type and endocrine events (Jeffcott et al., 1986). In addition, 
Jacobs & Bolton (1982) reported that altering the diet, from pasture to hay and concentrate 
or vice versa, in the week prior to testing, resulted in significantly different oral glucose 
tolerance curves. However, for both diets assessed in that study, the plasma glucose 
response would have been considered ‘normal’ by conventional standards (i.e. peak glucose 
concentration > 85% increase above BGC) (Mair et a l, 1991).
Although xylose absorptive capacity, following oral D-xylose loading, decreases with 
advancing maturity in the growing foal (Merritt, Mallonee & Merritt, 1986), the effect of 
age on the OGTT has not been reported.
5.2.2 Experimental objectives
The objectives of this study were two fold: i) to determine whether significant differences in 
OGTT results exist between foals and adult ponies when maintained on the same diet and, 
ii) to evaluate alterations in the OGTT when adult ponies are maintained on a hay diet 
compared with when maintained on a ‘complete’ pelleted ration.
5.2.3 Materials and methods
5.2.3.1 Animals and experimental design 
Fourteen British native-breed ponies were used in this study (Table 2.1), All animals were 
considered to be healthy based on history and clinical examinations. The ponies were 
assigned to two groups: Group A (6 - 9 months) and Group B (6 - 13 years). All ponies in 
Group A were reared indoors with their dams during which time they were bedded on straw 
and had free access to hay. Following weaning at four months, they were maintained on a 
high fibre pelleted ration, fed twice daily, and bedded on woodshavings. Oral glucose 
tolerance tests were performed on this group on three occasions over a two-week period. 
The animals in Group B were stabled for at least six months prior to the beginning of this 
study, during which time they were fed hay only (Diet 1) and bedded on barley straw.
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Subsequently, these animals were changed to a high fibre pelleted ration (Diet 2), fed twice 
daily, and bedded on shredded paper. OGTT’s were performed on all animals in Group B 
while maintained on Diet 1, then on Diet 2. Tests were repeated on each animal on three 
occasions while on each diet. A period of 4 weeks was allowed, for acclimatisation to Diet 
2, before tests were carried out. Each pony was weighed on a weekly basis and these body 
weights were used to determine the required amount of glucose. When tests were repeated 
on individuals, at least 72 hours were allowed between tests.
5.2.3.2 Oral glucose tolerance tests
A standard OGTT protocol was established based on that described by Roberts & Hill
(1973), and performed as outlined in Section 2.2.3. All samples were analysed for glucose 
concentration on the day of collection.
5.2.3.3 Statistical analyses
The effect of age on the OGTT was analysed by two-factor ANOVA. A repeated measures 
design was used with the pony treated as a random effect nested within age group. 
Comparison of the OGTT results for the adult ponies, when maintained on different diets, 
was performed using two-factor ANOVA with repeated measures with the pony, again, 
treated as a random effect and without nesting. In both cases, each replicate was analysed 
separately. Paired Student’s t-tests were used to test for statistical significance between 
groups for the glucose concentration at each sampling time. In order to assess possible 
weight alterations in the adult ponies due to the change in diet, mean weights while on Diet 
1 were compared to mean weights while on Diet 2 by a paired student’s t-test. For all 
analyses, significance was set at the 5% level.
5.2.4 Results
Data which contributed to the results presented in this section are detailed in Appendices 
14, 15 and 16.
When analysis of the OGTTs was performed on the foal and adult ponies, maintained on the 
same diet, there was a significant difference between the groups in their response over time 
(p<0.05) (i.e. a significant interaction between age and time for each replicate). No 
significant difference was detected between groups for BGC. However, from 30 min until 
240 min post oral glucose loading, plasma glucose concentrations were consistently lower 
for the adults (peak glucose concentrations (G Iu m ax) (mean ± SD ) = 6 .8  ±  1 .3  mmol/L at 90
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min) when compared to the foals (G 1uMa x  = 11.5 ± 1.3 mmol/L at 90 min) (Fig. 5.1). For 
adult animals, plasma glucose concentrations returned to pre-test values by 240 min, 
whereas, for the foals, return to pre-test concentrations occurred at 300 min. In addition, 
for the foal group, glucose concentrations were significantly lower at 360 min (p<0.001) 
when compared to those recorded for BGC. For 15 of the 21 OGTTs performed on the 
foal group, plasma glucose concentrations of 3 mmol/L or less were detected at 300 and/or 
360 min.
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Fig. 5.1: Mean (±SD) plasma glucose concentrations, following the 
administration of lg glucose/kg bwt to seven adult and seven pony foals 
when maintained on Diet 2 (pelleted ration).
When comparing the results of OGTT’s performed on the adult ponies, when maintained on 
different diets, a significant difference in the plasma glucose response over time was 
detected (p<0.05) (i.e. a significant interaction between diet and time). Glucose 
concentrations at 0 min were significantly greater for Diet 1 (p<0.01) when compared to 
Diet 2. In general, ponies maintained on Diet 1 had a higher plasma glucose response, 
following oral glucose loading, and G Ium ax occurred later (9.6 ± 2.1 mmol/L at 150 min) 
when compared to Diet 2 (6.8 ± 1.3 mmol/L at 90 min) (Fig. 5.2). In addition, when on 
Diet 1, the mean plasma glucose concentration returned to pre-test values at 360 min, 
compared to 240 min for Diet 2. When maintained on the hay diet, assessment of individual 
pony responses to oral glucose loading indicated that G Ium ax exceeded 11.0 mmol/L in
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three animals (two ponies on two occasions, one pony on one occasion), and on four of the 
21 occasions that the test was performed plasma glucose concentrations had not decreased 
below 6 mmol/L by 360 min post-glucose administration.
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Fig. 5.2: Mean (±SD) plasma glucose concentrations, following 
the administration of lg glucose/kg bwt to seven adult ponies, 
when maintained on Diet 1 (hay diet) compared with when 
maintained on Diet 2 (pelleted ration).
Analysis of adult pony weights indicated that the ponies were significantly heavier (p<0.05) 
at the time of performing the OGTT’s on Diet 2 compared to Diet 1 (Fig. 5.3).
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Fig. 5.3: Mean body weight of the individual adult 
ponies when maintained on the hay diet compared with 
when maintained on the pelleted ration only.
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5.2.5 Discussion
The results of this study indicate that both age and diet have significant effects on plasma 
glucose concentrations, measured during an OGTT.
In this study there were marked effects of diet on the OGTT: The mean peak plasma 
glucose concentration of ponies, when maintained on the pelleted ration, represented an 
increase of only 68 % above basal glucose concentrations. Jacobs & Bolton (1982) were 
first to demonstrate an effect of diet on the OGTT. They reported that stabled horses, 
receiving a diet of a commercial complete feed, oats and alfalfa chaff, had significantly 
lower glucose tolerance curves compared to those obtained when animals were maintained 
at pasture, which led them to suggest that diet influenced either the amount of glucose 
which was absorbed or glucose metabolism (Jacobs & Bolton, 1982).
The effect of diet on glucose metabolism has been acknowledged since the early 
1970’s, when Argenzio & Hintz (1972) observed greater glucose availability and more 
efficient glucose utilisation when ponies were maintained on an oat diet compared with 
when receiving a high-fibre diet of alfalfa/beet pulp, despite the fact that the latter diet 
supplied greater digestible energy. In addition, plasma glucose concentrations while on the 
grain diet were less than those measured while on the roughage diet. These results 
demonstrated the marked effect of the type of diet on glucose metabolism and may explain, 
in part, the differences observed in BGC and the glucose response following oral glucose 
loading when maintaining ponies on different diets. The increased weight observed in these 
animals when fed Diet 2 was most likely due to increased energy intake, but analysis of 
nutrient intake by individual adult animals, while on each diet, was not performed.
Based on the classification system described by Freestone, Shoemaker, Bessin & 
Wolfsheimer (1992), adult ponies with peak plasma glucose concentrations exceeding 11.1 
mmol/L, following oral glucose loading are defined as having impaired glucose tolerance. 
Using this criterion, three adult ponies in this study when maintained on the hay diet 
exhibited evidence of impaired glucose tolerance. In a different study, Freestone, Beadle, 
Shoemaker, Bessin, Wolfsheimer & Church (1992), reported that rested ponies fed a 
complete pelleted feed ration, ad libitum, lost weight and showed evidence of improved 
insulin sensitivity. Although animals in this study gained weight while maintained on a 
complete pelleted diet, fed twice daily, impaired glucose tolerance was not observed and, on 
all occasions, plasma glucose concentrations returned to pre-test values within the six hour 
sampling period (i.e. in this study, an apparent improved insulin sensitivity was observed on 
the pelleted versus the hay diet). Therefore, it is possible that, regardless of body condition
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status, the type of diet may influence insulin response/sensitivity and might account for the 
observed differences in plasma glucose response. Interestingly, Smyth, Young & Hammond 
(1989) reported that, although postprandial insulin secretion in horses is affected by dietary 
composition, the exocrine pancreas readily adapts to changes in dietary composition. Their 
results suggest that insulin response (output) following oral loading with a particular dose 
and concentration of glucose should not be influenced by maintenance diet.
Other dietary factors which may affect the plasma glucose response in healthy ponies, 
following oral glucose loading are those which result in altered absorption of glucose, such 
as, changes in intestinal motility/transit time and/or changes in bacterial populations in the 
small intestine and/or changes in mucosal cell function/glucose transport mechanism. 
Clarke, Roberts & Argenzio (1990) suggested that bolus feeding of concentrate meals will 
result in increased small intestinal transit of ingesta, due to increased bulk of ingesta and/or 
alterations in the intrinsic motor activity of the gut, when compared to a steady feeding 
state. Consequently, if the pattern of small intestine motor activity varies with diet, this 
would be expected to alter the efficiency of small bowel digestion/absorption and result in a 
variable proportion of soluble carbohydrate reaching the large intestine. Similarly, changes 
in diet have been shown to alter microbial populations and the fermentation process in the 
equine large intestine (Kern, Slyter, Weaver, Leffel & Samuelson, 1973; Willard, Willard, 
Wolfram & Baker, 1977). More recently, Mackie & Wilkins (1988) demonstrated that 
substantial populations of bacteria are present in the small intestine of grass-fed horses and 
that they contribute to the digestion of carbohydrates. Therefore, it would seem reasonable 
to suggest that dietary alterations will also influence microflora populations in the small 
intestine which could, presumably, influence the amount of glucose available for absorption 
from the gut lumen. In addition, variation in diet may influence intestinal/mucosal function. 
Mathers, Kennard & James (1993), when summarising the effects of diet on gut function, 
concluded that the amount and composition of a diet can have a major influence on mucosal 
proliferation at many sites in the gastrointestinal tract, but the mechanisms involved are not 
apparent. Similarly, alterations in gut flora in experimental animals are reported to have a 
profound effect on mucosal villous shape (Creamer, 1967).
The results of this study indicate that age also influences plasma glucose response 
following oral glucose loading and that significant differences exist between adults and 
ponies 6 - 9  months of age. Previously, Merritt, Mallonee & Merritt (1986) reported that 
xylose absorptive capacity decreased in growing foals and was similar to that of the adult 
horse by three months of age. Comparing the results of that study with those of the present
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study, it would appear that there may be differences in the rate of maturation of the equine 
intestine with regard to mucosal-glucose and mucosal-xylose interactions.
Because the principle source of energy for the suckling foal is lactose compared with 
enzymatic/fermentative products of complex carbohydrates in adults, differences in 
carbohydrate metabolism may exist between suckling foals and adults, which could 
contribute to the differences reported here, despite the fact that these foals had been weaned 
for at least three months. It was notable that, for the foal group, plasma glucose 
concentrations at 360 min were significantly lower than those recorded pre-test. It is 
possible that the greater peak plasma glucose concentrations achieved in the foals resulted 
in a relatively greater stimulus for insulin secretion and consequently more rapid 
normalisation of plasma glucose concentrations, which frequently resulted in an over-swing 
to relative hypoglycaemia.
Because both foals and adults were managed under the same conditions (i.e. stabled, 
fed the same diet twice daily) for at least one month prior to performing the repeated 
OGTT’s, we assume that factors such as intestinal motility and luminal flora would not be 
dissimilar between the groups and should not be expected to account for the differences 
observed in glucose tolerance. The differences may be explained by age-related changes in 
enterocyte function/transport mechanisms which may be responsible for altered intestinal 
absorption with advancing maturity as proposed by Merritt, Mallonee & Merritt (1986). In 
both man and rats it is known that there is an age-related decline in the digestive capacity of 
the small intestine (Feibusch & Holt, 1982; Mathers, Kennard & James, 1993), reduction of 
active sugar absorption (Esposito, Faelli, Tosco, Orsenigo & Battistessa, 1985; Freeman & 
Quamme, 1986; Beaumont, Cobden, Sheldon, Laker & James, 1987) and decline in 
intestinal blood flow (Csaky & Varga, 1975; Richey & Bender, 1977). Although similar 
alterations may have contributed to the differences observed in glucose tolerance between 
the foal and adult pony groups of the current study, these features were not specifically 
investigated. Moreover, it should be borne in mind that age-related change in dietary 
function often reflects transition to a geriatric state rather than comparisons between 
young/adolescent and mature adult groups as were performed in the present study. In the 
horse, such changes have not been documented, although it is known that alterations in 
enzymatic digestion occur as horses mature (i.e. decline in lactase activity) (Roberts, 1975).
Although the factors responsible for age- and diet-related alterations in the OGTT 
cannot be clearly defined in this study, the results indicate that when performing the OGTT 
for assessment of gastrointestinal function in equine animals, the resulting tolerance curve
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should be compared with tests for clinical healthy animals of the same age group and with a 
similar dietary history.
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5.3 A Modified Oral Glucose Tolerance Test as an Indicator of Small Intestinal 
Pathology in the Horse
5.3.1 Background
In the horse, diseases of the small intestine resulting in malabsorption are relatively 
uncommon, but when they present they can be severely debilitating, difficult to diagnose 
and carry a guarded to poor prognosis. Chronic inflammatory bowel diseases (e.g. GE, 
EGE, lymphocytic-plasmacytic enteritis) and alimentary lymphosarcoma account for the 
majority of true malabsorptive states (Mair et al., 1991). Numerous other recognised and 
potential causes have been documented and include idiopathic villous atrophy, verminous 
arteritis, intestinal ischemia, mucosal biochemical abnormalities, mucosal oedema and 
lymphangiectasia (Bolton et al., 1976; Roberts, 1985; Murray, 1989; Milne et a l, 1994). 
The predominant presenting clinical feature in cases of small intestinal malabsorption is 
chronic weight loss and, occasionally, horses may not exhibit specific physical signs of 
intestinal dysfunction. The OGTT is commonly used for the investigation of such cases, in 
particular for assessing small intestinal absorptive capacity. However, only limited 
information is available with regard to the reliability of the OGTT to detect small intestinal 
pathology and the relative incidence of different diseases that cause malabsorption in the 
horse. In addition, although the test is simple to perform and assay, repeat blood sampling 
over a six hour period is often impractical in a practice situation.
5.3.2 Study objective
The objective of this retrospective study was to assess the sensitivity and specificity of a 
‘modified’ OGTT for detecting/excluding a diagnosis of small intestinal pathology in the 
horse. The ‘modified’ OGTT was based on a single sample taken at 120 min post glucose 
administration and this was compared to serial sampling for the conventional six hour test 
period.
5.3.3 Materials and methods
5.3.3.1 Animals
The authors reviewed the records of 50 consecutive cases which had been subjected to an 
OGTT, performed as described by Roberts & Hill (1973), for investigation of either chronic 
weight loss and/or chronic diarrhoea and/or chronic colic. These animals were a mixed 
population of adult (>1 year) equidae, with variable dietary histories. Data from cases
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which did not have a full post mortem examination were excluded (n=27). In two individual 
tests BGC was >6 mmol/L and these were excluded from the analysis due to the difficulty 
interpreting subsequent plasma glucose response. The remaining OGTT results from 21 
necropsied cases were correlated with post mortem findings, that is, either the presence or 
absence of small intestinal pathology as determined by histopathological examination using 
standard techniques.
5.3.3.2 Data analyses
For each of these individual tests two values were determined: peak plasma glucose 
concentration, regardless of the time post glucose administration (A, i.e. ‘conventional’ 
OGTT), and plasma glucose concentration at 120 min post glucose administration (B, i.e. 
‘modified’ OGTT). Both (A) and (B) were expressed as a percentage increase above BGC. 
Using each of these values the sensitivity and specificity of the OGTT was assessed over a 
range of cut-off values from a 15 % to 50 % increase above BGC, where obtained values 
less than each cut-off level were taken to indicate ‘total’ malabsorption (Table 5.1).
Small intestinal Small intestinal
pathology present pathology absent
Total W Y
malabsorption true positive false positive
X Z
‘Normal’ OGTT false negative true negative
W + X Y + Z
Sensitivity = W/W+X 
Specificity = Z/Y+Z
Table 5.1: Determination of sensitivity and specificity.
5.3.4 Results
The characteristics of individual OGTTs included in this study are detailed in Appendix 17.
Of the 21 cases from which OGTTs were analysed, histopathological confirmation of 
small intestinal pathology was evident in 11 animals; CIBD and alimentary lymphosarcoma 
accounted for abnormal small intestinal histology in nine of these cases (Table 5.2), Small 
intestinal pathology was absent in 10 cases, two of which had no pathological abnormality 
detected at post mortem examination (Table 5.2). The sensitivities and specificities of the
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OGTT over the range of cut-off values, using either the peak plasma glucose concentration 
(A) or the plasma glucose concentration at 120 min (B), are shown in Table 5.3. When 
total malabsorption was defined as a less than 15 % increase over BGC, the OGTT, using 
either of the measurements (A) or (B), was 90 % specific (i.e. one false positive of 10 cases 
without small intestinal pathology); however, the sensitivity of the test using method (A) 
was only 9 % compared to 45 % when using method (B) (i.e. use of method (B) allowed 
detection of a higher proportion of true positives). Using a cut-off level of a 20 % increase 
above BGC in conjunction with method (B) resulted in the sensitivity of the test increasing 
to 64 %, without a deleterious effect on specificity. Using these criteria, the causes of 
‘total’ malabsorption which were identified included three cases of CEBD, two of alimentary 
lymphosarcoma, one coccidial enteropathy and one non-specific enteropathy. In one animal 
with a ‘total’ malabsorption no abnormality of the small intestine was detected (i.e. false 
positive): The post mortem findings in this case included, poor dentition, partial gastric 
impaction and a substantial caecal/colonic mucosal cyathostome burden. Although 
increasing the cut-off to a level greater than 20 % increase above BGC improved the 
sensitivity of the test there was a concurrent marked decrease in specificity.
Pathological Diagnosis SI pathology 
present
SI pathology 
absent
Alimentary lymphosarcoma 3 1
Chronic inflammatory bowel disease 6 1
Cyathostomosis 0 1
Poor dentition/partial gastric impaction/cyathostomosis 0 1
Coccidial enteropathy 1 0
Pyloric stenosis 0 1
Peritonitis 0 1
Equine motor neuron disease 0 1
Non-specific SI enteropathy 1 0
Non-specific colitis 0 1
No post mortem diagnosis 0 2
Total 11 10
Table 5.2: Post mortem histopathological findings in 21 adult horses 
investigated because of chronic weight loss and/or chronic gastrointestinal 
dysfunction. SI = small intestine.
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‘cut-off level*
% increase above BGC
15 20 25 30 35 40 45 50
(A) Sensitivity % 9 18 27 54 73 73 73 73
Specificity % 90 90 80 80 80 70 50 50
(B) Sensitivity % 45 64 64 73 73 73 73 82
Specificity % 90 90 60 60 60 50 50 50
Table 5.3: The sensitivities and specificities of the conventional (A) and the 
modified (B) OGTT for detecting/excluding a diagnosis of small intestinal 
pathology over a range of cut-off levels from a 15 % to a 50 % increase above 
basal glucose concentration (BGC).
*Less than each cut-off level is interpreted as ‘total’ malabsorption.
5.3.5 Discussion
The results of the present study indicate that the ‘conventional’ OGTT protocol offers no 
advantage over the ‘modified’ test based on a single sample taken at 120 minutes following 
oral glucose administration. This finding has both practical and economic implications, 
because the ‘modified’ test is more conducive to the practice situation and the numbers of 
blood samples to be analysed for glucose is reduced from the conventional nine to just two. 
When the criteria for ‘total’ malabsorption is defined as failure of the plasma glucose 
concentration at 120 min to increase greater than 15 % above BGC, the results of this study 
(specificity = 90 %, sensitivity = 45 %) are similar to those reported by Mair et al. (1991) 
(specificity = 100 %, sensitivity = 40 %); however, based on the present data, increasing the 
cut-off to a 20 % increase above BGC allows for greater sensitivity without affecting the 
specificity of the modified test. In addition, Mair et al. (1991) stated that a total 
malabsorption was indicative of either alimentary lymphoma or GE. Although this was not 
a consistent finding in the present study, it is true that the majority of cases which exhibit 
total malabsorption have severe infiltrative conditions of the small bowel and, consequently, 
this feature is an indicator of poor prognosis.
The reason for detection of total malabsorption in one case in the present study in 
which small intestinal pathology was absent is unclear. It is recognised that delayed gastric 
emptying may interfere with the normal plasma glucose response following oral glucose 
loading (Roberts, 1985) and may possibly have been a factor which contributed to the 
abnormal OGTT results detected in this case. It is important to consider that since 
detection of ‘total’ malabsorption in a clinical setting is likely to lead to a recommendation
Chapter 5 93
of euthanasia of the affected case, the necessity for a test to avoid “false positives” is of 
critical importance: The consequences of misclassifying an animal as negative are much less 
than the converse situation. In the present study, the specificity of the test was not 
compromised by using the modified protocol.
In conclusion, the results of the present study indicate that modification of the OGTT 
to a two sample test (i.e. 0 and 120 min) is appropriate and that the test, in this form, 
constitutes a useful, practical and economic investigative technique for assessing small 
intestinal absorptive capacity, where identification of total malabsorption is suggestive of 
extensive small intestinal pathology and a poor prognosis.
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Ch a p t e r  6
B r e a t h  H y d r o g e n  M e a su r e m e n t  f o r  A sse ssm en t  o f  G a st r o in t e st in a l  Tr ac t
Fu n c t io n  in  P o n ies
6.1 Introduction
6.1.1 The origin of hydrogen excreted in breath
Nielsen (1961), when investigating the origin and nature of bean-related flatulence, 
demonstrated that after feeding baked beans to volunteers hydrogen appeared in exhaled 
breath and that the rise in breath hydrogen was coincident with the subjects’ abdominal 
discomfort. Similar studies performed by Calloway (1966) indicated that breath hydrogen 
measurements were reproducible, substrate related and correlated to some extent with 
symptoms of abdominal discomfort. Formal studies of the site and rate of hydrogen 
production were performed by Levitt (1969) The results of these studies indicated that 
hydrogen production in the fasting state was negligible at all sites in the intestine, but after 
direct installation of a fermentable carbohydrate (lactose) into the gastrointestinal tract of 
healthy individuals, hydrogen concentration increased and was produced almost entirely in 
the colon. In addition, it was demonstrated that respiratory hydrogen excretion was linearly 
related to intestinal production, averaging 14 % of the total. These findings led the author 
to conclude that breath hydrogen measurement can be used as a reliable indicator of 
intestinal hydrogen production which, in the healthy human subject, is primarily dependent 
upon the delivery of ingested fermentable substrates to large intestinal flora. (Levitt, 1969).
6.1.2 Clinical applications of breath hydrogen measurement in human 
gastroenterology
Calloway, Murphy & Bauer (1969) and Levitt & Donaldson (1970) reported on the 
application of breath hydrogen measurement to detect intestinal lactase deficiency in man 
and this was the first breath test to be accepted for extensive clinical use. The results of 
breath hydrogen analysis after lactose ingestion have been found to correlate well with 
lactose tolerance tests using blood sugar analysis (Calloway, Murphy & Bauer, 1969; Levitt 
& Donaldson, 1970; Newcomer, McGill & Thomas, 1975) and with measurements of 
lactase specific activity in intestinal mucosal biopsies (Newcomer, McGill & Thomas,
1975). Furthermore, Bond & Levitt (1972) used this technique to demonstrate glucose 
malabsorption in partially gastrectomised patients. In addition, these authors indicated that 
by administering a measured dose of lactulose (1,4-b-galacto-fructose), a semi-synthetic
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non-absorbable disaccharide, and determining the resulting breath hydrogen excretion in 
each subject and comparing this with the hydrogen produced after the glucose load, the 
amount of carbohydrate malabsorbed could be estimated (Bond & Levitt, 1972). 
Therefore, it was proposed that breath hydrogen measurement could serve as a semi- 
quantitative indicator of carbohydrate absorption. More recently, Casellas, Chicharro & 
Malagelada (1993) reported that the breath hydrogen test, using D-xylose as a test substrate, 
was a useful and practical test for the diagnosis and follow-up of malabsorption in man due 
to either non-tropical sprue, lymphoma, Whipple’s disease or giardiasis: Test performance 
analysis indicated that the test had a sensitivity of 86 % and a specificity of 100 % for the 
detection/exclusion of small intestinal malabsorption.
In addition to the use of breath hydrogen measurement for assessment of carbohydrate 
malabsorption, the other main clinical application of this technique in man is for the 
investigation of small intestinal bacterial overgrowth. Metz et a l (1976a) assessed the 
patterns of breath hydrogen excretion after oral glucose administration to patients suspected 
of having bacterial colonisation of the small intestine and these were correlated with 
bacteriological examinations of jejunal juice aspirates. Rapid (i.e. within two hours of post­
glucose administration) and transient increases in breath hydrogen concentration (to levels 
greater than 20 ppm) were considered indicative of fermentation within the small intestine 
since no increase in breath hydrogen excretion would be expected following the 
administration of glucose to normal subjects. These authors reported that the test had a 
sensitivity of 66 % and a specificity of 100 % for the detection/exclusion of positive jejunal 
bacterial cultures (Metz et a l , 1976a). However, subsequent reports evaluating the 
diagnostic potential of this technique documented wide ranging results with sensitivities and 
specificities as low as 36 % (Taylor, Avgerinos, Taylor, Hill & Misiewicz, 1981) and 73 % 
(O’Connor, Healy, Kehely, Keane, O’Moore & Weir, 1987), respectively. Using the 
glucose-hydrogen breath test, Corazza, Menozzi, Strocchi, Rasciti, Vaira, Lecchini, 
Avanzini, Chezzi & Gasbarrini (1990) obtained sensitivity and specificity values of 62 % 
and 83 %, respectively: These authors concluded that examination of jejunal juice was still 
the preferred diagnostic technique for small intestinal bacterial overgrowth in man.
6.1.3 Clinical applications of breath hydrogen measurement in veterinary
medicine
In the past 10 years, breath hydrogen measurement has been applied to the clinical 
investigation of gastrointestinal disorders in calves, dogs and cats. Holland, Herdt & Refsal
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(1986) investigated the clinical usefulness of breath hydrogen measurement as a means of 
assessing chloramphenicol-induced carbohydrate malabsorption in preruminating calves. 
They observed that, compared to base-line data, chloramphenicol administration resulted in 
a significant decrease in intestinal villus length and xylose absorption, with a concurrent 
significant increase in the concentration of hydrogen excreted in breath following ingestion 
of a milk feed. Based on these findings, they concluded that this technique may be useful in 
evaluating malabsorption in calves with naturally occurring enteric disease (Holland, Herdt 
& Refsal, 1986). Subsequently, this group reported that breath hydrogen measurement 
facilitated detection of carbohydrate malabsorption in preruminating calves experimentally 
infected with Cryptosporidium spp. (Holland, Herdt & Refsal, 1989). Similarly, Washabau, 
Strombeck, Buffington & Harrold (1986b) demonstrated that hydrogen concentration 
increased in breath following lactulose administration to healthy dogs and that there was a 
quantitative relationship between the amount of unabsorbable carbohydrate ingested and 
hydrogen excretion. In addition, these authors found that although breath hydrogen 
excretion after the ingestion of a commercial hypoallergenic diet did not differ significantly 
from that after fasting, the addition of wheat or com flour to this diet significantly increased 
breath hydrogen excretion. Based on these results, it was suggested that wheat and corn 
appear to be incompletely assimilated in healthy dogs and they may be inappropriate dietary 
constituents in dogs with clinical evidence of carbohydrate malabsorption (Washabau et a l , 
1986b). Further work by this group indicated that breath hydrogen measurement could 
identify carbohydrate malabsorption in dogs with pancreatic exocrine insufficiency or 
chronic small intestinal disease, and that this technique was a more sensitive means of 
identifying carbohydrate malabsorption in dogs with clinical disease than xylose absorption 
testing (Washabau et al., 1986a). Moreover, in pancreatic exocrine insufficient dogs, 
pancreatic enzyme therapy partially corrected carbohydrate malassimilation, as evidenced by 
a significant decrease in hydrogen excretion when compared to pre-therapy data (Washabau 
et a l, 1986a). In the cat, breath hydrogen measurement has been used to evaluate 
carbohydrate malassimilation in healthy cats after oral antibiotic treatment (Muir, Gruffydd- 
Jones, Cripps & Brown, 1996) and carbohydrate malassimilation in clinical cases with 
intestinal disease (Muir, Gruffydd-Jones, Cripps, Papasouliotis & Brown, 1994). The 
results reported by Muir et a l (1994) indicate that, as was shown in canine studies, breath 
hydrogen measurement may be a more reliable indicator of carbohydrate malassimilation 
than the xylose tolerance test.
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To date, there is only a single report which describes the application of breath hydrogen 
measurement to the investigation of clinical disease in the horse: Murphy, Howie & Love 
(1994) reported rapid and transient increases in breath hydrogen concentration which was 
assumed to be a consequence of gastric fermentation, following the administration of xylose 
and lactulose to a horse with pyloric stenosis.
6.1.4 Assessment of gastrointestinal transit by breath hydrogen measurement
Although not directly applicable to the investigation of individual clinical cases, breath 
hydrogen measurement following a test meal is commonly employed in physiological studies 
as a simple, non-invasive means of assessing mouth-to-caecum transit time (MCTT), where 
MCTT is defined as the time between meal ingestion and the detection of a significant and 
sustained increase in breath hydrogen excretion (Bond & Levitt, 1975). This technique is 
routinely used in human studies and has been applied to the assessment of MCTT in dogs 
(Papasouliotis, Gruffydd-Jones, Sparkes & Cripps, 1995) and cats (Muir et al., 1991; 
Papasouliotis, Gruffydd-Jones, Galloway & Smerdon, 1993).
6.1.5 Aim of studies
The overall aim of the studies reported in this Chapter was to investigate the potential for 
use of breath hydrogen measurement as either a diagnostic and/or research technique in 
equine gastroenterology.
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6.2 Breath Hydrogen Measurement for Assessment of Small Intestinal Function in 
Ponies
6.2.1 Background
Information on the patterns of breath hydrogen excretion in equidae is limited. Zentek 
(1992) documented preliminary data which indicated that hydrogen was excreted in the 
breath of adult horses following the ingestion of either hay and/or oats and that the 
concentrations of hydrogen in breath were dependent on the quantity and quality of feed 
ingested. However, these studies had not been reported in full and a detailed account of the 
test protocol and results were not available. More recently, breath hydrogen measurement 
has been used to evaluate developmental changes in alimentary tract function of young foals 
(Bracher et al., 1995). These authors suggested that repeated breath hydrogen 
measurements may reflect the changes in alimentary tract function occurring during the 
post-natal adaptation period. However, there was great variation in hydrogen excretion 
profiles amongst animals such that it was not possible to draw definite conclusions from 
these studies.
6.2.2 Experimental objective
The objective of the study was to assess the patterns of breath hydrogen excretion in adult 
ponies following either voluntary consumption or the administration per stomach tube of 
different test meals/carbohydrate substrates.
6.2.3 Materials and methods
6.2.3.1 Animals
Seven British native-breed ponies were used in this study (Table 2.1). This group ranged in 
age from six to 13 years and in weight from 210 to 320 kg. All animals were considered to 
be healthy based on history and clinical examinations. The ponies were maintained on a hay 
only diet and bedded on barley straw. All animals were weighed at least once weekly 
during the study period and, where appropriate, these weights were used to calculate the 
amount of test substrate to be administered.
6.2.3.2 Experimental design
Following an overnight fast (14-16 hours), the pattern of breath hydrogen excretion was 
determined, for each pony, following the administration/ingestion of either no test meal (i.e.
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fasted), glucose, xylose, oats, wheat flour, lactulose or lactose (Table 6.1). Fasting tests 
were performed on all individuals on three separate occasions. A maximum of three animals 
were under test on any particular day and at least two days were allowed between tests on 
any individual. The choice of test substrate was selected randomly for each pony on a 
particular test day. Each test was started between 07:00 and 08:00 hours and breath 
samples were collected, in duplicate, at zero min (i.e. pre-test) and every 30 min thereafter 
for eight hours. All breath samples were analysed for hydrogen concentration within 30 min 
of collection. Animals under test had access to water at all times and access to food was 
denied until the end of the sampling period.
Test Substrate Dose Administration
None (i.e. fasted) - -
Glucose3 1 g/kg bwt, 20 % w/v solution per stomach tube
Xyloseb 0.5 g/kg bwt, 10 % w/v solution per stomach tube
Lactose0 1 g/kg bwt, 20 % w/v solution per stomach tube
Lactulosed 1 g/kg bwt, (0.67g lactulose/ml syrup) per stomach tube
Wheat flour6 1.6 g/kg bwt, 40 % w/v solution per stomach tube
Oats 1 kg voluntary intake
Table 6.1: Dose, concentration and method of administration of the test 
substrates used for initial assessment of hydrogen excretion in ponies, bwt = 
bodyweight.
a D(+)-Glucose, Sigma-Aldrich Company Ltd. 
b D(+)-Xylose, Sigma-Aldrich Company Ltd. 
c D-Lactose Monohydrate, Sigma-Aldrich Company Ltd. 
d Lactulose Solution BP, Cox Pharmaceuticals. 
e Allinson Original 100% Wholemeal Flour, Westmills Foods Ltd.
6.2.3.3 Data analyses
Analysis of test results utilised the mean of duplicate measurements at each time point 
{Appendix 18). Breath hydrogen excretion curves following the various test 
meals/carbohydrate substrates were analysed individually: They were regarded as being 
biologically significantly different from the fasting breath hydrogen excretion curves if there 
was a detected increase in breath hydrogen concentration greater than 10 ppm {Appendix 
19), sustained for at least two consecutive time points, i.e. 30 min. For each test, three
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variables were calculated; the total A U C  (A U C 8h0Urs), the peak hydrogen concentration 
(AH2) and the time at which a significant, sustained increase in hydrogen excretion (if any) 
was first noted (T sjg).
6.2.4 Results
Data which contributed to the results presented below are detailed in Appendices 19 and 20.
When the ponies were fasted (i.e. 21 individual tests), hydrogen concentrations 
excreted in breath for the eight hour sampling period were negligible (mean (±SD) hydrogen 
concentrations for that period ranged from 1.29 (±1.37) ppm to 3.71 (±3.26) ppm).
Sustained increases greater than 10 ppm were detected in all ponies following the 
ingestion/administration of oats (Fig. 6.1) and wheat flour, in three ponies following the 
administration of glucose and xylose and in two ponies following the administration of 
lactulose and lactose. In one animal (Pony No. 123), there were significant increases in 
breath hydrogen excretion following the ingestion/administration of each test substrate. The 
breath hydrogen responses of individual ponies, to both the oats and wheat flour test meals, 
were variable (Table 6.2). Following ingestion of oats, values for AUCghours, AH2 and Tsig 
ranged from 80-343 ppm x hour, 25.5-80 ppm and 60-300 min, respectively. Similarly, 
following the administration of wheat flour values for AUCghours, AH2 and Tsig ranged from 
38-875 ppm x hour, 14.5-279 ppm and 150-240 min, respectively.
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Fig. 6.1: Breath hydrogen concentrations detected following the ingestion of 1 
kg oats by seven adult ponies.
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6.2.5 Discussion
All animals excreted significant concentrations of hydrogen in breath following the 
ingestion/administration of both oats and also wheat flour. In human studies, Levine & 
Levitt (1981) reported that ingestion of flours derived from oats, corn and potatoes resulted 
in significant breath hydrogen excretion. In addition, Stephen, Haddad & Phillips (1983) 
demonstrated that 2-20 % of starch derived from different foods was not absorbed from the 
small intestine. Similarly, significant small intestinal malabsorption of wheat and corn flour 
has been reported in the dog (Washabu et a l , 1986b). In the present study, the breath 
hydrogen responses of individual ponies, as determined by T Sjg, AH2 and AUCghours were 
variable. These findings may be a consequence of individual differences in the rate of meal 
ingestion and/or gastric emptying/intestinal transit and/or small intestinal absorption and/or 
populations of luminal bacteria.
Interestingly, a number of animals in this study excreted hydrogen in breath following 
the administration of monosaccharides (glucose and xylose). In human medicine, significant 
increases in breath hydrogen concentration, following the administration of such 
carbohydrates, is indicative of small intestinal disease: a rapid and transient increase in 
breath hydrogen concentration, following a test substrate is indicative of bacterial 
fermentation within the proximal intestine (i.e. small intestinal bacterial overgrowth) (Metz 
et a l , 1976a), whereas significant increases in breath hydrogen concentration 2-5 hours 
after the administration of a glucose solution is suggestive of carbohydrate entry into the 
large intestine (i.e. small intestinal malabsorption) (Levitt & Donaldson, 1970). All animals 
used in this study were healthy and exhibited no evidence of gastrointestinal dysfunction, 
therefore significant small intestinal disease was considered unlikely. In addition, the 
pattern of breath hydrogen excretion in these ponies (significant increases noted between 30 
and 120 minutes and were sustained for five to seven hours) does not appear to represent a 
rapid fermentative process, but rather, a gradual presentation of substrate to the intestinal 
bacteria. By contrast, Murphy, Howie & Love (1994) reported significant and transient 
increases in breath hydrogen concentration which was assumed to be a consequence of 
gastric fermentation, following the administration of xylose and lactulose to a horse with 
pyloric stenosis. Breukink (1974) demonstrated that, in normal horses, a proportion (15-20 
%) of an oral glucose load will escape absorption from the small intestine and this fact may 
explain the findings in this study. Studies in man indicate that 5-10 g of unabsorbed 
carbohydrate entering the large intestine is sufficient to generate a detectable rise in breath 
hydrogen (Levitt & Donaldson, 1970). However, in healthy humans, hydrogen excretion is
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negligible even when administered 100 g of glucose orally (Levitt & Donaldson, 1970; 
Bond & Levitt, 1972), suggesting that in man relatively large doses do not exceed the 
absorptive capacity of the small intestine. The fact that hydrogen was excreted in the breath 
of some healthy ponies following the administration of an absorbable monosaccharide 
solution is likely to preclude the use of breath hydrogen measurement for the investigation 
of small intestinal malabsorption in equine animals.
Another interesting feature of this study was that only a few animals excreted 
significant concentrations of hydrogen in breath following the administration of both lactose 
and also lactulose. Lactose is a disaccharide which is enzmatically digested in the small 
intestine of young animals, and its constituent monosaccharides are subsequently absorbed. 
Lactase activity decreases with age and Roberts (1975) reported that equine animals over
2.5 years are lactase deficient. Therefore, in this group of ponies, it was surprising that all 
animals did not excrete significant concentrations of hydrogen due to bacterial fermentation 
of lactose. Similarly, hydrogen excretion following the administration of lactulose was 
infrequently observed. Lactulose, a semi-synthetic non-absorbable disaccharide, is 
commonly used with breath hydrogen tests, in human medicine, as a marker of small 
intestinal transit.
Bond & Levitt (1975) suggested that failure of individuals to excrete hydrogen 
following lactulose ingestion is uncommon but may occur due to the inability of intestinal 
flora to produce hydrogen or rapid utilisation of hydrogen by hydrogen-catabolising bacteria 
for the production of methane. These explanations are unlikely to account for the findings 
in this study because all ponies excreted significant concentrations of hydrogen following 
the ingestion/administration of oats and wheat flour. Another possible explanation for 
lactose and lactulose ‘false-negative’ tests is that insufficient substrate is presented to the 
intestinal bacteria. This may be a consequence of either enzymatic digestion of the 
disaccharides within the intestinal lumen or possibly their absorption as undigested whole 
molecules from the small intestine. However, adult equine animals are recognised as being 
lactase deficient, as stated previously, and studies in humans (Kynaston, Fleming, Laker & 
Pearson, 1993) and small animal species (Papasouliotis, Gruffydd-Jones, Sparkes, Cripps & 
Millard, 1993) have demonstrated that lactulose is poorly absorbed from the healthy small 
intestine. Kotler, Holt & Rosensweig (1982) observed that preloading individuals with 
lactulose on the evening prior to a lactulose-breath hydrogen test significantly altered the 
breath hydrogen excretion pattern, indicating more rapid hydrogen production. They 
hypothesised that the preload produced an adaptive response by the intestinal bacteria
Chapter 6 104
(increased enzymatic activity) which affected the rate of lactulose metabolism after the 
second dose (Kotler, Holt & Rosensweig, 1982). Therefore, it is possible that the intestinal 
flora in these ponies were unable to metabolise what were essentially ‘novel’ carbohydrates 
on primary exposure and may require repeated exposure to the sugar to enhance bacterial 
metabolic/enzymatic activity. The findings of the present study warrant further 
investigation, because, if lactulose is digested in and/or absorbed from the equine small 
intestine or if there is a delay in adaptation of intestinal bacteria to lactulose metabolism, this 
would have important implications with regard to the use of lactulose in the medical 
treatment of hepatic encephalopathy.
The results of this study indicate that hydrogen is excreted in the breath of ponies 
following the ingestion/administration of certain test meals, but the pattern of breath 
hydrogen excretion is subject to variation between individuals. The results of the present 
study indicate that further research must be performed before breath hydrogen measurement 
can be applied to the investigation of gastrointestinal dysfunction in the horse.
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St u d y  7
6.3 The Fate of Oral Lactulose in Horses 
6.3.1 Background
Lactulose is a synthetic disaccharide, which in healthy individuals is poorly absorbed from 
the small intestine and consequently the majority of it is degraded by colonic fermentation. 
In man, urinary excretion of lactulose following oral lactulose loading has been used for 
assessment of small intestinal permeability (Bjarnason, MacPherson & Hollander, 1995). In 
addition, lactulose is commonly used, in association with breath hydrogen measurement, for 
calculation of orocaecal transit time (Bond & Levitt, 1975). Furthermore, this carbohydrate 
is frequently used in many species for the symptomatic treatment of hepatic encephalopathy 
(Lanthier & Morgan, 1985): Acidification of the large intestinal contents reduces the intra­
luminal production of ammonia (NH3") and promotes the conversion of non-ionised 
(absorbable) NH3’ to the ionised (relatively unabsorbable) ammonium ion (NH3+).
From the results of the previous study (St u d y  6) it is evident that lactulose 
administration infrequently results in breath hydrogen excretion. The possible reasons for 
this include absorption of the molecule, whole, from the small intestine or an inability of 
large intestinal bacteria to ferment lactulose on primary exposure. In addition, it is possible 
that prolonged gastrointestinal transit due to delayed gastric emptying of a hyperosmolar 
solution (in previous studies lactulose was administered as a syrup with 3.75 g lactulose/5 
ml) may result in failure of hydrogen excretion within the eight hour sampling period.
6.3.2 Experimental objectives
The specific objectives of this study were i) to determine the effect of prolonged lactulose 
administration on breath hydrogen excretion patterns and ii) to the determine the proportion 
of an oral lactulose load, administered as a 20 % w/v solution, which is absorbed from the 
equine small intestine and subsequently excreted in the urine.
6.3.3 Materials and methods
6.3.3.1 The effect o f prolonged lactulose administration on hreath hydrogen 
excretion
6.3.3.1.1 Animals
Six yearling British native-breed ponies (Table 2.1), four female and two male ranging in 
weight from 162 to 236 kg, were used in this study. All were stabled, bedded on straw and 
maintained on a hay/coarse mix diet. All animals were considered to be healthy based on
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history and clinical examinations and none of these animals had been administered lactulose 
prior to this study.
6.3.3.1.2 Experimental design 
Day 1: Following an overnight fast (14-16 hours), lactulose at a dose of 1 g/kg bwt was 
administered to each individual per stomach tube. Breath samples were collected in 
duplicate at zero min (i.e. pre-test) and thereafter at intervals of 30 min for an eight hour 
period. Blood samples were collected into heparinised tubes at zero min and thereafter at 
intervals of 60 min for the eight hour sampling period. Breath samples were analysed for 
hydrogen concentration within 30 min of collection. Plasma NH3‘ concentrations were 
determined using a dry chemistry analyser (Vettest 8008, IDEXX Laboratories Ltd). 
Immediately after blood collection, samples were centrifuged at 9000 rpm for 2.5 min. The 
plasma was decanted, stored in sterile bijou bottles, and either placed on ice and analysed 
within 60 min or stored at -20°C and analysed within 12 hours.
Days 2-12: From the group of six animals, four were chosen at random and were 
administered 37.5 g of lactulose daily (Pony Nos. 114, 115, 117 & 119). The remaining 
two animals (Pony Nos. 116 &118) were used as ‘untreated’ controls.
Day 14: The protocol outlined above for Day 1 was repeated on all individuals (i.e. breath 
hydrogen measurement and plasma ammonia determination for an eight hour study period 
following oral lactulose loading).
Analysis of hydrogen excretion patterns utilised the mean of duplicate measurements at 
each time point {Appendix 18).
6.3.3.2 Urinary excretion o f lactulose in ponies
6.3.3.2.1 Animals
Six adult female British native-breed ponies (age, 7-15 years; weight, 211-320 kg) were 
used in this study (Table 2.1). All animals were stabled, bedded on straw and maintained 
on a hay only diet for at least one month prior to beginning this study. All animals were 
considered to be healthy based on clinical examinations and the results of haematological, 
blood biochemical and urine analyses were within normal limits.
6.3.3.2.2 Experimental design
Following an overnight fast (14-16 hours), 250 g of lactulose was administered by 
nasogastric tube as a 20 % w/v solution in warm water.
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Before lactulose administration a 24-F Foley catheter (Bard Limited) was inserted into 
the bladder and was retained in place by inflation of the balloon with 30 ml of 0.9 % sterile 
saline solution. In all cases, catheter placement initiated urine flow, a 20 ml sample of 
which (i.e. a pretest urine sample) was collected into a sterile container and stored at -20°C 
for use as a ‘blank’ in subsequent analyses. The catheter was then connected by plastic 
tubing to a two litre plastic bag suspended from a surcingle. Urine was allowed to flow 
continuously into the bag. Five hours after lactulose administration, the collection bags 
were removed and the bladder was completely evacuated by applying suction at the end of 
the urinary catheter using a 50 ml syringe. Clean collection bags were immediately attached 
to the urinary catheter for a further five hours with complete bladder evacuation at the end 
of that period. For each collection period (i.e. 0-5 hours, 5-10 hours) urine output was 
recorded and a 20 ml aliquot was stored in a sterile container with 0.25 ml thiomersal (1 
g/L) (BDH Chemicals Ltd) as preservative, at -20°C until analysed.
Following lactulose administration, breath samples were collected (see Section 2.2.4), 
in duplicate, at 30 min intervals for five hours and then hourly for the next five hours. 
Breath samples were analysed for hydrogen concentration within 30 min of collection. 
Analysis of hydrogen excretion patterns utilised the mean of duplicate measurements at each 
time point {Appendix 18).
6.3.3.2.3 Urine analysis 
Quantification of lactulose in urine was performed at the Department of Clinical Chemistry, 
Treliske Hospital, Royal Cornwall Hospitals, Truro, Cornwall, UK, using anion-exchange 
high pressure liquid chromatography (HPLC). Sample preparation and the HPLC analytical 
technique are described in detail elsewhere (Kynaston et al., 1993). Validation studies have 
determined that the assay is linear to 40 mg lactulose/L and has a detection limit of 0.4 
mg/L in urine. In addition, analytical recovery ranged from 89.1-97.6 % and the within 
assay coefficient of variation was calculated to be 4.9 % (Kynaston et al., 1993).
6.3.4 Results
6.3.4.1 The effect o f prolonged lactulose administration on hreath hydrogen 
excretion
Day 1: A significant increase in breath hydrogen excretion (i.e. a sustained increase greater 
than 10 ppm {Appendix 19)) was observed in one pony only (Pony No. 114). In all other 
animals, hydrogen excretion was negligible after lactulose administration.
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Pretest, the mean plasma ammonia concentration was 64.7 pmol/L (range, 61-73 
pmol/L). No marked decrease in plasma NH3' concentration was detected at any time 
during the 8 hour sampling period following oral lactulose dosing (Fig. 6.2).
Day 14: Breath hydrogen excretion was negligible in all 6 animals after lactulose 
administration. Similarly, plasma NH3" concentrations recorded in samples from all subjects 
(both ‘treated’ and ‘control’ animals) during the eight hour test period were not markedly 
different from the data recorded on Day 1 (Fig. 6.2).
Plasma ammonia Plasma ammonia120 120
♦  lactulose 'treated' group (n=4) 
♦control group (n=2)
■*Day 1 data (n=6)
110 -
Day 1 Day 14
100 - 100
90 - 90 -
80 -
70 -
60 - 60 -
0 60 120 180 240 300 360 420 480 0 60 120 180 240 300 360 420 480
Time (min) Time (min)
Fig. 6.2: Day 1 - Mean (±SD) plasma ammonia concentrations (jumol/L) 
measured during a lactulose breath hydrogen test in each of six ponies. Day 14 - 
Mean (± s d ) plasma ammonia concentrations (pmol/L) measured during a 
lactulose breath hydrogen test in i) four ponies which had been exposed to 
lactulose for the previous 12 days and ii) two ponies which had not received 
lactulose during that time.
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6.3.4.2 Urinary excretion o f lactulose in ponies 
Mean urinary recovery of lactulose (i.e. percentage of the administered dose) during the 10 
hour urine collection period was 0.075 % (range, 0.027-0.142 %) (Table 6.3).
A significant increase in breath hydrogen excretion was detected in one pony (Pony No. 
123) at 30 min after oral lactulose loading rising to a ‘peak’ of 90 ppm at 90 min. In all 
other animals, hydrogen excretion was negligible (i.e. did not exceed 10 ppm at any time 
during the eight hour sampling period).
0-5 hours 5-10 hours
urine lactulose % of oral urine lactulose % of oral
output (ml) (mg) dose output (ml) (mg) dose
Pony 123 570 42.5 0.017 350 25.0 0.01
Pony 124 755 75.0 0.03 530 45.0 0.018
Pony 125 720 75.0 0.03 560 25.0 0.01
Pony 127 405 221.5 0.089 1000 70.6 0.028
Pony 128 400 309 0.124 560 44.7 0.018
Pony 129 900 135.0 0.054 540 60.0 0.024
Table 6.3: Total urine output in each of six ponies and lactulose recovery in 
urine following oral lactulose dosing.
6.3.5 Discussion
The results o f  this study confirm the observation made in St u d y  6, that oral lactulose 
loading infrequently results in breath hydrogen excretion in ponies.
In man, lactulose is neither hydrolysed by intestinal disaccharidases nor metabolised by 
other tissues, and thus transfer across the intestinal mucosa, which is thought to occur via 
intercellular pathways (Kynaston etal., 1993), can be accurately and quantitatively reflected 
by excretion in urine. In this study, a normal range for urinary recovery of lactulose in 
healthy ponies was established: The percentage of the administered lactulose dose excreted 
in urine over the 10 hour sampling period is less than that reported in man, which in one 
study using a similar analytical technique was 0.15+0.09 % (mean+SD) for a five hour urine 
collection period (Fleming, Duncan, Russell & Laker, 1996). The range of values for the
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urinary recovery of lactulose seen in the present study, reflects the natural individual 
variation in the absorption of this sugar.
Although this study confirms that lactulose is absorbed only in small amounts from the 
healthy equine small intestine, there is no evidence from this study that the unabsorbed 
component is consistently fermented by bacteria in the large intestine. When this sugar was 
administered to lactulose-naive yearlings, a significant increase in hydrogen excretion was 
observed in only one of six ponies. In addition, repeated administration of lactulose, and 
thus exposure of large intestinal bacteria to this novel carbohydrate did not apparently result 
in adaptation of sugar metabolism of intestinal bacteria and did not result in induction of 
detectable increases in hydrogen excretion in a subsequent lactulose-hydrogen breath test. 
Indeed, the one pony which had a ‘positive’ initial test failed to excrete hydrogen in breath 
on the second occasion. These results indicate that failure of breath hydrogen excretion in 
ponies following lactulose administration is not due to inadequate exposure of large 
intestinal bacteria to this sugar.
Similarly, there was no apparent effect on the plasma ammonia concentrations 
recorded during both the initial and second lactulose-hydrogen breath tests. These results 
may reflect the failure of large intestinal bacteria to ferment lactulose and consequently 
insignificant alteration (i.e. acidification) of the intra-luminal environment. Interestingly, no 
studies have been reported which confirm the proposed therapeutic benefit of lactulose for 
the treatment of equine hepatic encephalopathy. However, it must be remembered that the 
present study was conducted on healthy individuals and that, in all animals, the resting (i.e. 
pretest) plasma ammonia concentrations were within normal limits. Portal venous blood 
characteristically contains relatively high concentrations of ammonia and this is effectively 
removed by the healthy liver, with the result that blood in the systemic circulation contains 
only low concentrations of ammonia (Centre, 1995). Therefore, it could be argued that 
administration of lactulose to individuals with a normal functioning liver is unlikely to result 
in an observable effect on plasma ammonia concentration.
In conclusion, from this study, it is clear that the inability of an individual to excrete 
hydrogen in breath following oral lactulose loading is not due to either inadequate exposure 
of the intestinal flora to what is essentially a novel carbohydrate or absorption of the sugar 
from the small intestine. The fate of lactulose, administered orally, in the horse remains to 
be elucidated.
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St u d y  8
6.4 Dietary Influences on Equine Gastrointestinal Tract Function: Assessment by 
Breath Hydrogen Measurement
6.4.1 Background
The rapid ingestion of large quantities of energy-dense feeds has been implicated in the 
development of clinical abnormalities such as hyper-excitability, wood-chewing, diarrhoea, 
flatulent colic and large intestinal volvulus (Clarke, Roberts & Argenzio, 1990). However, 
accurate assessment of the physiological effects of diet type and feeding frequency on 
gastrointestinal tract (GIT) function in the horse has been limited by the requirement for 
expensive, complicated and invasive techniques. Many of the conventional methods which 
are used to provide precise data on motility function require some surgical preparation, for 
example myoelectrical activity recording (Sama, 1986), extra-mural strain gauge 
transducers (Davies & Gerring, 1983; Clarke, Thompson, Becht & Moore, 1988) or 
intraluminal pressure recording (Sellars, Lowe & Brondum, 1979). Similarly, in vivo 
evaluation of fermentation in the large intestine requires the use of animals with 
caecal/colonic fistulae (Willard et al., 1977). In human gastroenterology, breath hydrogen 
measurement is commonly employed as a simple, non-invasive technique for the 
investigation of GIT function. This is based on the principle that, in healthy individuals, the 
detection of hydrogen in breath, following a test meal, indicates incomplete small intestinal 
absorption and bacterial fermentation of carbohydrate in the large intestine (Levitt, 1969). 
Consequently, in man, breath hydrogen analysis has been successfully applied to the 
investigation of carbohydrate malabsorption (Stephen, Haddad & Phillips, 1983; Casellas, 
Chicharro & Malagelada, 1993) and assessment o f MCTT (Ladas, Latoufis, Giannopoulou, 
Hatziioannou & Raptis, 1989).
6.4.2 Experimental objective
The objective of the study was to investigate, indirectly, the effect of maintenance diet on 
intestinal function in healthy ponies by evaluating breath hydrogen excretion patterns 
following the administration of a standard test meal.
6.4.3 Materials and methods
6.4.3.1 Animals and breath collection 
Seven adult British native-breed ponies were used in this study (Table 2.1). All were 
considered to be healthy based on history and clinical examinations. The ponies were
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maintained on either a hay only diet and bedded on barley straw (Diet 1) or a complete 
pelleted ration and bedded on shredded paper (Diet 2). Either the hay or the pelleted ration 
was fed twice daily, at 08:00 and 15:30 hours. Breath samples were collected from ponies, 
stored and analysed as described above (Section 2.2.4).
6.4.3.2 Experimental design
Following an overnight fast (14-16 hours), breath samples were obtained, in duplicate, at 
times zero min (i.e. pre-test) and every 30 min thereafter for eight hours following either no 
test meal (i.e. fasted) or the administration of 1.6g wheat flour (Allinson Original 100% 
Wholemeal Flour, Westmills Foods Ltd) per kg bwt, as a 40% w/v solution, by stomach 
tube. All samples were analysed for hydrogen concentration within 30 min of collection. 
Animals under test had access to water at all times and access to food was denied until the 
end of the sampling period. Breath hydrogen tests were performed on all animals while 
maintained on Diet 1 and Diet 2, each procedure (i.e. fasted and test meal) repeated on 
three occasions while on each diet. A period of 4 weeks was allowed for acclimatisation to 
each diet before tests were carried out. At least 72 hours were allowed between tests on a 
single individual. Each pony was weighed on a weekly basis and these weights were used to 
determine the required amount of test substrate.
6.4.3.3 Data analyses
All analyses utilized the mean of duplicate measurements at each time point (Appendix 18).
As the data were units and followed a Poisson distribution, a loge (x+1) transformation 
was performed before statistical analyses. Statistical analyses for significance were 
performed by use of two-way ANOVA, with repeated measures, for each of the following 
combinations, fasted (Diet 1) versus test meal (Diet 1), fasted (Diet 2) versus test meal 
(Diet 2), test meal (Diet 1) versus test meal (Diet 2), with factors being time, animal and 
treatment (e.g. fasted (Diet 1) or test meal (Diet 1)). Test replicates were analysed 
separately and significance was set at the 5% level.
For all tests, following the administration of the test meal, the total area under the hydrogen 
excretion curve (AUCghouns) was calculated using the equation
AUCghours (ppm x hour) = (0.5Hi+H2+. .. .+Hn.i+0.5Hn) x 1 hour 
where Hn is the breath hydrogen concentration (ppm) at time point n. The AUC at hourly 
intervals (hourly AUC data), for each test was calculated and expressed as a percentage of 
the AUCghours-
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6.4.4 Results
Data which contributed to the results presented in this section are detailed in Appendices 
19, 21 and 22.
When the ponies were fasted, hydrogen concentrations excreted in breath for the eight 
hour sampling period were consistently low and the mean breath hydrogen concentrations 
during this period ranged from 1.29 (±1.37) ppm to 3.71 (±3.26) ppm when maintained on 
Diet 1 and from 0.67 (±1.15) ppm to 1.48 (±1.45) ppm when maintained on Diet 2.
Following administration of the test meal, breath hydrogen concentrations were 
significantly greater, over time, than the respective ‘fasting data’, when maintained on Diet 
1 (p<0.001) and Diet 2 (p<0.001) (i.e. there was a significant time x treatment interaction). 
In addition, analysis of the AUCghours data indicated that, although considerable within- and 
between-animal variability existed (Table 6.4), cumulative excretion of hydrogen, following 
administration of the test meal, was greater when ponies are maintained on a hay diet (range 
23-875 ppm x hour) compared with when on a complete pelleted ration (range 8-261 ppm x 
hour) (Table 6.4).
Procedure
(Replicate) Variable
123 124 125
Pony
126 127 128 129
Diet 1
(i) A U C s h o u r s 875 83 38 57 350 107 343
(2)
(ppm x hour)
A U C s h o u r s 421 28 32 125 341 43.5 106
(3)
(ppm x hour)
A U C g h o u r s 376 30 24 91.5 23 131.5 812
Diet 2
(i)
(ppm x hour)
A U C g h o u r s 192.5 13 17 184 65 11 26
(2)
(ppm x hour)
A U C g h o u r s 98 20.5 27.5 54.5 261 37 29
(3)
(ppm x hour)
A U  C g h o u r s 141.5 8 10 218 87 31 26.5
(ppm x hour)
Table 6.4: Area under the hydrogen excretion curve (AUCghours, ppm x hour) 
for each of three breath hydrogen tests performed on each of seven ponies, 
following the administration of wheat flour, while maintained on Diet 1 (hay 
only) and Diet 2 (pelleted ration only).
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When the effect of diet on hydrogen excretion over the eight-hour sampling period 
following administration of the test meal was assessed (i.e. test meal (Diet 1) versus test 
meal (Diet 2)), a significant time x diet interaction was detected (p<0.001) (i.e. there was a 
significant difference between treatments in the response over time). Comparison of mean 
hourly hydrogen excretion (expressed as a percentage of AUCghours) indicates that a greater 
proportion of the total hydrogen excretion occurs earlier during the sampling period when 
on the complete pelleted ration compared with when maintained on the hay diet (Fig. 6.3).
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Fig. 6.3 : Mean (±SD) hourly hydrogen excretion (expressed as a percentage of 
the total AUC), following administration of the test meal, when maintained on 
Diet 1 (hay only) compared with when maintained on Diet 2 (pelleted ration).
6.4.5 Discussion
The results of this study indicate that, in ponies, maintenance diet has a marked effect on 
breath hydrogen excretion patterns and, by inference, gastrointestinal function.
The use and interpretation of breath hydrogen measurement for the investigation of 
GIT function requires that 1) intestinal flora are capable of liberating appreciable quantities 
of hydrogen during carbohydrate fermentation, 2) bacterial fermentation in the gut is the 
sole source of hydrogen production, 3) hydrogen production, in healthy individuals,
360- 420-
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originates almost entirely from bacterial fermentation in the large intestine and 4) pulmonary 
hydrogen excretion reflects intestinal hydrogen production (Bond & Levitt, 1975). Based 
on the results of STUDY 6, it has been shown that hydrogen excretion in fasted ponies is 
negligible and increases only after the ingestion/administration of certain test meals. In 
addition, although Mackie & Wilkins (1988) demonstrated that substantial populations of 
bacteria are present in the stomach and small intestine of healthy horses and that they 
contribute to the digestion of carbohydrates, the microbial counts were 100-fold higher in 
the caecum and colon confirming that these are more favourable sites for microbial 
colonisation and fermentation. Similarly, studies detailing VFA production in the equine 
intestine concluded that the caecum and colons were the primary sites for microbial 
digestion (Argenzio, Southworth & Stevens, 1974). Therefore, in the present study, it was 
assumed that hydrogen detected in breath originates from bacterial fermentation in the large 
intestine.
Because hydrogen excretion in breath is an indirect measure of bacterial fermentation of 
unabsorbed carbohydrate in the intestine, the differences observed in cumulative hydrogen 
excretion indicate that when the ponies in the present study were maintained on hay, either a 
greater proportion of the test substrate was available for fermentation because of less 
efficient digestion/absorption from the small intestine or conditions in the intestinal lumen 
facilitated increased production and/or absorption of hydrogen. Studies in the rat have 
demonstrated that dietary composition can modify the mucosal architecture and the 
intestinal mucus composition and therefore alter the functional characteristics of the small 
intestine (Sharma, Schumacher, Ronassen & Coates, 1995). On the other hand, Kern et al.,
(1973) demonstrated that, in the horse, diet has a marked effect on bacteria numbers in the 
caecum and other authors indicated that the microbial population and micro-environment of 
the equine large intestine are substantially and rapidly altered following dietary change 
(Garner, Moore, Johnson, Clark, Amend, Tritschler, Coffman, Sprouse, Hutcheson & 
Salem, 1978). Changes in the microbial populations of the gut may influence the amount of 
hydrogen available for absorption by variation in the numbers of either hydrogen-producing 
or hydrogen-utilising bacteria.
In human studies, Florent, Flourie, Leblond, Rautureau, Bernier & Rambaud (1985) 
demonstrated that when individuals ingested a non-absorbable carbohydrate (lactulose) over 
a period of eight days, hydrogen excretion in breath decreased, whereas the molar ratio of 
acetic acid to total VFA and lactic acid of caecal content increased. It was suggested that 
the associated decrease in caecal pH favours the growth of certain species of bacteria which
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catabolise carbohydrates to acetic and lactic acid and, consequently, is responsible for a 
marked decrease in hydrogen production. Studies in the horse have indicated that twice 
daily concentrate feeding is responsible for a significant reduction in caecal pH compared 
with when maintained on hay (Willard et al., 1977). In addition, those authors 
demonstrated a significant dietary influence on VP A profiles in caecal content, indicative of 
differences in the metabolic pathways of bacterial carbohydrate fermentation. When 
maintained on the concentrate ration, the molar percentage of proprionate in caecal content 
was increased, indicating the passage of soluble carbohydrate into the large intestine and 
subsequent fermentation (Willard et a l, 1977). Therefore, the reduction in hydrogen 
excretion observed in the present study, when ponies were maintained on the pelleted diet, 
possibly represents an adaptation of intestinal bacteria to the repeated caecal/colonic load of 
fermentable carbohydrate and an associated alteration in the luminal environment of the 
large intestine.
Hydrogen is consumed by a number of bacterial reactions including methanogenesis, 
reduction of sulphate and acetate production and it has been demonstrated that hydrogen 
consumption, as indicated by methane-producing status, influences the results of breath 
hydrogen tests (Corazza, Strocchi, Sorge, Benati & Gasbarrini, 1993). Therefore, breath 
hydrogen measurements reflect net rather than absolute hydrogen production. The factors 
which influence hydrogen consumption within the intestinal lumen are not fully understood. 
However, it is recognised that poor mixing of ingesta produces a high faecal hydrogen 
tension which facilitates rapid hydrogen consumption (Strocchi & Levitt, 1992). Based on 
this information, it is interesting to speculate that one of the possible reasons for lower 
hydrogen excretion when these ponies were maintained on the pelleted ration is that 
consumption of hydrogen is greater due to altered composition of ingesta resulting in less 
effective caecal/colonic mixing.
In the present study, the amount of hydrogen excreted in breath, following 
administration of the test meal, varied considerably within and between individuals, on 
occasion resulting in low/negligible breath hydrogen excretion. In human gastroenterology, 
failure of individuals to excrete appreciable quantities of hydrogen in breath after the 
administration of non-absorbable carbohydrates is well recognised. It has been commonly 
accepted that an inability to excrete detectable/significant quantities of hydrogen primarily 
reflects a lack of hydrogen-producing large intestinal flora and that animal variation in 
hydrogen excretion is the result of individual/daily variability in bacterial populations in the 
gut (LaBrooy, Male, Beavis & Misiewicz, 1983; Hammer, 1993). Numerous other
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variables which may influence breath hydrogen excretion in healthy individuals, following a 
test meal, include small intestinal digestive/absorptive capacity, methane-producing status, 
colonic mucosal function and ventilation rate/sampling technique (Bjorneklett & Jenssen, 
1980; Cloarec, Bomet, Gouilloud, Barry, Salim & Galmiche, 1990; Strocchi, Ellis & Levitt, 
1991). In addition, in the present study, the amount of test meal for individual animals was 
calculated based on bodyweight, therefore, it is likely that different quantities of test 
substrate were available for bacterial fermentation in each pony and may account for some 
of the between-animal variability observed. The variability in test results which have been 
detected in this and human studies (Corazza et a l , 1993) emphasises the need to regard 
breath hydrogen tests as semi-quantitative assessments of intestinal hydrogen production.
Despite the observed individual differences and dietary influences on the quantities of 
hydrogen excreted, assessment of the patterns of hydrogen excretion over the eight hour 
sampling period (hourly AUC data) indicate more rapid presentation of unabsorbed 
components of the test meal to intestinal bacteria when on the pelleted ration compared 
with when maintained on hay. Based on the assumption that exhaled hydrogen originates 
almost entirely in the large intestine, these results may be explained by a dietary influence on 
the intrinsic motor activity of the gut resulting in an altered rate of gastric emptying/small 
intestinal transit (i.e. MCTT).
The influence of feeding and dietary composition on equine intestinal motility is not 
fully understood. However, it has been suggested that horses on different feeding regimens 
(steady-state feeding versus ‘bolus’ feeding) will experience markedly different small 
intestinal motor activity in response to feeding (Clarke, Roberts & Argenzio, 1990). 
Although the regulatory peptides and the precise mechanisms involved are poorly 
understood, it is recognised that intestinal motor activity is mediated to some extent by 
neurohormonal responses to feeding and the presence of digestive byproducts in the 
alimentary tract. In addition, it has been documented that secretion of certain regulatory 
peptides is influenced by ration type: Smyth, Young & Hammond (1989) reported increased 
and prolonged (>12 hours) postprandial gastrin secretion after refined (pelleted) diets when 
compared to hay, even when in vitro analysis indicated that both diets had a similar nutrient 
composition. Moreover, gastrin secretion was influenced by the duration of feeding of a 
particular diet in that all mean gastrin concentrations measured after seven days on the 
pelleted diet were significantly higher than during the first feed of pellets (Smyth, Young & 
Hammond, 1989). Therefore, in the present study, it is plausible that neurohormonal
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influences were, in part, responsible for the apparent increased rate of small intestinal transit 
of the test meal while on the pelleted ration.
In conclusion, the results of the present study indicate that maintenance diet has an 
apparent effect on gastric/small intestinal motility and add weight to the theory that the 
episodic feeding of large quantities of ‘concentrate’ ration results in increased transit of 
ingesta. Although, logically, this could be expected to decrease the efficiency of small 
intestine digestion/absorption and result in greater amounts of soluble carbohydrate 
reaching the large intestine, in turn fueling intense caecal/colonic fermentation (Clarke, 
Roberts & Argenzio, 1990), there is no direct evidence from this study to suggest increased 
bacterial fermentation when the ponies were maintained on the pelleted diet. Bearing in 
mind the economic and welfare implications of conventional methods used for the 
evaluation of gastrointestinal function in the horse (e.g. scintigraphy, radiography, 
myoelectrography, intestinal fistulation), the results of this study indicate that breath 
hydrogen measurement may prove to be a simple, cheap and non-invasive alternative for the 
assessment of MCTT and alterations in caecal/colonic function. On this basis, further 
studies investigating the potential of this technique are justified.
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St u d y  9
6.5 Effect of Cisapride and Codeine Phosphate on Intestinal Transit in Healthy 
Ponies: Assessment by Breath Hydrogen Measurement.
6.5.1 Background
Drugs which alter gastrointestinal motility are frequently used for the treatment of 
numerous medical conditions in the horse. However, due to a lack of simple, non-invasive 
techniques, little objective information is available with regard to their efficacy at 
influencing gastrointestinal transit in this species. Roberts & Argenzio (1986) evaluated the 
effect of a variety of motility-modifying drugs in healthy horses by monitoring both their 
clinical effects and alterations in whole gut transit, using polyethylene glycol as a marker 
substrate. Although this paper provided useful clinical/physiological information, the 
techniques used were subjective and lack detail about transit through specific sections of the 
gut. Similarly, Davies & Gerring (1983) investigated the effect of spasmolytic drugs on 
motility patterns of the equine small intestine by recording electrical and smooth muscle 
activity at pre-selected sites. While these were valid techniques for the investigation of 
gastrointestinal physiology, they are invasive and are not a direct measure of the rate of 
transit of ingesta.
The ideal technique to investigate the efficacy of motility-modifying drugs should assess 
ingesta transit through specific parts of the intestine without directly influencing the 
physiological control of gastrointestinal motility. In man the ‘gold standard’ technique for 
this purpose is the imaging of meals labeled with radio-isotopes, using scintigraphy 
(Sciarretta, Furno, Mazzoni, Garagnani & Malaguti, 1994). Although this method has been 
used in the horse, its application has been limited to the assessment of gastric emptying 
(Ringger, Lester, Neuwirth, Merritt, Vetro & Harrison, 1996). In addition, the technique 
requires expensive, complex equipment.
At present, breath hydrogen measurement is the most commonly used simple, non- 
invasive, non-radiological method of assessing intestinal transit in man. Determination of 
MCTT, by measuring the time taken to detect a significant and sustained increase in breath 
hydrogen measurement, following the ingestion of a test meal, was first introduced by Bond 
& Levitt (1975).
6.5.2 Experimental objective
The objective of the study was to assess, in healthy ponies, the effects of cisapride and 
codeine phosphate on MCTT, determined by breath hydrogen measurement.
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6.5.3 Materials and methods
6.5.3.1 Animals
Three adult British native-breed ponies (mean age, five years) were used in this study 
(Table 2.1). All were considered to be healthy based on history and clinical examinations. 
The ponies were stabled, bedded on wood shavings and maintained on a high-fibre complete 
pelleted ration, fed twice daily.
6.5.3.2 Experimental design
Following an overnight fast (14-16 hours), one of three procedures ([A]-[C]) was assessed 
by monitoring breath hydrogen excretion. Breath hydrogen concentrations were determined, 
in duplicate, at 30 min intervals for eight hours following the ingestion of one kg of the 
high-fibre pelleted meal (i.e. the test meal) without premedication [A] or ingestion of the 
test meal one hour after premedication with either cisapride (Prepulsid, Janssen-Cilag; 0.5 
mg/kg bwt, per os (PO)) [B] or codeine phosphate (Codeine Phosphate 30 mg, Norton; 2 
mg/kg bwt, PO) [C]. Procedures were selected randomly for each pony on a particular test 
day. Each procedure was repeated on three occasions on each pony and at least three days 
were allowed between tests on any individual. Breath samples were collected, stored and 
analysed as outlined previously {Section 2.2.4).
6.5.3.3 Data analyses
All analyses utilised the mean of duplicate measurements at each time point {Appendix 18). 
For all breath hydrogen tests, increases in breath hydrogen concentration greater than 5 ppm 
were regarded as being a ‘positive’ test, if sustained for two consecutive readings (i.e. 30 
min) {Appendix 19). For all tests, the time at which the significant increase in breath 
hydrogen concentration occurred (T sjg) and the time of peak hydrogen concentration (Tah2) 
were noted. In the present study, T sig was considered to indicate the time at which the head 
of the test meal entered the caecum (i.e. M C T T ).
As the data were units and followed a Poisson distribution a loge (x+1) transformation 
was performed before statistical analyses. The effect of treatment on hydrogen excretion 
following the administration of the test meal was statistically analysed by two-way 
ANOVA, with repeated measures, with factors being time, animal and treatment (i.e. [A], 
[B] or [C]). Significance was set at the 5 % level.
For all tests, the total area under the hydrogen excretion curve (AUCghours) was 
calculated using the equation,
AUCghours (ppm x hour) = (0.5H i+H2+. .. ,+Hn.i+0.5Hn) x 1 hour,
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where Hn is the breath hydrogen concentration (ppm) at time point n The AUC at hourly 
intervals (hourly AUC data), for each test was calculated and expressed as a percentage of 
the AUCshours-
6.5.4 Results
Data which contributed to the results presented in this section are detailed in Appendix 23.
Significant concentrations of hydrogen (i.e. >5 ppm, sustained for two consecutive 
readings) were excreted in the breath of all ponies, on all occasions, following ingestion of 
the test meal (i.e. on all occasions for procedures [A], [B] and [C]) (Table 6.5),
When the effect of treatment on hydrogen excretion over the eight-hour sampling 
period, following administration of the test meal, was assessed, a significant time x 
treatment interaction was detected (p<0.001) (i.e. there was a significant difference between 
treatments in the response over time). Comparison of mean hourly hydrogen excretion 
(expressed as a percentage of AUCghours) (Fig. 6.4) indicates that, compared to the control 
data, a greater proportion of the total hydrogen excretion occurs earlier during the sampling 
period following premedication with cisapride [B] By contrast, following premedication 
with codeine [C], a greater proportion of the total hydrogen excretion occurred at a later 
stage during the eight hour sampling period
ua
<
©
&
co
e
CJ
6J0
©u■o
©
CQ
35
30
25
20
15
10
■  Control
□  C isapride
□  C o d e in e
0-60 60- 120- 
120 180
180- 240-
240 300
Time  (min)
300-
360
360-
420
420-
480
Fig. 6.4 : Mean (±SD) hourly hydrogen excretion (expressed as a percentage of 
the total AUC), following the ingestion of the test meal without premedication 
[A] or ingestion of the test meal one hour after premedication with either 
cisapride [B] or codeine phosphate [C],
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Pony [Al [B] [C]
(Procedure) V ariable Control C isapride +  [A] Codeine +  [A]
PO N Y  129
1 Tsig (min) 2 1 0 120 150
Tah2 (min) 3 0 0 3 0 0 4 2 0
AUCghours (ppm X hour) 5 8 .5 43 6 7
2 Tsig (min) 180 90 180
T a h ? (min) 3 3 0 2 4 0 4 5 0
AUCghours (ppm X hour) 5 3 .5 96 66
3 T^g (min) 150 2 1 0 24 0
TAH2 (min) 2 7 0 2 7 0 3 9 0
AUCghours (ppm X hour) 26 36 2 7 .5
PO NY  126
1 Tsig (min) 2 4 0 120 180
TAH2 (min) 2 4 0 3 9 0 30 0
AUCghours (ppm X hour) 19 88 101
2 Tsig (min) 3 0 0 90 120
Tah2 (min) 3 6 0 3 0 0 39 0
AUCghours (ppm x hour) 34 103 .5 6 1 .5
3 T^g (min) 150 90 180
Tahi (min) 3 6 0 4 2 0 2 1 0
AUCghours (ppm x hour) 43 32 57
PO NY 122
1 T^g (m in ) 90 120 60
Tah2 (min) 3 0 0 2 7 0 4 2 0
AUCghours (ppm X hour) 102 141 2 1 0
2 Tsig (m in ) 150 6 0 120
Tah2 (min) 3 3 0 180 4 5 0
AUCghours (ppm x hour) 273 2 3 3 .5 117
3 Tsig (min) 180 120 120
Tah2 (min) 3 3 0 3 9 0 4 5 0
AUCghours (ppm x hour) 4 5 .5 147 .5 97
m edian Tsig (m in ) 180 120 150
(range) (9 0 -3 0 0 ) (6 0 -2 1 0 ) (6 0 -2 4 0 )
T Ah 2 (m in ) 33 0 3 0 0 4 2 0
(2 4 0 -3 6 0 ) (1 8 0 -4 2 0 ) (2 1 0 -4 5 0 )
AUCghours (ppm x hour) 4 5 .5 96 67
(1 9 -2 7 3 ) (3 2 -2 3 3 .5 ) (2 7 .5 -2 1 0 )
Table 6.5: Breath hydrogen excretion in individual ponies following the administration 
of a test meal after either no premedication [A] or premedication with cisapride [B] or 
codeine phosphate [C]. Each procedure was repeated on three occasions. AUCghours = 
total area under the hydrogen excretion curve for the eight hour sampling period, Tah2 
= time of peak hydrogen excretion, Tsig = time at which significant increases in 
hydrogen excretion were first noted.
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These observations were supported by assessment of Tsig and Tah2 recorded for each 
procedure. The median Tslg and Tah2 for the control data were 180 min (range, 90-300 min) 
and 330 min (range, 240-360 min), respectively. For procedure [B], Tslg (median, 120 min; 
range, 60-210 min) and Tah2 (median, 300 min; range, 180-420 min) were notably shorter 
than the control data. Although administration of codeine phosphate did not result in an 
appreciable delay in Tslg (median, 150 min; range, 60-240 min), the time of peak hydrogen 
excretion (median, 420 min; range, 210-450 min) was markedly delayed relative to the 
control data. In addition, hydrogen excretion at the end of the eight hour sampling period 
was greater following the administration of codeine than for either of the other procedures 
(Fig. 6.4). For all procedures ([A]-[C]), considerable within and between animal variability 
in TSig, Tah2 and AUCghours was observed (Table 6.5).
6.5.5 Discussion
The results of this study indicate that both cisapride and codeine phosphate modify the 
pattern of breath hydrogen excretion in healthy ponies following ingestion of a test meal.
In this study, the use of breath hydrogen measurement to assess small bowel transit 
time assumes that hydrogen production occurs entirely in the large intestine, where the 
unabsorbed component of the test meal is presented to and fermented by intestinal bacteria. 
Clearly, overgrowth of bacteria within the small intestine or a caecal/colonic intraluminal 
environment which does not favour the production of hydrogen may compromise the 
validity of this technique. However, for all animals in this study, a marked increase in 
breath hydrogen excretion was detected on all occasions for each procedure and the pattern 
of hydrogen excretion was suggestive of a gradual presentation of substrate to intestinal 
bacteria rather than a rapid and transient hydrogen ‘peak’ which would be expected in the 
case of bacterial colonisation of the small intestine. Moreover, in man, it is considered that, 
in the absence of massive bacterial overgrowth, hydrogen production in the small bowel is 
unimportant (Bond & Levitt, 1972) and, as previously discussed, a number of studies have 
been conducted which indicate that the caecum and colons are the primary sites for 
microbial digestion in the equine intestinal tract (Argenzio, Southworth & Stevens, 1974; 
Mackie & Wilkins, 1988). In addition, studies undertaken to validate breath hydrogen 
measurement for the assessment of MCTT in man, have demonstrated that, in healthy 
individuals, there is a highly significant linear correlation between the rise in breath 
hydrogen excretion and the onset of colonic filling as determined by scintigraphy (i.e. the
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‘gold’ standard) (Read, Miles, Fisher, Holgate, Kime, Mitchell, Reeve, Roche & Walker, 
1980; Read, Al-Janabi, Edwards & Barber, 1984; Sciarretta et al., 1994)
It has been suggested that, as a strict measure of transit time, it is advantageous for the 
test substrate to be totally non-absorbable (e.g. lactulose), since individual differences in the 
rate of absorption of other test materials would affect the size of the intestinal bolus and 
hence influence transit time (Bond & Levitt, 1975). However, more recent studies have 
indicated that, when lactulose alone is used, it induces abnormally rapid MCTT and yields 
poorly reproducible results (Staniforth & Rose, 1989), while the use of a standardised test 
meal (with or without lactulose) produced more consistent results (LaBrooy et al., 1983; 
Ladas et al., 1989). Moreover, the results of STUDY 6 and S tu d y  7 have indicated that 
lactulose is totally unsuitable for this purpose in the horse since hydrogen is infrequently 
excreted in breath following its administration. For these reasons, voluntary ingestion of a 
high-fibre meal was considered appropriate as a test meal, in that it would provide more 
physiologically relevant information. In addition, the pelleted feed was chosen as the 
maintenance diet because previous observations {unreported observations) indicated that 
Tslg, as defined above, is less variable between individuals following the administration of a 
test meal when on this diet compared to when maintained on hay only. However, despite 
the test protocol adopted in an attempt to reduce variability, variation in Tslg (i.e. MCTT) 
was observed, for all procedures, both between subjects and in the same subject at different 
times. While it is likely that individual differences in the rate of meal ingestion contributed 
to the variation observed, perhaps the most important factor was between and within animal 
variation in intestinal function itself.
Cisapride is a relatively new gastrointestinal prokinetic agent which acts selectively on 
the gut by facilitating the release of acetylcholine at the myenteric plexus (Schuurkes, Van 
Nueten, Van Daele, Reyntjens & Janssen, 1985). King & Gerring (1988) demonstrated that 
it enhances motor activity in the stomach, small intestine and colon of healthy ponies and 
based on this knowledge it is commonly employed for the prophylaxis/treatment of post 
operative ileus (Gerring & King, 1989). In the present study, Tsig and the time of peak 
hydrogen excretion were reduced by cisapride pretreatment when compared to the control 
data. These results indicate an acceleration of gastric emptying and/or small intestinal 
transit and verify the proposed effect of this drug on gastrointestinal tract function in 
healthy animals.
From our results, the effect of codeine on gastrointestinal motility is less clear. 
Codeine phosphate is a morphine derivative which is used for the symptomatic relief of
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chronic diarrhoea in man (Palmer, Corbett & Holdsworth, 1980) and the horse (Love, Mair 
& Hillyer, 1992). The proposed mechanism of action of opiates on gastrointestinal transit is 
that they block acetylcholine release in the myenteric plexus, by presynaptic inhibition, 
which in turn diminishes propulsive motility (Schiller, Davis, Santa Ana, Morawski & 
Fordtran, 1982). Although codeine has been shown to prolong small intestinal transit in 
man (Pressman, Hofmann, Witztum, Gertler, Steinbach, Stokes, Kelts, Stone, Jones & 
Dharmsathaphorn, 1987), no such effect on Tslg was observed in the present study. 
However, the time to peak hydrogen excretion was delayed when compared to the control 
data and hydrogen excretion at the end of the eight hour sampling period was greater. 
Therefore, it is possible that the premedication time of one hour did not allow sufficient 
time for the drug to have an effect prior to the test and that it only began to influence 
ingesta transit after the time of presentation of the head of the test meal to large intestinal 
flora.
In conclusion, despite the limitations associated with this indirect measure of MCTT 
and the between and within-individual variability recorded, the results of the present study 
indicate that breath hydrogen measurement appears to be sufficiently sensitive to detect the 
contrasting effects of both cisapride and codeine phosphate on small intestinal transit. 
Therefore, further studies to investigate the clinicopharmacological potential of this 
technique are justified.
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C h a p t e r  7
G e n e r a l  C o n c lu sio n s  a nd  Fu r t h e r  Re se a r c h  Ar e a s
7.1 Review of Clinical Cases
Although there are numerous known and potential causes of chronic gastrointestinal disease 
in the adult horse, the results presented in Chapter 3 indicated that the diagnoses most 
commonly encountered at the University of Glasgow Veterinary School were CIBD, 
cyathostomosis and alimentary lymphosarcoma. Despite employing numerous diagnostic 
techniques for the investigation of these cases, there was considerable overlap in the clinical 
features of different disease entities such that a definitive ante mortem diagnosis was often 
difficult to achieve: few investigative techniques provided specific diagnostic information 
and, not infrequently, test results were open to misinterpretation.
In this case series, the most useful diagnostic test was, simply, the identification of large 
numbers of cyathostome larvae in faeces. In the absence of such a feature, the definitive 
diagnosis of cyathostomosis is difficult but may be aided by historical and clinical features 
such as age, season of presentation, presence of diarrhoea, pyrexia, leucocytosis and 
hypoalbuminaemia. Interestingly, this study also serves to emphasise that cyathostome- 
associated disease is not limited to the classical presentation of acute larval cyathostomosis 
and that, as reported in other studies (Mair, 1993, 1994; Lyons et al., 1994; Mair & 
Pearson, 1995; Matthews & Morris, 1995), clinical manifestations may range from chronic 
weight loss to acute, life-threatening gastrointestinal disease.
The fact that the majority of the remaining cases had either a severe inflammatory or 
neoplastic infiltrate of the intestine suggests a potentially valuable role for intestinal biopsy 
in the investigation of such cases. Although obtaining intestinal biopsies via laparotomy 
may be of limited practical value because of financial considerations and the increased risks 
associated with abdominal surgery in debilitated and/or hypoalbuminaemic animals, the 
results presented in this study suggested that histopathological examination of biopsied 
rectal tissue is a safe, simple and relatively non-invasive means of effecting a definitive 
diagnosis in a small proportion of cases. These results are in broad agreement with the 
results of a larger and more comprehensive study on the usefulness of the rectal biopsy 
technique reported by Lindberg, Nygren & Persson (1996).
It is recognised that the accurate description of the pattern of a disease within a 
population is essential to the understanding of that disease and that, in certain instances, 
such a description can help identify factors which may be associated with predisposition to
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or initiation of the disease under study. Knowledge of predisposing factors for a given 
disease also allows for the identification of high-risk groups. With this in mind, a limited 
epidemiological study was performed in an attempt to highlight any factors which may be 
associated with an increased risk of developing a particular chronic enteropathy. A control 
population was established using cases presented to the referral clinic for a period of one 
year: This time period was chosen for the principal reason that the computing system and 
the method of data entry used facilitated rapid, easy data retrieval. Therefore it could be 
suggested that this population is not an ideal control because it is not time matched and is 
based on a referral population. However, it could be argued that if conclusions based on a 
control population are to be compared with those generated at other referral centres, then 
the use of a referral population, rather than a local general population as the control, would 
be appropriate.
When historical data from our clinical group was compared to that of a control 
population, it appeared that, ponies are at a greater risk of developing either cyathostomosis 
or alimentary lymphosarcoma than horses and that female animals are at a greater risk of 
developing either CIBD or alimentary lymphosarcoma than males. Although it is accepted 
that there is a relationship between the age of an individual and the risk of developing 
clinical disease due to cyathostome infection (Reid et al., 1995), the associations between 
animal type and/or gender and the development of either CIBD, cyathostomosis and/or 
alimentary lymphosarcoma have not been previously reported. This study does serve to 
highlight that specific animal factors may be associated with a greater risk of developing 
certain chronic equine enteropathies and warrants further investigation.
Chronic diseases of the gastrointestinal tract are relatively uncommon, but they have 
important welfare implications, in that they can be severely debilitating and often have a 
guarded to poor prognosis. While this study fulfills the intended objective by highlighting 
factors which may help differentiate between disease entities and in doing so expanding the 
information base on chronic gastrointestinal tract diseases in the adult horse, it also serves 
to emphasise the difficulties associated with achieving a definitive diagnosis in these cases 
and the limited means of objectively assessing gastrointestinal function in the horse. Further 
studies into the casual factors, epidemiological associations and pathogenesis of chronic 
gastrointestinal diseases are justified and because of the relatively low prevalence of these 
diseases this could possibly be best approached by seeking input from colleagues in general 
practice and other referral institutions (i.e. a multicentre study). Such studies may lead to 
the development of improved diagnostic tests and/or help define approaches to therapy.
Chapter 7 128
7.2 Fructosamine Analysis
In Chapter 4, a validation study for measurement of fructosamine in equine plasma was 
outlined and the use of this parameter for monitoring alterations in protein metabolism in 
ponies using, as a model, experimental cyathostome infection was evaluated.
The results of the validation study indicated that the assay is rapid and precise and 
accurate for measuring low concentrations of fructosamine in equine plasma, which is in 
broad agreement with validation studies performed in other species (Jensen, 1992; Reusch 
et a l, 1993; Graham, 1995). Using this assay, a reference range for plasma fructosamine in 
healthy, stabled British native-breed ponies was calculated to be 203-310 p,mol/L. While 
the reference range for fructosamine in equine plasma, established in the present study, is 
appropriate for stabled British native-breed ponies, it should not be considered appropriate 
for the general equine population and, if fructosamine is to gain acceptance as a marker of 
protein metabolism in equine medicine, it would be necessary to establish a reference range 
based on a greater number and more diverse population of animals, and to investigate the 
possible effects of age, breed or environment on plasma fructosamine concentrations.
It was possible to monitor the effects of experimental cyathostome infections in groups 
of ponies by sequential clinical measurements. All infected animals failed to gain weight at 
the same rate as the uninfected controls and one pony developed overt clinical disease. As 
expected, fructosamine concentrations decreased in all infected animals post-infection and 
this was considered to be due to increased rate of protein turnover and/or enteric protein 
loss and/or altered composition of serum proteins. Although fructosamine is used as a 
marker of the rate of protein turnover in human medicine (Lloyd & Marples, 1986; 
Waterson & Mills, 1988), it was not possible, from the results of the present study, to state 
categorically that fructosamine decreased in parasitised animals due to an increased rate of 
protein turnover. However, there is evidence to suggest that this parameter may be a more 
effective means, than albumin measurement, for monitoring alterations in protein 
metabolism. With this in mind, further research should be directed towards evaluating the 
use of this parameter for monitoring the relatively subtle effects of low-level (i.e. 
subclinical) cyathostome infection and for the assessment and/or clinical monitoring of overt 
clinical disease due to equine chronic enteropathies.
It is acknowledged that the statistical analysis of data generated from the experimental 
cyathostome infection study is compromised by small group sizes. Therefore, the emphasis 
in interpretation was weighted towards reporting the results in a descriptive manner, using 
the statistical analysis to support observations. A useful and practical implication of the
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statistical analysis performed in this study is that, having quantified the variability in the 
system, this information can be used to calculate the number of animals which should be 
included in future studies to produce statistically useful results.
7.3 The Oral Glucose Tolerance Test
The results of Chapter 5 provide further confirmation that extraintestinal factors can 
influence the OGTT: Both age and diet had a significant effect on plasma glucose 
concentrations in ponies, following oral glucose loading. These results suggest that both 
variables should be considered when interpreting tests in the clinical situation. Although not 
investigated in the present study, there are numerous mechanisms by which both age and 
diet may hypothetically influence OGTT results. Perhaps one of the most interesting 
theories for the diet-associated effect is the suggestion that there was evidence of an 
improvement in insulin sensitivity when ponies were maintained on the pelleted versus the 
hay diet. This theory had been advocated previously by Smyth, Young & Hammond (1989) 
and warrants further investigation, because it may have important implications for the 
management of conditions associated with insulin insensitivity, in particular laminitis in 
obese ponies.
Retrospective analysis of OGTTs performed on clinical cases, from a variety of 
backgrounds, indicated that the conventional OGTT protocol as described by Roberts & 
Hill (1973) offers no advantage over a modified test protocol, based on a single sample 
taken at 120 min following oral glucose administration for the detection/exclusion of small 
intestinal pathology. Use of the modified protocol is both cheaper and more suited to the 
practice situation. Because this study was based on test results from a relatively small 
number of animals (n=21), it would seem appropriate to confirm this observation by 
repeating these analyses on a different, larger group of clinical cases. Again, as observed by 
Mair et al. (1991), detection of total malabsorption suggested a diagnosis of either CIBD or 
alimentary lymphosarcoma and was, therefore, considered to be an indicator of poor 
prognosis.
7.4 Breath Hydrogen Analysis
The studies on breath hydrogen measurement began by assessing the patterns of breath 
hydrogen excretion in healthy adult ponies following the ingestion/administration of a 
variety of test meals, and interpretation of the results was based on the assumption that, in 
the horse, hydrogen excreted in breath originated from bacterial fermentation of unabsorbed
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carbohydrate in the caecum/colon. When fasted, hydrogen concentration in breath was 
negligible, but significant concentrations of hydrogen were detected in breath of all ponies 
one to five hours after the ingestion of oats or the administration of wheat flour by stomach 
tube suggesting that hydrogen is excreted in response to feeding and that a proportion of 
both meals was unabsorbed. However, there were two unexpected, yet interesting, 
findings: Some ponies excreted hydrogen in breath following the administration of simple 
sugars (glucose and xylose) and the majority of ponies failed to excrete hydrogen in breath 
following the administration of unabsorbable sugars (lactulose and lactose). The fact that 
dramatic increases in hydrogen excretion were noted in healthy ponies following either 
glucose or xylose administration indicates that a proportion of the oral sugar load escaped 
absorption from the small intestine, which is in agreement with the findings of Breukink
(1974), and is likely to preclude the use of this test for the investigation of small intestinal 
malabsorption in individual clinical cases. The reasons for the majority of these adult ponies 
‘failing’ to excrete hydrogen in breath following the administration of either lactulose or 
lactose were unclear, but suggested that these sugars were either removed from the small 
intestine or were not fermented by large intestinal bacteria. However, the results of a study 
designed to investigate the fate of lactulose following oral administration to ponies 
demonstrated that, as in human (Fleming et a l , 1996) and small animal species 
(Papasouliotis et al., 1993), only a small fraction of an oral lactulose load is absorbed from 
the equine small intestine. In addition, there was no evidence to suggest that lactulose is 
fermented by large intestinal bacteria, even after repeated exposure of intestinal bacteria to 
this sugar. Therefore the fate of lactulose is still unclear. Regardless of the reasons for 
lactulose ‘failure’, this finding would have implications with regard to the use of lactulose in 
the medical management of hepatic encephalopathy in the horse. One positive aspect of this 
study was the technical success of the urine collection method and the analysis for urine 
lactulose concentration. These observations suggest that determination of the percentage of 
urinary recovery of orally administered sugars may be a safe, simple and minimally-invasive 
diagnostic and/or research tool for the assessment of small intestinal permeability in the 
horse and is, therefore, worthy of further investigation.
In further studies, maintenance diet was found to have a significant effect on breath 
hydrogen excretion patterns and, by inference, gastrointestinal tract function. Following the 
administration of wheat flour, cumulative hydrogen excretion was greater when the ponies 
were maintained on hay compared with when maintained on the pelleted ration. Although 
the precise mechanisms involved are unclear, these findings suggest diet-related changes in
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either the functional characteristics of the small intestine (i.e. a greater proportion of the 
administered test meal is available for bacterial fermentation when maintained on the hay 
diet) or the large intestinal intra-luminal environment (i.e. conditions facilitated greater net 
production of hydrogen when maintained on the hay diet). In addition, despite the within 
and between animal variation in hydrogen excretion, the patterns of hydrogen excretion 
recorded when maintained on the pelleted ration indicated more rapid presentation of the 
unabsorbed component of the test meal to intestinal bacteria compared with when 
maintained on the hay diet. This was interpreted as a diet-related change in gastric/small 
intestinal motility and, consequently, a reduced MCTT when maintained on the pelleted 
diet.
The potential use of breath hydrogen measurement for the assessment of MCTT 
(defined as the time at which a significant, sustained increase in hydrogen excretion is 
detected) was further investigated using the motility modifying drugs, cisapride and codeine 
phosphate. In man, it has been shown that there is a highly significant correlation between 
MCTT’s as determined by breath hydrogen measurement and that calculated using the gold- 
standard technique, scintigraphy (Sciarretta et a l , 1994). In the present study, cisapride did 
appear to reduce MCTT. In addition, although MCTT was not prolonged following 
codeine pretreatment, the patterns of breath hydrogen excretion recorded did indicate a 
delay in presentation of the test meal to intestinal bacteria. Therefore, based on the results 
of this preliminary study, it was concluded that breath hydrogen measurement was 
sufficiently sensitive to detect the contrasting effects of both cisapride and codeine 
phosphate on gastrointestinal motility in the horse.
These findings suggest that breath hydrogen measurement may be a useful, non- 
invasive means of assessing certain aspects of gastrointestinal tract function in groups of 
animals. However, more accurate interpretation of test results would necessitate further 
validation studies in which breath hydrogen measurement was compared with more 
conventional, direct methods of assessing gastrointestinal tract function in the horse such as 
myoelectrography. In addition, interpretation of test results in the present series of studies 
assumes that, in healthy ponies, hydrogen excreted in breath originates from the large 
intestine and although this has been confirmed in man (Levitt, 1969), this aspect remains to 
be investigated in the horse.
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A p pe n d ix  1 
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Ap p e n d ix  2
Hospital case numbers of the 29 cases of chronic equine gastro-/enteropathies included in 
Chapter 3.
Identification No. Case No.
1 115705
2 119519
3 121786
4 123918
5 123455
6 107652
7 128325
8 128368
9 128234
10 122259
11 123810
12 124258
13 104810
14 105806
15 104206
16 128620
17 116133
18 122783
19 127091
20 109739
21 116328
22 119669
23 125597
24 105402
25 114660
26 124992
27 128581
28 105698
29 120147
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A p p e n d ix  3
Case numbers, age, breed/type, sex and ‘reason for referral’ of all animals included in the 
control population generated for use in Chapter 3. NR=not recorded, TB=Thoroughbred, 
STB= Standardbred, ID=Irish Draught, F=female, M=male, MN=gelding.
Case No. Age Breed Sex Referral Group
128324 13 Warmblood F Surgery
128325 4 Dales F Medicine
128326 8 TB MN Surgery
128327 1 TB M Surgery
128328 15 TB x F Surgery
128329 10 Riding pony F Surgery
128330 8 Hackney x MN Surgery
128331 8 TB x F Surgery
128332 9 Shire MN Medicine
128333 15 Riding pony F Surgery
128334 5 Hunter F Medicine
128335 6 Hanovarian MN Surgery
128336 15 Riding pony MN Medicine
128337 16 Riding pony F Medicine
128338 4 TB MN Medicine
128339 3 STB MN Surgery
128340 8 Riding pony MN Surgery
128341 7 ID MN Surgery
128342 3 TB F Surgery
128343 5 TB x MN Medicine
128344 9 ID x F Surgery
128345 15 Welsh cob F Surgery
128346 5 Warmblood M Surgery
128347 7 Hunter MN Medicine
128348 11 Appaloosa MN Surgery
128349 15 Arab x F Medicine
128350 14 TB x MN Medicine
128351 6 TB x MN Medicine
128352 16 TB F Surgery
128353 11 Hunter MN Surgery
128354 8 TB x F Medicine
128355 5 Shetland M Surgery
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Case No. Age Breed Sex Referral <
128356 2 Shetland F Surgery
128357 2 Shetland F Surgery
128358 16 TB x MN Surgery
128359 21 Clydesdale MN Medicine
128360 17 Shetland F Medicine
128361 7 Shetland F Medicine
128362 8 Welsh cob MN Surgery
128363 3 Shetland MN Surgery
128364 16 Shetland x MN Medicine
128365 6 Warmblood M Surgery
128366 16 TB x F Medicine
128367 5 TB x MN Surgery
128368 4 Welsh cob F Medicine
128369 4 Shetland F Surgery
128370 3 Shetland F Surgery
128371 20 Connemara MN Medicine
128372 11 Riding pony MN Surgery
128373 11 TB x F Surgery
128374 11 TB MN Surgery
128375 8 TB MN Surgery
128376 6 TB F Medicine
128377 7 Hunter MN Surgery
128378 11 TB MN Surgery
128379 13 TB x MN Surgery
128380 16 TB x MN Surgery
128381 3 Fell MN Surgery
128382 5 TB x MN Surgery
128383 12 TB x F Surgery
128384 12 TB F Medicine
128385 3 Shetland M Surgery
128386 2 Shetland F Surgery
128387 9 Shetland F Surgery
128388 NR TB x F Surgery
128389 10 TB x F Surgery
128390 NR TB x MN Surgery
128391 8 TB F Surgery
128392 20 Riding horse MN Medicine
Appendices 139
Case No. Age Breed Sex Referral Group
128393
128394
128395
128396
128397
128398
128399
128400
128401
128402
128403
128404
128405
128406
128407
128408
21
15
15 
20 
30
16 
5 
8 
8 
7 
15 
17 
11 
13 
20 
9
TB
TB
TB
TB
Donkey 
Connemara x 
TB x
Warmblood 
Riding pony 
TB x 
TB x 
Highland 
TB x 
TB x 
Donkey 
Clydesdale
MN
MN
MN
MN
F
MN
F
F
F
F
F
MN
MN
MN
F
F
Surgery
Surgery
Surgery
Surgery
Medicine
Medicine
Medicine
Medicine
Medicine
Surgery
Surgery
Medicine
Surgery
Surgery
Medicine
Medicine
128410
128411
128412
128413
128414
128415
128416
128417
128418
128419
128420
128421
128422
128423
128424
128425
128426
128427
128428
128429
7
10
11
6
9
18
19
5
14
33
6 
2 
4 
0.1 
3
7
6
9
NR
TB
Riding pony 
Highland 
TB x 
Arab
Connemara x 
TB
Hackney x 
Riding pony 
Riding horse 
TB x
Riding pony
Riding pony
Warmblood
Warmblood
STB
Arab x
TB
Riding horse 
TB x
MN
F
F
MN
MN
MN
F
MN
MN
MN
MN
M
M
F
M
MN
F
MN
F
MN
Surgery
Surgery
Medicine
Surgery
Surgery
Surgery
Surgery
Surgery
Surgery
Medicine
Surgery
Surgery
Medicine
Surgery
Surgery
Surgery
Medicine
Surgery
Surgery
Surgery
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Case No. Age Breed Sex Referral <
128430 8 Clydesdale x MN Medicine
128431 6 TB F Medicine
128432 20 Clydesdale F Medicine
128433 3 Welsh cob M Surgery
128434 11 TB MN Surgery
128435 20 Riding pony MN Surgery
128436 16 Riding pony MN Surgery
128437 9 TB F Surgery
128438 7 TB MN Medicine
128439 4 Warmblood F Medicine
128440 16 Donkey F Medicine
128441 3 Welsh mt F Medicine
128442 12 TB F Surgery
128443 16 Hunter MN Surgery
128444 6 Welsh mt MN Surgery
128445 28 Highland MN Medicine
128446 28 Shetland MN Medicine
128447 2 TB F Surgery
128448 5 TB x F Medicine
128449 11 Hunter MN Surgery
128450 13 Shire x MN Medicine
128451 7 Hunter MN Medicine
128452 13 TB F Medicine
128453 2 Hanovarian F Surgery
128454 6 TB MN Medicine
128456 9 Clydesdale x MN Medicine
128457 4 Clydesdale x MN Medicine
128458 8 Shetland F Medicine
128459 11 Riding pony F Medicine
128460 5 NR MN Medicine
128461 6 NR MN Medicine
128462 6 Riding pony F Medicine
128463 16 Arab x MN Surgery
128464 2 Hanovarian x M Surgery
128465 1 TB x F Surgery
128466 11 Connemara F Surgery
128467 8 Riding pony F Medicine
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Case No. Age Breed Sex Referral <
128468 15 Highland MN Surgery
128469 4 STB MN Surgery
128470 0.4 Clydesdale F Medicine
128471 9 Hunter MN Surgery
128472 14 NR MN Surgery
128473 18 NR F Surgery
128474 10 TB MN Surgery
128475 2 Warmblood x F Medicine
128476 10 Riding pony F Surgery
128477 10 TB x F Surgery
128478 10 Riding pony MN Surgery
128479 4 Riding horse NR Medicine
128481 4 TB MN Medicine
128482 14 Connemara x F Surgery
128483 4 Arab x MN Surgery
128484 11 TB MN Surgery
128485 6 Welsh cob F Medicine
128486 20 Riding pony MN Surgery
128487 9 Riding pony MN Surgery
128488 5 TB x F Surgery
128489 6 Riding horse MN Surgery
128490 4 STB MN Surgery
128491 7 Riding horse F Medicine
128493 1 Welsh mt M Surgery
128494 8 Welsh cob MN Medicine
128495 4 Riding horse F Surgery
128496 10 TB x F Medicine
128497 6 TB x F Surgery
128498 5 Warmblood x F Medicine
128499 8 Hunter MN Medicine
128500 12 Riding horse MN Medicine
128501 13 Arab x F Medicine
128502 4 Riding horse F Medicine
128503 6 TB MN Medicine
128504 14 Riding horse MN Surgery
128505 2 ID x M Surgery
128506 22 TB x MN Medicine
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Case No. Age Breed Sex Referral <
128507 0.9 Hanovarian F Surgery
128508 21 TB x MN Medicine
128509 20 Connemara x MN Surgery
128510 2 TB x F Surgery
128511 18 TB x F Medicine
128512 15 Highland x MN Medicine
128513 14 Connemara x MN Surgery
128514 6 Clydesdale x MN Surgery
128515 5 TB x F Surgery
128516 5 TB x MN Medicine
128517 22 Welsh mt F Medicine
128518 12 TB x MN Medicine
128519 7 TB x MN Medicine
128520 16 Riding pony F Surgery
128521 5 Arab x MN Surgery
128522 6 Riding pony F Surgery
128523 7 Highland F Surgery
128524 8 Riding pony MN Medicine
128525 14 Riding pony F Surgery
128526 21 Riding pony MN Medicine
128527 6 Warmblood MN Surgery
128528 8 Riding horse MN Surgery
128529 4 Heavy cob MN Surgery
128530 8 TB x MN Surgery
128531 12 Riding pony MN Medicine
128532 9 Riding horse MN Surgery
128533 8 Clydesdale MN Medicine
128534 7 TB MN Surgery
128535 7 TB MN Surgery
128536 5 Riding pony MN Medicine
128537 2 Riding pony F Surgery
128538 6 Riding pony F Surgery
128539 10 Riding pony MN Surgery
128540 7 TB F Medicine
128541 15 TB x MN Medicine
128542 1 Riding pony M Medicine
128543 24 TB x MN Medicine
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Case No. Age Breed Sex Referral <
128544 19 Welsh cob F Medicine
128545 NR Warmblood MN Surgery
128546 12 Riding horse MN Surgery
128547 6 TB x F Surgery
128548 0.8 Riding pony F Medicine
128549 3 STB MN Surgery
128550 13 Appaloosa MN Surgery
128551 1 Arab x M Surgery
128552 17 Highland x MN Medicine
128553 9 Welsh mt MN Medicine
128554 5 Riding pony F Surgery
128555 15 TB x MN Surgery
128556 9 TB MN Surgery
128557 7 TB F Surgery
128558 7 Riding pony MN Surgery
128559 9 STB F Surgery
128563 4 TB x MN Surgery
128564 5 Riding horse F Surgery
128565 4 ID x F Surgery
128566 7 TB x F Surgery
128567 9 Hanovarian MN Surgery
128568 20 Riding horse MN Medicine
128569 6 Welsh cob MN Surgery
128570 12 Riding horse MN Surgery
128571 19 TB x F Medicine
128572 4 TB MN Surgery
128573 2 TB x M Surgery
128574 30 Riding pony MN Medicine
128575 17 Hunter MN Medicine
128576 3 Riding pony MN Medicine
128577 7 Welsh mt F Medicine
128578 9 Riding pony MN Surgery
128579 5 TB x F Medicine
128580 0.5 Highland F Medicine
128581 20 TB x F Medicine
128582 9 Warmblood F Surgery
128583 6 Connemara F Surgery
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Case No. Age Breed Sex Referral Group
128584 16 TB x F Surgery
128585 17 Riding pony F Surgery
128586 5 Riding horse F Surgery
128589 5 NR MN Surgery
128591 2 Warmblood x MN Surgery
128592 6 TB F Surgery
128593 6 TB x MN Surgery
128594 20 TB x MN Medicine
128595 3 Arab x F Surgery
128596 NR TB x MN Surgery
128597 17 Riding pony F Medicine
128598 17 Connemara x MN Medicine
128599 6 Highland MN Medicine
128600 9 TB x F Medicine
128601 12 Hunter F Surgery
128602 1 Clydesdale M Medicine
128604 15 Riding pony F Surgery
128605 12 Welsh cob MN Medicine
128606 7 TB x MN Medicine
128607 3 ID x F Medicine
128608 6 TB x MN Surgery
128609 NR Riding horse MN Medicine
128610 3 Riding pony MN Medicine
128611 6 Riding pony F Surgery
128612 8 Hunter MN Surgery
128613 6 Hanovarian x MN Surgery
128614 8 Riding pony MN Surgery
128615 7 TB x F Surgery
128616 8 Riding pony F Surgery
128617 10 Riding horse F Surgery
128618 7 TB MN Surgery
128619 6 TB x MN Surgery
128620 20 Fell F Medicine
128621 12 TB x F Medicine
128622 7 Shetland F Medicine
128623 7 TB F Surgery
128624 14 TB x F Medicine
Appendices 145
A p p e n d ix  4
Serum and plasma fructosamine concentrations (pmol/L) measured in adult (Group A) and
yearling (Group B) ponies for five consecutive weeks.
Animal
Identification
Week
1
Week
2
Week
3
Week
4
Week
5
mean±SD plasma 
fructosamine 
concentration
G roup A  
123 serum 250 272 268 282 249
plasma 250 255 243 256 246 250.0±5.61
124 serum 260 315 285 298 258
plasma 246 280 279 279 252 267.2+16.75
125 serum 279 304 317 298 282
plasma 247 291 302 285 255 276.0+23.79
126 serum 301 331 316 344 287
plasma 285 315 300 329 279 301.6±20.73
127 serum 261 293 288 297 248
plasma 252 271 275 279 253 266.0±12.65
128 serum 265 308 281 308 267
plasma 264 290 273 291 257 275.0±15.25
129 serum 234 274 264 279 239
plasma 226 261 251 269 233 248.0+18.22
G roup B  
114 serum 304 306 312 334 289
plasma 289 310 317 329 272 303.4±22.79
115 serum 201 223 241 246 217
plasma 192 211 221 232 209 213.0+14.88
116 serum 166 297 306 322 268
plasma 267 278 290 296 257 277.6±16.04
117 serum 284 287 306 324 287
plasma 277 290 291 304 278 288.0±11.07
118 serum 227 223 258 255 227
plasma 222 233 243 243 233 234.8+8.73
119 serum 250 246 206 138 240
plasma 233 236 304 266 229 253.6±31.75
120 serum 232 255 254 244 235
plasma 227 238 246 245 231 237.4+8.38
121 serum 282 286 275 275 247
plasma 272 263 249 265 240 262.4±18.28
Mean (+SD ) Serum Fructosamine Concentration* 
Mean (+SD ) Plasma Fructosamine Concentration*
270.4±37.7
263.3+29.1
Calculated based on the mean of 75 observations.
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A p p e n d ix  5
Plasma fructosamine concentrations (p,mol/L) measured in yearling (Group C) ponies for 
five consecutive weeks.
A nim al
Identification
Week 1 Week 2 Week 3 Week 4 Week 5 mean+SD
G roup C 
101 274 269 263 267 238 262.2+14.1
102 261 258 249 271 245 256.8+10.26
103 199 168 183 201 181 186.4+13.7
104 233 232 227 245 224 232.2+8.04
105 251 230 223 229 213 229.2+13.94
106 279 257 238 238 223 247.0+21.58
111 271 276 242 285 283 271.4+17.36
112 258 254 242 295 286 267.0+22.47
113 259 265 239 277 287 265.4+18.3
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Ap p e n d ix  6
Fructosamine concentrations (pmol/L) of two plasma pools assayed repeatedly for 
calculation of intra-assay precision.
Number Adult (Group A) Foal (Group B)
Plasma Pool Plasma Pool
1 261 251
2 258 251
3 265 247
4 260 246
5 258 248
6 252 253
7 253 251
8 255 246
9 253 250
10 258 240
Mean+SD 457.3+4.11 248.3+3.77
CV 1.6% 1.52%
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A p p e n d ix  7
Fructosamine concentrations (pmol/L) of two plasma pools assayed repeatedly for 
calculation of inter-assay precision.
Assay Adult (Group A) Foal (Group B)
Number Plasma Pool Plasma Pool
1 261 251
2 256 240
3 245 233
4 264 255
5 235 236
Mean+SD 252.2+12.03 243+9.57
CV 4.77 % 3.94%
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Ap p e n d ix  8
Fructosamine concentrations (|umol/L) of a plasma sample measured at 4 dilutions for 
assessment of assay linearity.
Dilution Predicted Fructosamine 
Concentration (pmol/L)
Measured Fructosamine 
Concentration (pmol/L)
0 255.6 255.6
1:1.5 192.0 197.0
1:2 128.0 137.3
1:4 64.0 74.0
1:8 32.0 36.6
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A p pe n d ix  9
Fructosamine concentrations (p,mol/L) measured in plasma samples at different times after 
sample collection for assessment of the effects of sample storage on plasma fructosamine 
measurement.
Immediate1 72 hours2 7 days3 30 days4
Pony
114 288 246 272 271
115 305 260 310 297
116 304 259 304 293
117 333 280 319 317
118 333 285 307 309
119 343 296 321 322
123 313 268 304 300
124 308 261 292 286
125 293 236 294 273
126 327 277 305 321
127 308 267 299 294
128 320 268 338 301
129 279 234 258 268
Mean+SD 311.85±18.94 264.0+18.23 301.0±20.54 296.3+18.26
Analysed within 4 hours of sample collection.
2analysed following storage of whole blood for 72 hours at room temperature. 
3analysed following storage of plasma for 7 days at 4°C.
4analysed following storage of plasma for 28 days at -20°C.
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Ap p e n d ix  10
Individual pony weights (kg) measured following experimental cyathostome infections.
Week
Infected Group 1 Infected Group 2 Control Group 3
101 104 105 111 112 113 102 103 106
-8 130 79 103 109 76 83 95 80 102
-6 129 79 103 112 80 88 90 80 103
-4 133 84 105 114.5 82 89 93 84 106
-2 131 88 106 114.5 87 94 96 87 106
0 138 90 111 113 91 98 104 91 113
1 143 93 116 - - - 110 94 119
2 141 89 113 108 86 91 106 92 119
3 142 93 111 - - - 110 95 120
4 142 92 111 114.5 92 100 111 93 121
5 147 92 114 - - - 118 101 131
6 143 90 112 112 91 100 118 101 128
7 143 92 112 103 88 98 121 102 132
8 142 90 112 99 84.5 90.5 118 102 130
9 142 95.5 116 96 84.5 91 127 111 137
10 145 98 117 - 86.8 91 130 112 138
11 147 99 119 - 88 93 132 117 141
12 148 99 118 - - - 135 121 139
13 146 100 118 - 90 93 137 122 145
14 153 98 126 - 92 93 142 125 147
15 150 95.5 119 - 94 98 134 122 144
16 154 94 121 - 99 107 136 127 145
17 154 91 122 - 101 106 136 124 140
18 154 96 120 - 98 107 136 126 143
19 - - - - - - - - -
20 159 99.5 128 - 99.5 107 144 136 152
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A p p e n d ix  11
Individual plasma fructosamine concentrations (|imol/L) measured following experimental 
cyathostome infections.
Week
Infected Group 1 Infected Group 2 Control Group 3
101 104 105 111 112 113 102 103 106
-4 274 233 251 271 258 259 261 199 279
-3 269 232 230 276 254 265 258 168 257
-2 263 227 223 242 242 239 249 183 238
-1 267 245 229 285 295 277 271 201 238
0 238 224 213 283 286 287 245 181 223
1 257 232 230 331 283 296 255 204 241
2 240 226 219 257 242 252 246 196 251
3 241 222 224 281 274 279 255 197 244
4 216 208 210 282 314 314 242 196 247
5 247 238 240 289 276 275 275 215 265
6 233 227 238 256 281 268 280 214 280
7 210 212 228 252 263 269 258 228 275
8 232 225 231 219 250 257 286 241 294
9 209 224 222 186 218 250 281 210 278
10 215 228 226 - 222 222 287 248 290
11 207 216 219 - 226 193 277 235 288
12 205 204 230 - 227 186 291 247 288
13 201 207 196 - 208 175 285 254 260
14 211 202 208 - 217 188 285 261 294
15 237 213 225 - 232 203 293 285 296
16 216 194 209 - 184 185 296 258 279
17 223 177 203 - 190 189 285 258 274
18 249 193 218 - 196 193 289 275 288
19 261 200 234 - 203 199 312 294 316
20 257 194 248 - 250 258 314 294 328
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Ap p e n d ix  12
Individual plasma albumin concentrations (g/L) measured following experimental 
cyathostome infections.
Infected Group 1 Infected Group 2 Control Group 3
Week
101 104 105 111 112 113 102 103 106
-4 28 21 27 31 27 30 26 16 27
-3 28 21 23 32 28 30 24 15 24
-2 26 21 23 30 27 30 23 15 23
-1 26 23 25 35 31 33 26 17 25
0 24 22 22 35 33 33 25 16 22
1 25 24 25 37 31 28 25 18 25
2 25 24 25 35 32 33 25 18 24
3 26 24 26 35 34 37 27 18 26
4 24 23 25 34 34 34 26 18 26
5 24 24 25 36 35 34 27 21 25
6 25 25 26 35 34 32 29 22 30
7 22 23 23 37 33 32 26 21 31
8 24 24 23 32 32 30 28 24 31
9 22 24 22 31 26 24 29 22 29
10 23 26 23 - 25 22 30 27 31
11 21 24 23 - 29 26 29 26 31
12 21 25 25 - 30 28 26 25 29
13 22 23 19 - 33 28 30 29 29
14 23 21 20 - 29 26 29 28 29
15 23 22 22 - 31 29 30 28 30
16 24 22 23 - 30 30 30 29 31
17 25 20 22 - 30 30 30 31 29
18 27 21 23 - 28 27 29 29 28
19 28 22 26 - 30 30 33 32 33
20 29 24 28 - 31 31 33 33 33
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A p p e n d ix  13
Individual serum globulin concentrations (ot2, p i, P2, y) (g/L) measured following
experimental cyathostome infections.
a2-globulin concentrations (g/L)
Week
Infected Group 1 Infected Group 2 Control Group 3
101 104 105 111 112 113 102 103 106
-4 7.18 9.97 8.86 7.85 9.01 6.83 9.29 7.54 10.42
-3 7.72 8.96 9.43 8.44 8.47 7.56 8.97 5.84 9.74
-2 7.04 9.97 8.16 7.08 8.49 7.98 8.27 6.79 9.92
-1 7.56 9.80 9.07 7.54 8.53 7.74 8.03 7.27 9.88
0 6.85 9.83 7.15 8.00 8.56 7.50 7.74 6.84 8.14
1 6.78 9.35 7.79 7.90 9.00 7.75 7.84 8.84 9.06
2 6.75 10.32 8.06 7.81 9.41 8.10 7.69 8.14 9.46
3 6.75 8.53 8.57 9.11 9.42 7.88 7.61 6.76 9.50
4 7.10 7.73 8.80 10.60 10.21 8.49 7.34 6.02 9.06
5 7.70 7.78 9.13 11.36 11.21 10.27 7.99 6.21 7.69
6 8.32 8.06 9.92 10.02 10.03 9.48 7.84 5.83 9.58
7 8.22 8.93 15.94 9.24 9.86 10.14 8.99 6.66 10.53
8 8.37 10.21 12.52 7.79 12.42 11.04 8.82 7.00 8.68
9 8.58 9.07 10.80 7.76 10.20 9.41 9.46 7.84 8.93
10 8.96 8.45 12.29 - 9.11 9.26 8.64 7.07 8.97
11 7.70 7.00 10.44 - 11.27 10.60 7.45 6.60 7.83
12 8.69 7.80 10.69 - 11.47 11.02 7.52 5.99 8.18
13 8.18 8.50 9.64 - 10.46 9.42 7.80 6.21 8.46
14 7.56 7.55 9.39 - 8.68 9.15 8.13 6.61 9.73
15 8.32 8.83 10.30 - 9.68 8.78 7.13 6.44 9.47
16 6.63 7.31 9.30 - 9.75 9.77 6.61 5.99 8.38
17 7.17 7.67 8.80 - 11.78 9.95 7.02 6.50 9.11
18 6.20 7.28 9.09 - 10.89 10.95 6.27 6.10 8.80
19 8.90 9.92 11.52 - 10.04 9.64 10.94 8.51 8.82
20 9.30 10.52 11.25 - 10.79 9.57 8.70 8.00 11.08
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B 1-globulin concentrations (g/L)
Week
Infected Group 1 Infected Group 2 Control Group 3
101 104 105 111 112 113 102 103 106
-4 3.13 5.10 4.07 6.37 5.13 4.37 7.41 6.03 6.45
-3 2.97 5.4 4.08 6.05 5.01 4.88 7.54 6.22 5.92
-2 3.06 5.54 3.74 6.55 5.36 4.86 6.97 6.02 5.64
-1 3.78 5.42 4.43 7.09 4.80 4.87 7.54 6.21 7.69
0 3.25 4.89 4.31 7.69 4.37 4.88 6.94 5.98 6.66
1 3.37 5.64 4.40 7.35 4.29 5.00 6.78 5.69 6.84
2 2.90 5.70 4.51 6.98 4.22 5.16 7.42 5.84 6.56
3 3.25 5.39 4.48 7.30 5.27 5.54 7.24 6.35 5.90
4 2.83 4.82 4.07 7.48 5.79 5.70 6.91 6.20 6.24
5 3.20 5.10 4.27 8.23 5.61 5.61 6.80 5.75 5.62
6 3.33 5.57 5.05 6.99 4.85 4.80 7.06 5.88 6.04
7 3.80 6.32 7.17 6.39 5.07 5.54 7.83 6.03 6.31
8 4.27 6.31 6.01 5.62 5.10 4.86 7.25 5.55 6.26
9 4.06 6.93 6.14 6.38 5.10 4.80 7.93 4.95 4.99
10 5.13 7.09 6.66 6.44 4.85 4.78 7.71 6.05 5.55
11 5.20 5.88 6.90 - 6.08 6.14 6.78 5.25 5.92
12 5.41 8.45 9.04 - 6.51 7.26 6.95 5.67 6.01
13 6.22 9.18 8.63 - 6.30 6.08 7.38 5.87 5.70
14 6.66 8.73 8.51 - 5.54 5.96 7.25 5.92 5.63
15 5.59 9.86 9.11 - 5.43 5.55 6.61 5.67 5.76
16 5.14 8.76 8.37 - 6.04 6.99 6.56 5.30 5.37
17 5.82 8.90 8.56 - 6.62 6.83 7.02 5.51 5.37
18 6.43 8.62 6.22 - 6.66 7.99 6.27 5.40 5.83
19 5.50 8.99 9.36 - 6.70 6.73 7.20 6.08 5.67
20 4.68 8.69 10.26 - 6.88 6.73 6.91 6.08 5.85
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(32-globulin concentrations (g/L)
Infected Group 1 Infected Group 2 Control Group 3
Veek
101 104 105 111 112 113 102 103 106
-4 5.94 7.06 5.45 3.60 5.47 4.87 3.36 5.34 6.57
-3 5.99 5.99 5.72 3.53 5.45 5.25 2.75 4.45 6.44
-2 5.41 6.55 5.04 2.83 5.87 5.46 2.55 4.73 6.78
-1 6.10 6.04 5.67 3.00 5.20 5.26 2.53 4.92 6.65
0 5.50 5.30 4.95 3.22 4.60 5.06 2.70 4.69 6.60
1 5.61 6.04 5.57 3.28 4.30 5.14 2.86 5.17 6.84
2 5.60 6.60 5.57 3.33 4.05 5.22 2.33 4.78 6.27
3 5.30 6.44 5.77 3.35 5.15 5.73 2.75 4.97 6.61
4 6.38 4.98 5.56 3.32 5.66 5.70 2.57 4.89 6.72
5 6.05 4.87 5.51 3.40 5.80 6.62 2.48 4.51 5.04
6 6.55 5.45 6.32 2.96 5.13 6.12 2.46 4.65 5.61
7 6.92 6.45 8.26 3.16 5.42 6.49 2.32 4.66 5.59
8 7.24 7.15 8.49 3.23 6.42 7.02 2.84 4.45 5.46
9 6.92 6.99 8.08 3.36 5.81 5.98 3.11 4.90 5.34
10 7.18 7.93 9.22 - 5.05 5.77 2.20 4.81 5.12
11 6.78 7.11 8.94 - 5.84 7.07 2.30 4.52 5.05
12 7.47 7.87 10.23 - 6.63 8.05 2.17 4.37 5.33
13 7.75 8.16 10.27 - 6.24 7.69 2.28 4.62 4.92
14 7.68 7.38 11.21 - 5.60 7.61 2.02 4.70 5.50
15 6.67 7.49 10.56 - 6.55 7.87 1.74 3.41 5.25
16 6.41 7.48 9.80 - 6.56 7.94 1.71 3.87 4.78
17 6.66 6.44 8.93 - 6.87 7.93 2.22 4.12 5.21
18 7.20 6.89 10.98 - 6.27 7.40 1.68 3.73 6.01
19 7.04 7.19 11.45 - 7.50 8.91 2.95 4.80 5.73
20 7.41 6.87 11.70 _ 7.38 9.04 2.82 4.65 5.98
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Y-globulin concentrations (g/L)
Week
Infected Group 1 Infected Group 2 Control Group 3
101 104 105 111 112 113 102 103 106
-4 4.32 6.05 4.24 7.49 6.56 6.33 6.38 4.05 4.90
-3 3.89 6.53 4.35 7.80 7.54 6.71 6.77 3.28 4.70
-2 3.62 6.55 4.27 7.20 6.56 6.48 6.19 4.13 4.96
-1 3.94 6.56 4.88 7.57 6.26 6.50 6.33 4.09 5.37
0 3.70 6.08 4.41 7.94 5.96 6.53 6.15 3.74 4.90
1 3.83 6.50 4.88 8.50 5.69 7.00 6.04 4.04 5.16
2 4.05 7.38 5.04 9.09 5.42 7.92 6.04 3.91 4.79
3 4.55 7.42 5.54 9.98 6.88 8.38 5.99 4.05 5.02
4 4.66 6.05 5.56 9.30 7.15 8.18 5.78 3.43 4.92
5 5.30 6.50 5.62 9.93 7.31 9.39 5.67 3.31 4.08
6 5.72 7.31 6.03 8.82 6.90 10.20 5.77 3.48 4.64
7 5.56 8.31 6.21 8.06 7.01 10.65 10.44 3.87 5.01
8 5.78 8.00 6.45 5.88 6.24 7.68 6.03 3.45 5.15
9 5.62 7.88 6.14 6.11 5.20 5.59 6.47 3.87 4.58
10 5.83 8.13 6.66 - 4.61 9.57 6.32 4.32 4.82
11 5.46 7.11 6.48 - 6.20 11.72 6.16 4.11 4.87
12 6.04 8.32 7.39 - 7.75 11.55 6.90 4.27 5.64
13 6.66 8.70 7.18 - 6.74 9.67 7.38 4.39 4.62
14 6.24 8.14 7.56 - 5.82 9.20 6.87 4.29 5.31
15 5.59 8.58 7.72 - 6.14 8.72 6.21 4.73 5.18
16 5.35 8.12 7.38 - 7.01 9.89 6.10 4.13 4.90
17 5.71 7.56 7.75 - 7.81 9.88 6.48 4.47 5.15
18 6.55 7.67 7.26 - 8.10 11.62 6.10 4.16 5.70
19 5.70 7.32 9.22 - 8.43 9.77 6.41 4.93 6.11
20 5.72 7.06 9.65 - 7.63 9.90 6.02 4.53 6.46
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Ap p e n d ix  14
The results of individual OGTTs performed on three occasions on each of seven adult 
ponies when maintained on a hay only diet.
Replicate 1
Pony
Time (min)
123 124 125 126 127 128
Plasma Glucose Concentrations (mmol/L)
129
0 4.2 4.4 4.4 4.2 4.1 4.9 4.2
30 6.1 6.0 7.4 6.5 5.8 7.2 7.1
60 6.8 8.6 9.3 8.3 8.6 8.5 8.6
90 7.4 9.6 10.6 10.1 10.9 10.1 9.3
120 7.6 10.6 11.7 10.1 11.5 10.7 8.5
150 6.4 11.0 11.7 10.0 10.2 10.9 7.1
180 6.9 10.4 10.7 9.4 9.8 9.0 5.4
240 6.0 8.4 9.7 6.6 7.1 8.7 3.3
300 4.9 5.9 6.9 3.5 5.0 8.3 3.2
360 5.9 5.6 6.1 3.1 3.3 6.3 4.3
Replicate 2
Pony
Time (min)
123 124 125 126 127 128
Plasma Glucose Concentrations (mmol/L)
129
0 4.5 4.8 4.5 4.7 4.5 4.9 4.5
30 5.5 7.7 6.3 5.6 6.8 6.8 7.1
60 6.0 10.0 9.0 6.9 9.7 7.9 8.1
90 6.8 11.3 11.3 7.0 11.3 9.6 8.7
120 7.6 12.8 11.3 6.6 12.3 9.7 8.9
150 6.9 13.5 13.0 7.2 12.2 10.4 8.9
180 7.3 13.7 11.7 5.8 11.7 8.6 7.7
240 6.6 9.2 9.7 4.1 8.2 8.2 5.8
300 6.6 5.1 8.2 4.0 5.0 6.2 3.2
360 5.6 2.8 6.8 4.1 3.2 3.8 3.3
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Replicate 3
Pony 123 124 125 126 127 128 129
Time (min) Plasma Glucose Concentrations (mmol/L)
0 4.6 4.4 5.1 6.0 4.1 4.9 4.3
30 5.7 6.6 7.3 7.4 6.0 5.6 6.4
60 6.3 9.2 8.9 8.5 7.3 6.9 6.9
90 7.1 11.0 8.6 10.9 8.8 8.3 7.3
120 7.5 10.4 8.2 10.7 9.5 8.7 6.9
150 7.1 10.4 7.7 10.5 9.5 9.3 7.3
180 6.9 10.3 7.9 8.3 8.4 9.6 5.5
240 6.4 7.3 8.2 5.3 5.5 8.5 2.8
300 6.0 7.0 6.6 3.0 3.9 6.9 3.7
360 5.3 5.6 7.2 4.3 2.9 4.8 4.8
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A ppe n d ix  15
The results of individual OGTTs performed on three occasions on each of seven adult 
ponies when maintained on a pelleted ration only.
Replicate 1
Pony 123 124 125 126 127 128 129
Time (min) Plasma Glucose Concentrations (mmol/L)
0 4.1 4.0 4.1 4.0 4.0 4.2 4.7
30 5.3 5.5 5.4 5.8 4.5 4.7 5.5
60 5.3 6.8 5.2 6.3 6.2 5.2 6.3
90 5.2 6.7 5.9 6.5 7.0 6.1 5.4
120 4.7 5.6 5.6 6.0 7.3 6.6 5.1
150 4.6 5.1 4.9 6.0 5.5 6.0 3.8
180 4.6 4.6 4.7 4.5 3.1 5.8 3.9
240 4.7 3.4 4.7 3.6 1.9 4.9 4.6
300 4.3 4 4.6 4.1 3.9 3.2 3.9
360 4.2 4.1 5.0 3.9 3.9 4.2 4.3
Replicate 2
Pony
Time (min)
123 124 125 126 127 128
Plasma Glucose Concentrations (mmol/L)
129
0 4.2 4.0 4.3 4.1 4.3 4.2 4.5
30 5.2 6.3 5.8 6.4 5.6 4.6 6.8
60 6.0 6.9 6.5 6.8 6.3 5.5 9.1
90 6.1 5.0 5.7 7.0 7.7 6.2 9.9
120 5.5 4.5 4.6 6.0 8.2 6.7 10.0
150 5.0 3.4 4.7 5.4 8.3 6.6 9.8
180 4.4 4.9 4.4 5.0 5.4 6.2 9.6
240 3.5 4.2 4.3 3.3 2.5 3.3 6.0
300 4.0 4.7 4.4 3.8 1.5 3.5 2.5
360 4.1 4.4 5.5 4.0 3.5 4.5 2.0
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Replicate 3
Pony 123 124 125 126 127 128 129
Time (min) Plasma Glucose Concentrations (mmol/L)
0 4.5 3.9 4.6 4.2 4.3 4.5 4.7
30 5.5 5.1 5.8 6.6 6.7 5.9 6.1
60 5.7 6.9 6.7 7.9 8.0 7.1 7.7
90 5.7 7.5 5.7 7.9 9.0 8.7 8.1
120 6.2 7.0 5.2 6.7 9.3 8.8 7.3
150 5.9 6.5 5.3 6.1 8.0 7.9 5.8
180 5.1 4.5 4.4 5.8 6.8 8.3 4.7
240 4.8 4.7 5.3 4.7 6.0 5.4 5.0
300 4.8 5.1 5.1 3.6 3.5 4.9 5.4
360 5.6 4.9 5.1 3.7 1.7 3.8 5.8
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A p p e n d ix  16
The results of individual OGTTs performed on three occasions on each of seven pony foals 
when maintained on a pelleted ration only.
Replicate 1
Pony
Time (min)
101 102 103 105 106 112
Plasma Glucose Concentrations (mmol/L)
113
0 4.7 3.8 4.0 4.7 4.9 4.8 4.6
30 8.2 8.1 7.0 8.8 7.3 8.0 7.7
60 9.8 11.0 8.7 11.0 10.2 11.2 9.9
90 11.8 12.0 11.5 12.2 12.3 12.5 11.1
120 10.4 11.6 11.4 13.4 12.0 12.2 10.1
150 10.1 10.5 10.0 13.3 10.9 10.5 7.6
180 9.4 8.7 10.5 12.6 8.1 8.2 4.9
240 7.8 5.5 8.6 12.0 4.7 3.5 3.1
300 3.8 3.3 6.2 6.2 2.4 2.1 4.2
360 2.1 3.1 3.6 3.0 3.7 4.0 4.1
Replicate 2
Pony
Time (min)
101 102 103 105 106 112
Plasma Glucose Concentrations (mmol/L)
113
0 4.7 4.2 4.3 4.5 4.4 4.1 4.5
30 7.1 7.5 8.3 8.3 7.8 6.3 7.4
60 8.6 10.8 10.6 11.5 10.7 7.5 10.2
90 9.1 12.9 12.6 13.1 13.6 10.4 10.8
120 10.1 12.9 13.0 14.1 15.1 9.8 7.3
150 9.3 12.3 13.9 14.2 16.1 8.0 5.6
180 8.6 10.6 13.2 14.1 13.9 6.1 3.0
240 9.2 7.7 9.7 10.6 10.1 4.7 2.2
300 6.7 4.7 6.2 5.8 5.9 4.1 3.6
360 5.6 2.3 3.7 3.0 2.7 2.4 3.8
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Replicate 3
Pony 101 102 103 105 106 112 113
Time (min) Plasma Glucose Concentrations (mmol/L)
0 3.9 4.1 3.6 3.9 3.1 4.9 4.5
30 6 . 1 6 . 6 5.8 6.9 5.8 7.6 6 . 8
60 8 . 2 8 . 6 8 . 0 9.9 9.4 9.8 8 . 0
90 1 0 . 0 9.1 1 0 . 0 12.3 1 0 . 6 1 1 . 8 8.9
1 2 0 11.9 8 . 2 1 2 . 2 1 2 . 2 9.4 11.4 9.7
150 1 0 . 6 7.1 1 2 . 6 1 0 . 0 8 . 0 6 . 1 6.7
180 8.4 5.9 11.4 7.4 6 . 2 5.5 5.3
240 5.0 3.1 8 . 2 4.0 2.9 2.7 2.7
300 2.4 3.1 5.2 2 . 2 2.9 2 . 6 2 . 8
360 3.6 3.6 2.9 3.8 3.4 4.2 3.8
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Ap p e n d ix  17
Characteristics of the individual OGTTs which were included in the study to assess the 
sensitivity and specificity of the OGTT for detecting/excluding a diagnosis of small intestinal 
pathology in the horse (STUDY 5).
Case Number Peak glucose Glucose concentration
concentration* at 1 2 0  min*
Small intestinal pathology present
104810 157% 145 %
124258 119% 109 %
123810 1 1 1  % 107%
105698 134% 106%
122783 126% 126%
127091 1 2 1  % 117%
119669 125 % 104%
125597 196% 196%
114660 168 % 168 %
124992 128 % 118%
118875 131 % 0 %
Small intestinal pathologv absent
105806 236 % 236 %
119519 187% 187%
116328 2 0 0  % 2 0 0  %
103815 135 % 1 2 2 %
110578 184% 184%
120147 124 % 124 %
113360 107% 0 %
120387 141 % 139%
121616 300 % 300 %
125466 141 % 1 2 0  %
*data presented as a percentage of basal glucose concentration.
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Ap pe n d ix  18
Repeatability of the breath collection/storage technique.
Repeatability of the breath collection/storage technique was determined by analysing the 
duplicate breath hydrogen concentrations detected for all tests performed, in all ponies, 
following the ingestion/administration of each different test meal/carbohydrate substrate as 
described in St u d y  6 (i.e. 42 separate tests). For all duplicate measurements, the mean of 
each pair was taken as 1 0 0  % and the percentage deviation from the mean value was 
determined. The average deviation from the mean value for all pairs analysed (n = 714), 
over a range of concentrations from 0  ppm to 280 ppm was calculated to be 15 . 0 0  %, with 
308 identical paired readings. When the analysis was repeated on duplicate measurements, 
with an initial reading of 5 ppm or greater (n = 342) the average deviation decreased to 6.26 
% and included 79 identical paired readings.
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Analysis of duplicate breath hydrogen measurements (n=714). The mean of 
each duplicate was taken as 1 0 0  % and each point represents the deviation of 
each measurement from the mean value.
Appendices 166
These results compare favourably with those of Metz, Gassull, Leeds, Blendis & Jenkins 
(1976b) who, when using the same data analysis, reported a mean variation of 1 1 . 6  % in 
hydrogen concentrations in duplicate, end-expiratory breath samples.
The collection technique was similar to a ‘nasal prong’ method described by Perman, 
Barr & Watkins (1978) for breath collection from children. Although these authors 
acknowledged a potential for error due to dilution of the sample if collection begins too 
early in expiration, they found that the method was highly correlated with other reliable 
collection procedures. In addition, they observed that hydrogen concentrations in breath 
samples stored in plastic syringes were not significantly altered over an eight hour period 
(Perman, Barr & Watkins, 1978).
Based on the analysis described above, the reproducibility of the collection/storage 
method was regarded as being satisfactory and all data analyses performed in Chapter 6  
utilized the mean of duplicate measurements at each time point.
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Ap p e n d ix  19
Assessment of the pattern of breath hydrogen excretion following a test meal in relation to 
fasting data.
When the adult ponies were maintained on either the hay only diet (Diet 1) or the pelleted 
ration (Diet 2) the group mean (±SD) breath hydrogen concentrations at each time point 
during the ‘fasting’ tests (i.e. 2 1  separate tests when maintained on each diet) were 
determined. Breath hydrogen excretion curves following the various test 
meals/carbohydrate substrates were analysed individually and were regarded as being 
biologically significantly different from fasting if there was a detected increase in breath 
hydrogen concentration greater than the greatest mean+2sD value for the respective 
‘fasting’ data (i.e. 10 ppm* and 5 ppm* when the maintenance diets were Diet 1 and Diet 2, 
respectively), sustained for at least 2 consecutive time points (i.e. 30 min).
Diet 1 Diet 2
Time mean SD mean+2SD mean SD mean+2SD
0 2.90 2.37 7.64 1.48 1.45 4.38
30 3.71 3.27 10.25 10 * 1.38 1.58 4.54
60 3.33 2.77 8.88 1.48 1.32 4.11
90 3.31 2.47 8.25 1.33 1.30 3.93
120 3.05 2.13 7.31 1.19 1.26 3.71
150 2.17 1.70 5.56 1.10 1.29 3.68
180 2.17 2.03 6.22 0.98 1.25 3.48
210 2.21 1.78 5.77 0.81 1.15 3.10
240 1.93 1.58 5.10 0.88 1.01 2.90
270 2.17 1.74 5.65 0.98 1.26 3.50
300 2.02 1.96 5.94 0.79 0.99 2.77
330 2.10 1.42 4.93 0.90 1.40 3.71
360 1.67 1.29 4.24 0.86 1.06 2.98
390 1.33 1.42 4.17 0.83 1.42 3.67
420 1.50 1.57 4.65 0.67 1.15 2.98
450 1.71 1.58 4.87 0.69 1.26 3.21
480 1.29 1.38 4.05 0.83 1.36 3.56
*greatest mean+2SD rounded to the nearest whole number.
Appendices 168
A p p e n d ix  20
Concentrations of hydrogen (mean of duplicate measurements) detected in excreted breath 
of adult ponies following the administration/ingestion of a variety o f ‘test meals’.
Tsig (min) = the time at which significant increases in hydrogen (if any) were first noted.
AH2 (ppm) = the peak hydrogen concentration measured during the test period.
Tah2 (min) = the time of peak hydrogen concentration.
AUCshours (ppm x hours) = the total area under the hydrogen excretion curve.
NA = not applicable.
Glucose
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 4 2 3.5 3 1 1.5 6
30 4 2 3.5 2.5 0 1 10.5
60 8 0.5 4 6 1 2 28.5
90 26.5 1 2.5 5.5 2 2 48
1 2 0 55.5 2 2 7 0 4 70
150 65.5 1 2 1 0 1.5 2.5 64.5
180 91 2 3 8.5 3 2.5 84
2 1 0 89 4 2 11 4 2.5 93.5
240 85.5 3.5 3 10.5 4 2 93
270 125.5 2 1.5 15 1 3.5 96.5
300 134.5 0 0.5 23 1 2 62
330 94 1.5 0 36 3 3 42.5
360 32.5 4 1.5 13 2 6.5 14.5
390 27 2.5 0 6.5 4 2.5 11.5
420 15 3 3 4 2 2 11.5
450 13 1.5 1.5 2 2 1.5 16
480 11 2 1 1 0 1 11.5
Tsig (min) 90 NA NA 2 1 0 NA NA 30
AH2 (ppm) 134.5 NA NA 36 NA NA 96.5
Tah2 (min) 300 NA NA 330 NA NA 270
AUCshours 
(ppm x hours)
437 16.25 16.125 81.25 15.5 20.375 377.625
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Xylose
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 2.5 8.5 7 4 0 2 3.5
30 2.5 4 7.5 4.5 2 0.5 8
60 5.5 5.5 6 5 2 0 17.5
90 16.5 5.5 5.5 5.5 4 2 17
1 2 0 27 4 11 13 3 0 23.5
150 50 0.5 3 11 2.5 1 25
180 70 2 1.5 19.5 2 0 25.5
2 1 0 107 0.5 1.5 29 1.5 0 35.5
240 125.5 2.5 4 38 2.5 0.5 29
270 136 2 3 42.5 2 0 16
300 153 2.5 1 32.5 0 0.5 10.5
330 133.5 0 2 39 1 1 10.5
360 139.5 2 2 1 0 3 2 14
390 143 1 3 4.5 2 3 9.5
420 2 1 1 2 1 3 1 3 1 2
450 175 1 2 5.5 2 2 9.5
480 173 0 0 1 2 0 1 2
Tsig (min) 90 NA NA 1 2 0 NA NA 60
AH2 (ppm) 2 1 1 NA NA 42.5 NA NA 35.5
Tah2 (min) 420 NA NA 270 NA NA 2 1 0
AUCshours 
(ppm x hours)
791.375 19.625 28.75 132.5 15.75 8.25 135.375
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Oats
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 5 3 1 3.5 1 2.5 9
30 3.5 6 0.5 4 0.5 1.5 7
60 2 6 0 4 2 2 17
90 5 6 2 6 2 1 20.5
1 2 0 3.5 5 3 3 2 6 45
150 5.5 6 4 4.5 2 15.5 43
180 7 8 2 6 3 28.5 50
2 1 0 6.5 8.5 3 1 0 5 53.5 51
240 8.5 1 0 4 13.5 5.5 50 56.5
270 9.5 18.5 3 2 1 12.5 80 59.5
300 16 12.5 1 2 38 13.5 53.5 59.5
330 16.5 25 19 29 18.5 30 69.5
360 17.5 55 19 27.5 18.5 23.5 59
390 19.5 60 21.5 28.5 16.5 24.5 63.5
420 33.5 73 30 29 23 42 44.5
450 30.5 49.5 26 18 22.5 49 27.5
480 36.5 17 40 9 25.5 34.5 18
Tsig (min) 300 240 300 2 1 0 270 150 60
AH2 (ppm) 36.5 73 40 38 25.5 80 69.5
Tah2 (min) 480 420 480 300 480 270 330
AUCshours 
(ppm x hours)
102.625 179.5 84.75 124.125 80.125 239.5 343.25
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Wheat Flour
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 3 16 0.5 1 0.5 0.5 2
30 1 8.5 0 3 0 1 0.5
60 3 7 0 3.5 0 0 2
90 4 4 2.5 6.5 2 0 5
1 2 0 5.5 4 2.5 5.5 8 1.5 9
150 23.5 11 4 7 2 2 5 10.5
180 52 23 6 4 33 17 14.5
2 1 0 77 12.5 6.5 5.5 79 11 18.5
240 1 2 0 14.5 1 0 4.5 80.5 11 32.5
270 88.5 15.5 5 1 0 92 1 0 60
300 170.5 1 0 11.5 11.5 90 15 79
330 133 1 2 14.5 14 91.5 17.5 103.5
360 242.5 13 3.5 16 8 8 47 1 2 1
390 279 9.5 3 1 0 6 8 36 98
420 191 8 4.5 5 26.5 23 80
450 252 5 1.5 6 15 13 33
480 211.5 2 2 4 8 10.5 35.5
Tsig (min) 150 150 240 270 150 180 150
AH2 (ppm) 279 23 14.5 16 92 47 1 2 1
Tah2 (min) 390 180 330 360 270 360 360
A-UCghours 
(ppm x hours)
874.875 83.25 38.125 57.25 349.875 106.75 342.875
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Lactulose
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 6 3.5 1 5 3 0 1.5
30 6 1 7.5 5 3 0.5 2
60 3 2 0 27.5 3 0 4
90 4 2 1 28.5 1 0 4
1 2 0 2.5 1 1 34 1.5 1 4.5
150 5.5 1 0 43.5 1 0 4
180 8.5 1 0 43.5 2 0 2.5
2 1 0 1 0 0.5 0 48 3.5 1 3
240 14.5 2 0.5 54.5 1 0 2.5
270 19 1 0 50 1 2 1
300 22.5 1 0 50.5 1 0 0
330 17 1 0 44 3.5 1 0.5
360 35.5 2 3 36.5 3 0 1
390 45 2.5 0.5 45 2 0.5 1
420 40.5 2 2.5 46.5 0.5 0 2
450 65 1.5 2 37 2 1 0
480 44 0 2 2 0 2 0 0.5
Tsig (min) 2 1 0 NA NA 60 NA NA NA
AH2 (ppm) 65 NA NA 54.5 NA NA NA
T a h 2 (min) 450 NA NA 240 NA NA NA
AUCshours 
(ppm x  hours)
161.75 11.625 9.75 303.25 15.75 3.5 16.5
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Lactose
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 2 4.5 2 0 0 0 1.5
30 3.5 6 0.5 0.5 0.5 1 1
60 6 5.5 0 4 2 0.5 2
90 7.5 8 1.5 4.5 0.5 0 2
1 2 0 11 7 0 1 2 0.5 4.5
150 21.5 9 0.5 2 2 0.5 7.5
180 32 7.5 1 1.5 2 1 4
2 1 0 44 9.5 0 0.5 2 1.5 7
240 27 6.5 0.5 0 2.5 1.5 7.5
270 36 11 0 0 2 0 9.5
300 63.5 9 0 0 1.5 0 14
330 72.5 5 0.5 1 2 0.5 19
360 47.5 4 1 0.5 2 0 2 0
390 65.5 3.5 0 6 0 0 17
420 96 3 0 5.5 0 0 14
450 85.5 0.5 0 6.5 0 0 10.5
480 93 1.5 0 6 1 0 9
Tsig (min) 1 2 0 NA NA NA NA NA 300
AH2 (ppm) 96 NA NA NA NA NA 2 0
Tah2 (min) 420 NA NA NA NA NA 360
A U C s h o u r s  
(ppm x hours)
333.25 49 3.25 18.25 10.75 3.5 72.375
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A p p e n d ix  21
Concentrations of hydrogen (mean of duplicate measurements) detected in excreted breath 
of adult ponies following the administration of wheat flour by stomach tube when 
maintained on a hay only diet. Tests were repeated on each pony on three occasions.
Tslg (min) = the time at which significant increases in hydrogen (if any) were first noted.
AH2 (ppm) = the peak hydrogen concentration measured during the test period.
Tah2 (min) = the time of peak hydrogen concentration.
AUCghours (ppm x hours) = the total area under the hydrogen excretion curve.
NA = not applicable.
Replicate 1
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 3 16 0.5 1 0.5 0.5 2
30 1 8.5 0 3 0 1 0.5
60 3 7 0 3.5 0 0 2
90 4 4 2.5 6.5 2 0 5
1 2 0 5.5 4 2.5 5.5 8 1.5 9
150 23.5 11 4 7 2 2 5 10.5
180 52 23 6 4 33 17 14.5
2 1 0 77 12.5 6.5 5.5 79 11 18.5
240 1 2 0 14.5 1 0 4.5 80.5 11 32.5
270 88.5 15.5 5 1 0 92 1 0 60
300 170.5 1 0 11.5 11.5 90 15 79
330 133 1 2 14.5 14 91.5 17.5 103.5
360 242.5 13 3.5 16 8 8 47 1 2 1
390 279 9.5 3 1 0 6 8 36 98
420 191 8 4.5 5 26.5 23 80
450 252 5 1.5 6 15 13 33
480 211.5 2 2 4 8 10.5 35.5
Tsig (min) 150 150 240 270 150 180 150
AH2 (ppm) 279 23 14.5 16 92 47 1 2 1
T ah2 (rnin) 390 180 330 360 270 360 360
A U C g h o u r s  
(ppm x hours)
874.875 83.25 38.125 57.25 349.875 106.75 342.875
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Replicate 2
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 3 4 3 0 1.5 0.5 0
30 2.5 2.5 2 0.5 0 0 1
60 2.5 3 3 0 0 0 1
90 6 8 6 5 2 0 5.5
1 2 0 7 4.5 5.5 12.5 2 0 5
150 15 5 4.5 1 0 5 0 6
180 23.5 2 3.5 6.5 17 0 14
2 1 0 48.5 3.5 3.5 16 67 0 17.5
240 6 6 0 2 15 90.5 4 16.5
270 106.5 2.5 3.5 1 2 61.5 6 2 1
300 108.5 4.5 3.5 28.5 77 6 30.5
330 135 3.5 3.5 30.5 72.5 8 17
360 121.5 3.5 5 41 8 8 9 12.5
390 84 3 4.5 30.5 123 19.5 13.5
420 64 3.5 6 18.5 39 18 18.5
450 35.5 4.5 5 2 0 28.5 13.5 2 1
480 30 2.5 3 8 15 5.5 2 2
Tsig (min) 150 NA NA 1 2 0 180 390 180
AH2 (ppm) 135 NA NA 41 123 19.5 30.5
Tah2 (min) 330 NA NA 360 390 390 300
AUCghours 
(ppm x hours)
421.25 28.375 32 125.25 340.625 43.5 105.75
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Replicate 3
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 2.5 5.5 0.5 2.5 0 2 27.5
30 2 3 1 2 1 3 58
60 3 2.5 1 4.5 2 2.5 51.5
90 1 3 2.5 7 2 4 56.5
1 2 0 7 1.5 5 8.5 1 8 108
150 29.5 1.5 3 17 4.5 17 133
180 63 4.5 5.5 15.5 1.5 29.5 107
2 1 0 94 5.5 3.5 18 4 24.5 77.5
240 8 6 4.5 3.5 12.5 5.5 40.5 135.5
270 76 6 2 8 3.5 39 145
300 126 6 2 7.5 2.5 35 118
330 165.5 5 2 8.5 3 2 2 123.5
360 38 5 3.5 13.5 2 1 2 117
390 16 4.5 3.5 12.5 5 7 98
420 16.5 2 4 14 4 8.5 118
450 19 2 3.5 27 3 7 132
480 17.5 3 4 11.5 2 5 62.5
Tsig (min) 150 NA NA 150 NA 150 30
AH2 (ppm) 165.5 NA NA 27 NA 40.5 145
T a h 2 (m in ) 330 NA NA 450 NA 240 270
A U C ghours 
(ppm x hours)
376.25 30.375 23.875 91.5 22.75 131.5 811.75
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Concentrations of hydrogen (mean of duplicate measurements) detected in excreted breath 
of adult ponies following the administration of wheat flour by stomach tube when 
maintained on the pelleted ration. Tests were repeated on each pony on three occasions.
Tslg (min) = the time at which significant increases in hydrogen (if any) were first noted.
AH2 (ppm) = the peak hydrogen concentration measured during the test period.
Tah2 (min) = the time of peak hydrogen concentration.
AUCghours (ppm x hours) = the total area under the hydrogen excretion curve.
NA = not applicable.
Replicate 1
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 3 1.5 2.5 0.5 0 0.5 0.5
30 2 0.5 1 0 0.5 0 1.5
60 3.5 2 0 2 0.5 0 1
90 2.5 2 2 15 2 0 4
1 2 0 13 2.5 0 37.5 2.5 0 5.5
150 25 5.5 4.5 38.5 24 0 6.5
180 41 4 8.5 46 25.5 0.5 6.5
2 1 0 51 3 5 52.5 23 2 4.5
240 70 3 1 70.5 16.5 3.5 5.5
270 69.5 1 1.5 54 11 3 3.5
300 31 0.5 0.5 2 1 8.5 2 2
330 15 0.5 0 7.5 4 1 2
360 14.5 0 0 8 4 3 2.5
390 13 0 1 6.5 2.5 3 3
420 13.5 0 3 4 2.5 1.5 0.5
450 13 0 3 2.5 2 2 2
480 1 2 0 3 3 1.5 2 2
Tsig (min) 1 2 0 NA 180 90 150 NA 1 2 0
AH2 (ppm) 70 NA 8.5 70.5 25.5 NA 6.5
T a h 2 (min) 240 NA 180 240 180 NA 150
AUCghours 
(ppm x  hours)
192.5 12.625 16.875 183.625 64.875 11.375 25.875
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Replicate 2
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 3 0 0.5 0 1 0.5 4.5
30 3 0 0 0 1 0.5 5.5
60 3 1.5 0 1 2 0 7
90 3 2 2.5 4 3.5 0 4
1 2 0 8 4 3 5.5 2 4 4
150 15.5 3.5 7.5 11 15.5 5 4.5
180 24.5 4.5 7 13 23.5 7 2
2 1 0 21.5 3 1 0 2 2 50.5 11 5
240 30.5 4 13 28.5 93.5 8.5 4
270 17.5 3.5 2 13 111.5 9.5 2.5
300 13 3.5 0 3.5 74.5 6 2.5
330 13.5 2 0.5 0.5 69 5 0.5
360 10.5 1.5 2 0 40 4 0.5
390 11 2.5 2 2 16 4.5 2.5
420 10.5 3 2.5 2 8 5 3.5
450 7.5 2 2 2 7.5 3 5
480 5.5 1 1.5 2 5.5 1.5 4
Tsig (min) 1 2 0 NA 150 1 2 0 150 150 NA
AH2 (ppm) 30.5 NA 13 28.5 111.5 11 NA
Tah2 (min) 240 NA 240 240 270 2 1 0 NA
A U C g h o u r s  
(ppm x hours)
98.375 20.5 27.5 54.5 260.625 37 28.625
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Replicate 3
Pony 123 124 125 126 127 128 129
Time (min) Breath Hydrogen Concentrations (ppm)
0 9 0 5 1.5 2 0 1
30 4.5 0 0.5 2.5 1 0 1
60 4 0.5 1.5 2 7 0.5 1.5
90 29 3 1.5 13 18 2.5 2
1 2 0 39 3 3 29 48.5 7 3
150 40 3 5.5 48 22.5 1 2 5.5
180 39 2.5 2.5 91 56 7 7.5
2 1 0 37.5 1 2 54 5 7 4
240 31.5 0 1 67.5 5 7.5 3.5
270 9.5 1.5 0 69.5 0.5 5.5 4
300 14 0.5 0 23.5 1 3 2.5
330 6.5 0 0 11 3.5 3.5 4
360 1 0 0 0 9 4 3 3.5
390 8.5 0.5 0 5 1 1 3
420 3 0 0 4 0 1 3
450 2 0 0 4 0.5 1 3
480 1 0.5 0.5 4 0.5 0.5 3
Tsig (min) 90 NA NA 90 60 1 2 0 150
AH2 (ppm) 40 NA NA 91 56 1 2 7.5
Tah2 (min) 150 NA NA 180 180 150 180
AUCghours 
(ppm x hours)
141.5 7.875 10.125 217.875 87.375 30.875 26.5
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Concentrations of hydrogen (mean of duplicate measurements) detected in excreted breath 
of adult ponies following the ingestion of a test meal after either no premedication or 
premedication with cisapride or codeine phosphate. Tests were repeated on each pony on 
three occasions.
Tslg (min) = the time at which significant increases in hydrogen (if any) were first noted.
AH2 (ppm) = the peak hydrogen concentration measured during the test period.
Tah2 (min) = the time of peak hydrogen concentration.
AUCghours (ppm x hours) = the total area under the hydrogen excretion curve.
Control (i.e no premedication)
Pony 122 126 129
Replicate 1 2 3 1 2 3 1 2 3
Time (min)
0 5.5 2 1.5 0 0 0 1 2 0
30 4.5 1 0 0 2 0 0 0 0
60 2 0 2.5 0 0 0.5 0.5 0 0
90 8.5 2.5 3 0 1.5 0 0 2.5 0.5
1 2 0 11.5 4.5 1 0.5 1.5 0.5 0 3 0.5
150 11 8 3 2 0 5 1 2.5 5
180 21.5 18.5 6 3 1 6 2.5 5.5 5
2 1 0 1 0 33 7 4.5 0.5 7.5 8.5 5.5 7.5
240 16 76 1 0 6 2 8.5 15 6.5 7.5
270 17 107 10.5 5 4.5 7.5 2 2 15.5 10.5
300 38.5 104 9.5 5.5 6 9.5 24.5 16 4.5
330 35.5 1 2 0 15 3 11 11.5 21.5 18.5 2
360 16 35 10.5 4 1 2 13.5 1 2 12.5 3
390 6 21.5 6 2 1 0 7 6 8.5 1.5
420 2.5 7.5 3 0.5 7.5 4.5 2.5 3 1
450 1 5 2.5 2 6.5 3.5 0.5 4.5 3
480 0 3 1 0 3.5 2 0 3.5 1
Tsig (min) 90 150 180 240 300 150 2 1 0 180 150
AH2 (ppm) 38.5 1 2 0 15 6 1 2 13.5 24.5 18.5 10.5
Tah2 (min) 300 330 330 240 360 360 300 330 270
AUCghours 1 0 2 273 45.5 19 34 43 58.5 53.5 26
(ppm x hours)
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Premedication with cisapride
Pony 1 2 2 126 129
Replicate 1 2 3 1 2 3 1 2 3
Time (min) 
0
30
1
1
13
6
2.5
1.5
0.5
2
0
0.5
3
2
1.5
1
6.5
2.5
1
0
60 2 17 1.5 4.5 3.5 3 2.5 4.5 1
90 3.5 20.5 3.5 4.5 9.5 6 2.5 8 3.5
1 2 0 8.5 35.5 15 6.5 11 5.5 6 13.5 3
150 15.5 36.5 25.5 7 17 4.5 6.5 11 1.5
180 14.5 50.5 28 7 18 3.5 5.5 20.5 2.5
2 1 0 19 48 2 2 11 14 3.5 6 2 1 5
240 34 41 18 1 2 24 2 5 22.5 7.5
270 54 36 26.5 16 25 3.5 9 20.5 11
300 51 32.5 26 23 30 3.5 12.5 19 9
330 32 33 24 25 19 3.5 11 12.5 9
360 27.5 32.5 22.5 17.5 15.5 5 5 10.5 1 0
390 11.5 26 29.5 29 9 4.5 4 7 4
420 1 21.5 27.5 6 5 6 6 6.5 2.5
450 4 17 16.5 3.5 4 5 2 6 1.5
480 4.5 13.5 13 3 3.5 3 2 5.5 0
Tsig (min) 1 2 0 60 1 2 0 1 2 0 90 90 1 2 0 90 2 1 0
AH2 (ppm) 54 50.5 29.5 29 30 6 12.5 22.5 11
T ah2 (min) 270 180 390 390 300 420 300 240 270
A U C g h o u r s  
(ppm x hours)
141 233.5 147.5 8 8 103.5 32 43. 96 36
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Premedication with codeine phosphate
Pony 1 2 2 126 129
Replicate 1 2 3 1 2 3 1 2 3
Time (min)
0 6.5 0.5 0 0 2 0 0 0.5 0
30 5 0 0 0 0 0 0 0.5 0
60 14.5 1 0 0 0 0 0 0.5 0
90 26 3.5 1 2 3 0 0 0 0
1 2 0 18 11.5 7.5 1.5 5 2.5 2.5 2 0.5
150 7 22.5 11 2.5 7.5 4.5 6 3 1.5
180 8.5 2 1 23.5 6 8 11.5 7 7 3
2 1 0 8.5 8.5 3.5 6 7 15.5 8.5 7 4
240 14.5 11.5 5 18.5 6 8.5 7 9 6.5
270 18 12.5 8.5 27.5 7 12.5 8.5 9 5
300 37 13.5 7 40 8 15 5 1 2 5
330 49 23 9 37.5 12.5 15 9.5 9.5 4
360 55.5 20.5 15 2 0 1 2 8.5 16 11.5 3.5
390 35 2 2 24.5 2 1 15 9.5 1 0 15 7
420 73 21.5 30.5 1 2 11.5 6 24.5 18 6.5
450 34 33 35 4 12.5 2.5 2 1 19 5.5
480 26 16 25.5 7.5 14 4.5 17.5 17.5 6
Tsig (min) 60 1 2 0 1 2 0 180 1 2 0 180 150 180 240
AH2 (ppm) 73 33 35 40 15 15.5 24.5 19 7
T a h 2  (min) 420 450 450 300 390 2 1 0 420 450 390
-A U C g h o u r s 2 1 0 117 97 1 0 1 61.5 57 67 6 6 27.5
(ppm x  hours)
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G l o s s a r y
ANOVA analysis of variance
AP alkaline phosphatase
AUC area under curve
AUCghoure area under curve for the eight hour test period
BGC basal glucose concentration
bwt body weight
51Cr 5 Chromium
CIBD chronic inflammatory bowel disease
CV coefficient of variation
EDTA ethylenediaminetetra-acetate
EGE eosinophilic gastroenteritis
GE granulomatous enteritis
GGT gamma-glutamyl transferase
GIT gastrointestinal tract
GLDH glutamate dehydrogenase
GIumax peak glucose concentration
H2 hydrogen
hr hour
L3 cyathostome third stage larvae
MCTT mouth-to-caecum transit time
min minutes
n number of observations
NBT nitroblue tetrazolium
NH3 ammonia
NA not applicable
NAD no abnormality detected
NSAID non-steroidal anti-inflammatory drug
OGTT oral glucose tolerance test
p probability
PI post infection
ppm parts per million
SD standard deviation
G lossary
SI small intestine
SPE serum protein electrophoresis
spp. species
VFA volatile fatty acids
w/v weight over volume
AH2 peak hydrogen excretion
TaH2 time of peak hydrogen excretion
Tsig time at which significant and sustained increases in hydrogen
excretion are detected.
U1ln 11 indium
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